{"title": "PDF", "author": "PDF", "url": "https://apps.legislature.ky.gov/recorddocuments/bill/22RS/hb136/orig_bill.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "UNOFFICIAL COPY 22 RS BR 50 Page 1 of 138 XXXX Jacketed AN ACT relating to medicinal cannabis and making an appropriation therefor. 1 Be it enacted by the General Assembly of the Commonwealth of Kentucky: 2 SECTI ON 1. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 3 READ AS FOLLOWS: 4 For the purposes of Sections 1 to 30 of this Act, unless the context otherwise requires: 5 (1) \"Bona fide practitioner -patient relationship\" means a treating or consulting 6 relationship, during the course of which a medicinal cannabis practitioner: 7 (a) Has completed an initial in -person examination and assessment of the 8 patient's medical history and current medical condition; 9 (b) Has consulted with the patient with respect to the possible medical, 10 therapeutic, and palliative properties of medicinal cannabis; 11 (c) Has advised the patient of the possible risks and side effects associated with 12 the use of medicinal cannabis, including possible interactions between 13 medicinal cannabis and any other drug or medication that the patient is 14 taking at that time; and 15 (d) Has established an expectation that he or she will provide follow -up care 16 and treatment to the patient; 17 (2) \"Cannabis business\" means an entity licensed under this chapter as a cultivator, 18 dispensary, processor, producer, or safety compliance facility; 19 (3) \"Cannabis business agent\" means a principal officer, board member, employee, 20 volunteer, or age nt of a cannabis business; 21 (4) \"Cardholder\" means: 22 (a) A registered qualified patient, designated caregiver, or visiting qualified 23 patient who has applied for, obtained, and possesses a valid registry 24 identification card issued by the department; or 25 (b) A visiting qualified patient who has obtained and possesses a valid out -of- 26 state registry identification card; 27 UNOFFICIAL COPY 22 RS BR 50 Page 2 of 138 XXXX Jacketed (5) \"Cultivator\" means an entity licensed as such under Sections 16, 17, and 18 of 1 this Act; 2 (6) \"Cultivator agent\" means a principal officer, board member, employee, 3 volunteer, or agent of a cultivator; 4 (7) \"Department\" means the Department for Public Health or its successor agency; 5 (8) \"Designated caregiver\" means a person who has registered as such with the 6 department as required by this chapter; 7 (9) \"Dispensary\" means an entity licensed as such under Sections 16, 17, and 18 of 8 this Act; 9 (10) \"Dispensary agent\" means a principal officer, board member, employee, 10 volunteer, or agent of a dispensary; 11 (11) \"Disqualifying felony offense\" means: 12 (a) A felony offense that would classify the person as a violent offender under 13 KRS 439.3401; or 14 (b) A violation of a state or federal controlled substance law that was classified 15 as a felony in the jurisdiction wh ere the person was convicted, except: 16 1. An offense for which the sentence, including any term of probation, 17 incarceration, or supervised release, was completed five (5) or more 18 years earlier; or 19 2. An offense that consisted of conduct for which Sections 1 to 30 of this 20 Act would likely have prevented a conviction, but the conduct either 21 occurred prior to the enactment of Sections 1 to 30 of this Act or was 22 prosecuted by an authority other than the Commonwealth of 23 Kentucky; 24 (12) \"Diversion\" of \"divert\" mean s the act of dispensing, selling, or otherwise 25 transferring possession of medicinal cannabis from a licensed cannabis business 26 or cardholder to any person or entity not authorized under the provisions of 27 UNOFFICIAL COPY 22 RS BR 50 Page 3 of 138 XXXX Jacketed Sections 1 to 30 of this Act to legal possess or use medicinal cannabis; 1 (13) \"Enclosed, locked facility\" means an indoor growing space such as a room, 2 greenhouse, building, or other indoor enclosed area that is maintained and 3 operated by a cultivator or producer and is equipped with locks and other securit y 4 devices that permit only authorized access by agents of the cultivator or producer, 5 as required by the department; 6 (14) \"Gross receipts\" means the total amount or consideration, including cash, credit, 7 property, and services, for which medicinal cannabis is sold, valued in money, 8 whether received in money or otherwise; 9 (15) \"Growth area\" means the same as an enclosed, locked facility; 10 (16) \"Marijuana\" has the same meaning as in Section 37 of this Act; 11 (17) \"Medicinal cannabis\" means marijuana as defined i n Section 37 of this Act 12 when cultivated, harvested, processed, produced, transported, dispensed, 13 distributed, sold, possessed, or used in accordance with Sections 1 to 30 of this 14 Act. The term \"medicinal cannabis\" includes medicinal cannabis products and 15 raw plant material but does not include industrial hemp or industrial hemp 16 products as defined in KRS 260.850; 17 (18) \"Medicinal cannabis accessories\" means any equipment, product, or material of 18 any kind which is used, intended for use, or designed for use in the preparing, 19 storing, using, or consuming medicinal cannabis in accordance with Sections 1 20 to 30 of this Act; 21 (19) \"Medicinal cannabis practitioner\" means a physician or an advanced practice 22 registered nurse who is authorized to prescribe controlled s ubstances under KRS 23 314.042, who is authorized by his or her state licensing board to provide written 24 certifications in accordance with Section 9 of this Act; 25 (20) \"Medicinal cannabis product\" means any compound, manufacture, salt, 26 derivative, mixture, or preparation of any part of the plant Cannabis sp., its seeds 27 UNOFFICIAL COPY 22 RS BR 50 Page 4 of 138 XXXX Jacketed or its resin; or any compound, mixture, or preparation which contains any 1 quantity of these substances when cultivated, harvested, processed, produced, 2 transported, dispensed, distributed, sold, possessed, or used in accordance with 3 Sections 1 to 30 of this Act. The term \"medicinal cannabis product\" does not 4 include industrial hemp products as defined in KRS 260.850; 5 (21) \"Minor\" means a person less than eighteen (18) years of age; 6 (22) \"Out -of-state registry identification card\" means a registry identification card, or 7 an equivalent document, that was issued pursuant to the laws of another state, 8 district, territory, commonwealth, or insular possession of the United States, 9 except that the card mu st be issued for a disease or medical condition that 10 appears on the approved list of qualifying medical conditions created by the 11 department, that allows the person to use medicinal cannabis in the jurisdiction 12 of issuance; 13 (23) \"Pharmacist\" means the same as in KRS 315.010; 14 (24) \"Processor\" means an entity licensed as such under Sections 16, 17, and 18 of 15 this Act; 16 (25) \"Processor agent\" means a principal officer, board member, employee, 17 volunteer, or agent of a processor; 18 (26) \"Producer\" means an entity l icensed as such under Sections 16, 17, and 18 of 19 this Act; 20 (27) \"Producer agent\" means a principal officer, board member, employee, volunteer, 21 or agent of a producer; 22 (28) \"Qualified patient\" means a person who has obtained a written certification from 23 a m edicinal cannabis practitioner with whom he or she has a bona fide 24 practitioner -patient relationship; 25 (29) \"Qualifyin g medical condition\" means a disease or medical condition that 26 appears on the approved list of qualifying medical conditions for which a 27 UNOFFICIAL COPY 22 RS BR 50 Page 5 of 138 XXXX Jacketed medicinal cannabis practitioner may provide a patient with a written certification 1 for the use of medicinal cannabis es tablished by the department pursuant Section 2 28 of this Act; 3 (30) \"Raw plant material\" means the trichome -covered part of the female plant 4 Cannabis sp. or any mixture of shredded leaves, stems, seeds, and flowers of the 5 Cannabis sp. plant. The term \"raw pl ant material\" does not include plant 6 material obtained from industrial hemp as defined in KRS 260.850; 7 (31) \"Registered qualified patient\" means a qualified patient who has applied for, 8 obtained, and possesses a valid registry identification card or provis ional 9 licensure receipt issued by the department; 10 (32) \"Registry identification card\" means a document issued by the department that 11 identifies a person as a registered qualified patient, visiting qualified patient, or 12 designated caregiver; 13 (33) \"Safety co mpliance facility\" means an entity licensed as such under Sections 16, 14 17, and 18 of this Act; 15 (34) \"Safety compliance facility agent\" means a principal officer, board member, 16 employee, volunteer, or agent of a safety compliance facility; 17 (35) \"Seedling\" m eans a medicinal cannabis plant that has no flowers and is not 18 taller than eight (8) inches; 19 (36) \"Serious violation\" means: 20 (a) Any violation of Sections 1 to 30 of this Act or any administrative regulation 21 promulgated thereunder that is capable of causin g death or which causes 22 serious and prolonged disfigurement, prolonged impairment of health, or 23 prolonged loss or impairment of the function of any bodily organ; 24 (b) Diversion of medicinal cannabis; or 25 (c) Any act that would constitute a violation of Secti on 38 of this Act; 26 (37) \"Smoking\" means the inhalation of smoke produced from the combustion of raw 27 UNOFFICIAL COPY 22 RS BR 50 Page 6 of 138 XXXX Jacketed plant material when ignited by a flame; 1 (38) \"State licensing board\" means, respectively: 2 (a) The Kentucky Board of Medical Licensure; or 3 (b) The Kentucky B oard of Nursing; 4 (39) \"Telehealth\" has the same meaning as in KRS 211.332; 5 (40) \"Use of medicinal cannabis\" includes the acquisition, administration, 6 possession, transfer, transportation, or consumption of medicinal cannabis or 7 medicinal cannabis accessori es by a cardholder in accordance with Sections 1 to 8 30 of this Act. The term \"use of medicinal cannabis\" does not include: 9 (a) Cultivation of marijuana by a cardholder; or 10 (b) The use or consumption of marijuana by smoking; 11 (41) \"Visiting qualified patient \" means a person who has registered as such through 12 the department as required under Section 11 of this Act or who possesses a valid 13 out-of-state registry identification card; and 14 (42) \"Written certification\" means a document dated and signed by a medicina l 15 cannabis practitioner, that: 16 (a) States, that in the medicinal cannabis practitioner's professional medical 17 opinion, the patient may receive medical, therapeutic, or palliative benefit 18 from the use of medicinal cannabis; 19 (b) Specifies the qualifying medi cal condition or conditions for which the 20 medicinal cannabis practitioner believes that the patient may receive 21 medical, therapeutic, or palliative benefit; and 22 (c) Affirms that the medicinal cannabis practitioner has a bona fide 23 practitioner -patient relat ionship with the patient. 24 SECTION 2. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 25 READ AS FOLLOWS: 26 (1) Nothing in Sections 1 to 30 of this Act shall be construed as applying to industrial 27 UNOFFICIAL COPY 22 RS BR 50 Page 7 of 138 XXXX Jacketed hemp or industrial hemp produ cts as defined in KRS 260.850. 1 (2) Notwithstanding any provision of law to the contrary: 2 (a) The use of medicinal cannabis by a cardholder shall be considered lawful if 3 done in accordance with Sections 1 to 30 of this Act and any administrative 4 regulations promulgated thereunder; 5 (b) The acquisition, blending, cultivation, delivery, distribution, 6 manufacturing, manipulation, packaging for sale, preparation, possession, 7 sale, testing, transportation, or transfer of medici nal cannabis or medicinal 8 cannabis accessories by a cannabis business or cannabis business agent 9 shall be considered lawful if done in accordance with Sections 1 to 30 of 10 this Act and any administrative regulations promulgated thereunder; 11 (c) A registered qualified patient or visiting qualified patient shall not be 12 considered to be under the influence of medicinal cannabis solely because 13 of the presence of tetrahydrocannabinol metabolites, including but not 14 limited to the cannabinoid carboxy THC which is al so known as THC - 15 COOH; 16 (d) A medicinal cannabis practitioner shall not be subject to arrest, 17 prosecution, or penalty in any manner, or denied any right or privilege, 18 including but not limited to a civil penalty or disciplinary action by a state 19 licensing bo ard or by any other occupational or professional licensing 20 board, solely for providing written certifications or for otherwise stating 21 that, in the medicinal cannabis practitioner's professional opinion, a patient 22 may receive medical, therapeutic, or palli ative benefit from the use of 23 medicinal cannabis, if done in accordance with Sections 1 to 30 of this Act; 24 (e) A pharmacist shall not be subject to arrest, prosecution, or penalty in any 25 manner, or denied any right or privilege, including but not limited t o a civil 26 penalty or disciplinary action by the Kentucky Board of Pharmacy or by any 27 UNOFFICIAL COPY 22 RS BR 50 Page 8 of 138 XXXX Jacketed other professional licensing board, solely for consulting with or providing 1 information with respect to the possible risks or side effects of medicinal 2 cannabis, including any potentially harmful or dangerous interactions 3 between medicinal cannabis and any other drug; 4 (f) An attorney shall not be subject to arrest, prosecution, or penalty in any 5 manner, or denied any right or privilege, including but not limited to a civil 6 penalty or disciplinary action by the Kentucky Court of Justice, the 7 Kentucky Bar Association, or any other professional licensing board, solely 8 for providing an individual or cannabis business with legal assistance 9 related to activity that is no longer su bject to criminal penalties under state 10 law pursuant to Sections 1 to 30 of this Act; and 11 (g) No person shall be subject to arrest, prosecution, or penalty in any manner, 12 or denied any right or privilege, including but not limited to a civil penalty 13 or dis ciplinary action by an occupational or professional licensing board, 14 solely for providing assistance or services, including but not limited to 15 accounting services, financial services, security services, or business 16 consulting services, to any individual or cannabis business related to 17 activity that is no longer subject to criminal penalties under state law 18 pursuant to Sections 1 to 30 of this Act. 19 (3) Nothing in subsection (2)(d) to (g) of this section shall be interpreted to prohibit 20 the arrest, prosecutio n, or imposition of any other penalty arising from but not 21 limited to breach of contract, breach of fiduciary duty, negligence, or engaging in 22 criminal activity that would constitute a felony or misdemeanor. 23 (4) A registered qualified patient who is injure d or defrauded, including by theft or 24 deprivation of the use and benefit of any money, personal property including 25 medicinal cannabis, or articles of value of any kind, by his or her designated 26 caregiver shall have a civil cause of action in Circuit Court to recover the actual 27 UNOFFICIAL COPY 22 RS BR 50 Page 9 of 138 XXXX Jacketed damages sustained, together with the costs of the lawsuit, including reasonable 1 fee for the individual's attorney of record. 2 SECTION 3. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 3 READ AS FOLLOW S: 4 (1) The Division of Medicinal Cannabis is hereby established within the Department 5 for Public Health and is charged with the implementation, operation, oversight, 6 and regulation of the medicinal cannabis program established in Sections 1 to 30 7 of this A ct. 8 (2) The Board of Physicians and Advisors is hereby established within the Division 9 of Medicinal Cannabis which shall consist of the following members: 10 (a) Five (5) physicians selected by the commissioner of the department from a 11 list of ten (10) physic ians who are authorized, pursuant to Section 9 of this 12 Act, to provide written certifications for the use of medicinal cannabis 13 submitted by the Kentucky Board of Medical Licensure and who are 14 certified by the appropriate board in one (1) of the following specialties: 15 1. Addiction medicine; 16 2. Anesthesiology; 17 3. Gastroenterology; 18 4. Obstetrics and gynecology; 19 5. Ophthalmology; 20 6. Optometry; 21 7. Infectious disease; 22 8. Neurology; 23 9. Oncology; 24 10. Pain management; 25 11. Pain medicine; 26 12. Pediatrics; 27 UNOFFICIAL COPY 22 RS BR 50 Page 10 of 138 XXXX Jacketed 13. Physical medicine and rehabilitation; or 1 14. Psychiatry. 2 One (1) of the physicians appointed to the board pursuant to this paragraph 3 shall be designated by the commissioner to serve as chairperson; 4 (b) Three (3) advanced practice registered nurses selected by the commissioner 5 of the department from a list of six (6) advanced practice registered nurses 6 who are authorized, pursuant to Section 9 of this Act, to provide written 7 certifications for the use of medicinal cannabis submitted by the Kentucky 8 Board of Nursing; 9 (c) One (1) pharmacist selected by the commissioner of the department from a 10 list of four (4) pharmacists submitted by the Kentucky Board of Pharmacy 11 and who is authorized pursuant to Section 1 0 of this Act to provide 12 medicinal cannabis consultation services; 13 (d) Six (6) patient advocates selected by the commissioner of the department; 14 (e) The commissioner of the department, who shall serve as a non -voting ex 15 officio member; and 16 (f) The director of the Division of Medicinal Cannabis, who shall serve as a 17 non-voting ex officio member. 18 (3) The members of the Board of Physicians and Advisors appointed by the 19 commissioner shall: 20 (a) Serve for a term of four (4) years and until their successors are ap pointed, 21 except that the term for members appointed to fill the initial appointments 22 after the effective date of this section shall be as follows: 23 1. Five (5) members shall be appointed for a term of two (2) years; 24 2. Five (5) members shall be appointed fo r a term of three (3) years; 25 3. Five (5) members shall be appointed for a term of four (4) years; and 26 4. The respective terms of the first members shall be designated by the 27 UNOFFICIAL COPY 22 RS BR 50 Page 11 of 138 XXXX Jacketed commissioner at the time of their appointment; 1 (b) Be eligible for reappointment; and 2 (c) Serve without compensation, but each member of the board not otherwise 3 compensated for his or her time or expenses shall be entitled to 4 reimbursement for his or her actual and necessary expenses in carrying out 5 his or her duties with reimbursement for expenses being made in 6 accordance with administrative regulations relating to travel expenses. 7 (4) The Board of Physicians and Advisors shall not be subject to reorganization 8 under KRS Chapter 12. 9 (5) The Board of Physicians and Advisors shall: 10 (a) Review and recommend to the department an approved list of qualifying 11 medical conditions for which a medicinal cannabis practitioner may provide 12 a patient with a written certification; 13 (b) Accept and review petitions to add diseases or medical conditions to t he 14 approved list of qualifying medical conditions for which a medicinal 15 cannabis practitioner may provider a patient with a written certification; 16 (c) Review and recommend to the department medicinal cannabis dosing 17 guidelines to be used by medicinal canna bis practitioners when providing 18 patients with medicinal cannabis dosing recommendations; 19 (d) Convene at least twice per year to conduct public hearings and to evaluate 20 petitions, which shall be maintained as confidential pursuant to subsection 21 (7) of this section, for the purpose of adding diseases or medical conditions 22 to the approved list of qualifying medical conditions for which a medicinal 23 cannabis practitioner may provide a patient with a written certification; 24 (e) Review and recommend to the departm ent protocols for determining: 25 1. The amount of medicinal cannabis or delta -9 tetrahydrocannabinol 26 that constitutes: 27 UNOFFICIAL COPY 22 RS BR 50 Page 12 of 138 XXXX Jacketed a. A ten (10) day maximum allowance of medicinal cannabis and a 1 thirty (30) day maximum allowance of medicinal cannabis for 2 registered qual ified patients and visiting qualified patients who 3 are over eighteen (18) years of age; and 4 b. A ten (10) day maximum allowance of medicinal cannabis and a 5 thirty (30) day maximum allowance of medicinal cannabis for 6 registered qualified patients who are un der eighteen (18) years of 7 age; and 8 2. The amount of raw plant material that medicinal cannabis products 9 are considered to be equivalent to; 10 (f) Review and recommend to the department evolving continuous quality 11 improvement metrics and minimal performance standards for the biennial 12 accreditation process of licensed cannabis businesses; 13 (g) Review relevant scientific data related to the delta -9 tetrahydrocannabinol 14 content limits established in subsection (2)(b) of Section 19 of this Act and 15 make recom mendations to the General Assembly regarding revisions to the 16 limits as the board deems appropriate; 17 (h) Review relevant scientific data related to the various methods of use and 18 consumption of medicinal cannabis and make recommendations to the 19 General Ass embly to approve or restrict certain methods as the board deems 20 appropriate; and 21 (i) Perform other duties related to the use of medicinal cannabis upon request 22 by the commissioner of the department or the director of the Division of 23 Medicinal Cannabis. 24 (6) When, in accordance with paragraphs (a) to (c) of subsection 5 of this section, 25 the Board of Physicians and Advisors considers which diseases and medical 26 conditions to recommend to the department for inclusion on the approved list of 27 UNOFFICIAL COPY 22 RS BR 50 Page 13 of 138 XXXX Jacketed qualifying medical co nditions for which a medicinal cannabis practitioner may 1 provider a patient with a written certification, the board shall prioritize 2 consideration of, but not limit their consideration to, end -of-life conditions and 3 terminal diseases as defined in KRS 217. 5401. 4 (7) The department shall promulgate administrative regulations, in accordance with 5 KRS Chapter 13A, to implement the provisions of this subsection, including but 6 not limited to the process by which petitions to add diseases or medical conditions 7 to the approved list of qualifying medical conditions for which a medicinal 8 cannabis practitioner may provide a patient with a written certification shall be 9 received, reviewed, and considered. Administrative regulations promulgated 10 pursuant to this subsection shall require that any individually identifiable health 11 information contained in a petition received by the department, the Division of 12 Medicinal Cannabis, or the Board of Physicians and Advisors shall be 13 confidential and shall not be subject to disclosur e under the Open Records Act, 14 KRS 61.870 to 61.884. 15 (8) No later than December 1 of each year beginning in 2023, the department, in 16 consultation with the University of Kentucky, College of Medicine shall submit 17 an annual report to the Legislative Research Commission. The report submitted 18 by the department shall, at a minimum, include: 19 (a) The number of applications and renewals received by the department for 20 registry identification cards for registered qualified patients, visiting 21 qualified patients, and de signated caregivers, individually and collectively; 22 (b) The number of applications and renewals for registry identification cards 23 that were approved and denied by the department; 24 (c) The number of registry identification cards revoked by the department for 25 misconduct and the nature of the misconduct; 26 (d) The number of physicians and advanced practice registered nurses 27 UNOFFICIAL COPY 22 RS BR 50 Page 14 of 138 XXXX Jacketed authorized pursuant to Section 9 of this Act to provide written certifications; 1 (e) The number of pharmacists authorized pursuant to Section 10 of this Act to 2 provide consultation to cardholders; 3 (f) The nature of the qualifying medical conditions for which medicinal 4 cannabis practitioners have provided written certifications; 5 (g) The number of applications and renewals received by the departme nt for 6 cannabis business licenses; the number of cannabis business licenses issued 7 for each business type and tier; and the number of cannabis business 8 license applications and renewals that were denied by the department; 9 (h) The number of cannabis busines s agents associated with each type of 10 cannabis business; 11 (i) An assessment of: 12 1. The ability of cardholders in all areas of the state to obtain timely and 13 affordable access to medicinal cannabis; 14 2. The evolving continuous quality improvement metrics and minimal 15 performance standards for the biennial accreditation process of 16 licensed cannabis businesses developed by the department pursuant to 17 Section 28 of this Act; 18 3. The effectiveness of the cultivators, processors, and producers licensed 19 under this chap ter, individually and collectively, in serving the needs 20 of processors, dispensaries, and cardholders, and whether they are 21 generating any complaints or security problems; 22 4. The effectiveness of the dispensaries licensed under this chapter, 23 individually a nd collectively, in serving the needs of cardholders, 24 including the provision of educational and support services, and 25 whether they are generating any complaints or security problems; 26 5. The effectiveness of the safety compliance facilities licensed under this 27 UNOFFICIAL COPY 22 RS BR 50 Page 15 of 138 XXXX Jacketed chapter, individually and collectively, in serving the needs of other 1 cannabis businesses, including the provision of testing and training 2 services, and whether they are generating any complaints or security 3 problems; and 4 6. The sufficiency of the reg ulatory and security safeguards contained in 5 Sections 1 to 30 of this Act and adopted by the department through 6 administrative regulations to ensure that access to and use of 7 medicinal cannabis cultivated and processed in this state is provided 8 only to car dholders; 9 (j) The profits and expenditures by cannabis businesses, individually and 10 collectively; 11 (k) The amount of medicinal cannabis sold per month in the Commonwealth; 12 (l) The total amount of revenue generated from cannabis business licensure 13 and cardho lder fees for each calendar year and aggregated by prior years; 14 (m) The total amount of revenue generated by the excise tax established in 15 Section 33 of this Act; 16 (n) The total cost of enforcement for the medicinal cannabis program at the 17 time of the repor t, by city, county, and overall; 18 (o) Any recommended additions or revisions to Sections 1 to 30 of this Act or 19 administrative regulations promulgated thereunder, including those 20 relating to security, safe handling, labeling, and nomenclature; 21 (p) Any recommendations for changes to the approved list of qualifying 22 medical conditions for which a medicinal cannabis practitioner may provide 23 a patient with a written certification and the rationale for those 24 recommendations; 25 (q) The results of any peer -reviewed, scientific research studies regarding the 26 health effects of cannabis; and 27 UNOFFICIAL COPY 22 RS BR 50 Page 16 of 138 XXXX Jacketed (r) Any other data requested by the Legislative Research Commission relating 1 to the medicinal cannabis program and Sections 1 to 30 of this Act. 2 (9) The department shall prov ide the University of Kentucky, College of Medicine 3 with all information necessary to allow collaboration with the department on the 4 preparation of this report. The University of Kentucky, College of Medicine may 5 also produce its own report regarding the m edicinal cannabis program 6 established in Sections 1 to 30 of this Act which, if produced, shall be submitted 7 to the Legislative Research Commission upon completion. 8 (10) The information contained in the report described in subsection (8) of this section 9 shall be presented in a manner that does not disclose any identifying information 10 about cardholders or licensed cannabis businesses. 11 (11) (a) Nothing in Sections 1 to 30 of this Act shall require the department to 12 assume duties in relation to the medicinal c annabis program that are more 13 than administrative in nature if federal law or a current and clear directive 14 from the federal government indicates that duties assumed by the 15 department that are more than administrative could result in the loss of 16 federal fu nds, federal prosecution, or invalidation of the medicinal 17 cannabis program established in Sections 1 to 30 of this Act. 18 (b) If the department makes a determination that it is required by Sections 1 to 19 30 of this Act to conduct duties that are more than ad ministrative in nature, 20 then it shall continue to conduct duties that are administrative in nature 21 and designate or enter into a contract with, in accordance with KRS 22 Chapter 45A, a qualified nongovernmental entity to conduct any duties 23 required by Section s 1 to 30 of this Act that are more than administrative in 24 nature. A nongovernmental entity contracted pursuant to this paragraph 25 shall not own, in whole or in part, any cannabis business in this state or any 26 other, or be owned, in whole or in part, by any cannabis business in this 27 UNOFFICIAL COPY 22 RS BR 50 Page 17 of 138 XXXX Jacketed state or any other. The department may reimburse the state for any costs 1 involved in working with outside consultants to implement the program. 2 SECTION 4. A NEW SECTION OF KRS CHAPTER 218A IS C REATED TO 3 READ AS FOLLOWS: 4 (1) A registered qualified patient, except as provided in subsection (2) of this section, 5 shall not be subject to arrest, prosecution, or denial of any right or privilege, 6 including but not limited to a civil penalty or disciplin ary action by a court or 7 occupational or professional licensing board, for the use of medicinal cannabis, 8 if the registered qualified patient does not possess more than: 9 (a) The thirty (30) day maximum allowance of medicinal cannabis, as 10 established by the department pursuant to Section 28 of this Act, at his or 11 her residence; or 12 (b) The ten (10) day maximum allowance of medicinal cannabis, as established 13 by the department pursuant to Section 28 of this Act, on his or her person, 14 except that an amount great er than the ten (10) day maximum allowance 15 may be transported by a registered qualified patient from a dispensary 16 directly to his or her residence if the medicinal cannabis is contained in a 17 sealed package that requires at least a two (2) step process for initial 18 opening. 19 (2) A registered qualified patient who is under eighteen (18) years of age shall not be 20 permitted to possess, purchase, or acquire medicinal cannabis and shall only 21 engage in the use of medicinal cannabis with the assistance of a designate d 22 caregiver. 23 (3) A visiting qualified patient shall not be subject to arrest, prosecution, or denial of 24 any right or privilege, including but not limited to civil penalty or disciplinary 25 action by a court or occupational or professional licensing board, fo r the use of 26 medicinal cannabis, if the visiting qualified patient does not possess more than an 27 UNOFFICIAL COPY 22 RS BR 50 Page 18 of 138 XXXX Jacketed amount of medicinal cannabis determined by the department to constitute the ten 1 (10) day maximum allowance of medicinal cannabis, as established by the 2 departm ent pursuant to Section 28 of this Act, on his or her person. 3 (4) A designated caregiver shall not be subject to arrest, prosecution, or denial of any 4 right or privilege, including but not limited to civil penalty or disciplinary action 5 by a court or occup ational or professional licensing board, for: 6 (a) Assisting a registered qualified patient to whom the designated caregiver is 7 connected through the department's registration process with the use of 8 medicinal cannabis if the designated caregiver does not p ossess more than: 9 1. The thirty (30) day maximum allowance of medicinal cannabis, as 10 established by the department pursuant to Section 28 of this Act, at his 11 or her residence for each registered qualified patient to whom the 12 caregiver is connected through the department's registration process; 13 or 14 2. The ten (10) day maximum allowance of medicinal cannabis, as 15 established by the department pursuant to Section 28 of this Act, on 16 his or her person for each registered qualified patient to whom the 17 caregiver is connected through the department's registration process, 18 except that an amount greater than he ten (10) day maximum 19 allowance may be transported by a designated caregiver from a 20 dispensary directly to his or her residence if the medicinal cannabis is 21 conta ined in a sealed package that requires at least a two (2) step 22 process for initial opening; or 23 (b) Receiving reimbursement for documented expenses associated with 24 assisting a registered qualified patient in the use of medicinal cannabis if 25 the designated c aregiver is connected to the registered qualified patient 26 through the department's registration process. 27 UNOFFICIAL COPY 22 RS BR 50 Page 19 of 138 XXXX Jacketed (5) (a) All medicinal cannabis possessed by a cardholder in accordance with 1 subsections (1), (2), (3), and (4) of this section shall be kept in the ori ginal 2 container in which the cardholder received the medicinal cannabis from a 3 dispensary. 4 (b) An individual who violates paragraph (a) of this subsection may be fined up 5 to one hundred dollars ($100) per violation. 6 (6) Notwithstanding subsections (1), (3) , and (4) of this section: 7 (a) A registered qualified patient shall not be permitted to purchase more 8 medicinal cannabis than the thirty (30) day maximum allowance of 9 medicinal cannabis, as determined by the department pursuant to Section 10 28 of this Act, d uring a given twenty -five (25) day period; 11 (b) A designated caregiver shall not be permitted to purchase more medicinal 12 cannabis than the thirty (30) day maximum allowance of medicinal 13 cannabis, as determined by the department pursuant to Section 28 of thi s 14 Act, for each registered qualified patient to whom the caregiver is connected 15 through the department's registration process during a given twenty -five 16 (25) day period; and 17 (c) 1. A visiting qualified patient who has applied for and obtained a registry 18 identification card issued by the department shall not be permitted to 19 purchase more medicinal cannabis than the ten (10) day maximum 20 allowance of medicinal cannabis, as determined by the department 21 pursuant to Section 28 of this Act, during a given eight (8 ) day period. 22 2. A visiting qualified patient who has not applied for and obtained a 23 registry identification card issued by the department but possesses a 24 valid out -of-state registry identification card shall not be permitted to 25 purchase medicinal cannabis is this state more than once per calendar 26 year and shall not be permitted to purcha se more medicinal cannabis 27 UNOFFICIAL COPY 22 RS BR 50 Page 20 of 138 XXXX Jacketed than the ten (10) day maximum allowance of medicinal cannabis, as 1 determined by the department pursuant to Section 28 of this Act. 2 (7) A cardholder shall not be subject to arrest, prosecution, or denial of any right or 3 privilege, including but not limited to a civil penalty or disciplinary action by a 4 court or occupational or professional licensing board, for: 5 (a) Possession of medicinal cannabis that is incidental to the use of medicinal 6 cannabis; 7 (b) Possession of medicinal cann abis accessories; or 8 (c) Transferring medicinal cannabis to a safety facility for testing. 9 (8) No person shall be subject to arrest, prosecution, or denial of any right or 10 privilege, including but not limited to a civil penalty or disciplinary action by a 11 court or occupational or professional licensing board, solely for: 12 (a) Selling medicinal cannabis accessories to a cardholder, who is over 13 eighteen (18) years of age, upon presentation of a valid registry 14 identification card issued by the department or, fo r a visiting qualified 15 patient, a valid out -of-state registry identification card; 16 (b) Being in the presence or vicinity of the use of medicinal cannabis; or 17 (c) Assisting a registered qualified patient or visiting qualified patient with 18 using or administe ring medicinal cannabis. For purposes of illustration and 19 not limitation, this includes preparing raw plant material or brewing tea for 20 a registered qualified patient or visiting qualified patient. This does not 21 include providing medicinal cannabis to a pa tient that the patient did not 22 already possess. 23 SECTION 5. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 24 READ AS FOLLOWS: 25 (1) (a) Any medicinal cannabis, medicinal cannabis accessories, lawful property, 26 or interest in lawful property that is possessed, owned, or used in connection 27 UNOFFICIAL COPY 22 RS BR 50 Page 21 of 138 XXXX Jacketed with the use of medicinal cannabis or acts incidental to that use, shall not 1 subject to seizure or forfeiture under KRS 218A.405 to 218A.460. 2 (b) Sections 1 to 30 of this Act shall not prevent the seizure or forfeiture of 3 marijuana exceeding the amounts allowed under Section 4 of this Act nor 4 shall it prevent seizure or forfeiture if the basis for that action is unrelated 5 to the use of medicinal cannabis in accordance with Sections 1 to 30 of t his 6 Act and any administrative regulation promulgated thereunder. 7 (2) Possession of, or application for, a registry identification card, an out -of-state 8 registry identification card, or cannabis business license shall not constitute 9 probable cause or reaso nable suspicion, nor shall it be used to support the search 10 of the person, property, or home of the person possessing or applying for the 11 registry identification card, an out -of-state registry identification card, or 12 cannabis business license. The possessi on of, or application for, a registry 13 identification card, an out -of-state registry identification card, or cannabis 14 business license shall not preclude the existence of probable cause or reasonable 15 suspicion if probable cause or reasonable suspicion exist s on other grounds. 16 (3) (a) There shall be a rebuttable presumption that a cardholder is engaged in the 17 lawful use of medicinal, or in the case of a designated caregiver, assisting 18 with the lawful use of medicinal cannabis, if the cardholder: 19 1. Possesses a valid registry identification card or, in the case of a 20 visiting qualified patient, a valid out -of-state registry identification 21 card; and 22 2. Possesses an amount of medicinal cannabis that does not exceed the 23 amount the cardholder is permitted to possess under Section 4 of this 24 Act. 25 (b) This presumption may be rebutted by a preponderance of evidence that 26 conduct was unrelated to the use of medicinal cannabis or was otherwise in 27 UNOFFICIAL COPY 22 RS BR 50 Page 22 of 138 XXXX Jacketed violation of Sections 1 to 30 of this Act. 1 SECTION 6. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 2 READ AS FOLLOWS: 3 (1) Sections 1 to 30 of this Act do not authorize any person to engage in, and shall 4 not prevent the imposition of any civil, criminal, or other penalties, including but 5 not limit ed to criminal prosecution or disciplinary action by the department or an 6 occupational or professional licensing board, for engaging in, the following 7 conduct: 8 (a) Operating, navigating, or being in actual physical control of any aircraft, 9 vehicle, vessel, or any other device known, or hereafter invented, that is 10 powered by machinery and that is or may be used to transport persons or 11 property while under the influence of medicinal cannabis; 12 (b) Consuming medicinal cannabis while operating, navigating, or be ing in 13 actual physical control of an aircraft, vehicle, vessel, or any other device 14 known, or hereafter invented, that is powered by machinery and that is or 15 may be used to transport persons or property; 16 (c) Possessing medicinal cannabis that is within the operator's arm's reach or 17 that is not contained in a package that requires at least a two (2) step 18 process for initial opening, in accordance with administrative regulations 19 promulgated pursuant to subsection (1)(c)12.a. of Section 28 of this Act, 20 while o perating, navigating, or being in actual physical control of an 21 aircraft, vehicle, vessel, or any other device known, or hereafter invented, 22 that is powered by machinery and that is or may be used to transport 23 persons or property; 24 (d) Undertaking any task under the influence of medicinal cannabis, when 25 doing so would constitute negligence or professional malpractice; 26 (e) Possessing medicinal cannabis, or otherwise engaging in the use of 27 UNOFFICIAL COPY 22 RS BR 50 Page 23 of 138 XXXX Jacketed medicinal cannabis: 1 1. On the grounds of any preschool or primary or secondary school, 2 except as permitted in accordance with policies enacted pursuant to 3 subsection (4)(c) of Section 8 of this Act; 4 2. In any correctional facility; or 5 3. On any property of the federal government ; 6 (f) Using marijuana, if that person is not a registered qualified patient or 7 visiting qualified patient; 8 (g) Using or consuming marijuana by smoking; or 9 (h) Cultivating marijuana unless that person is licensed by the department as a 10 cannabis cultivator o r cannabis producer pursuant to Sections 16, 17, and 11 18 of this Act or is a cultivator or producer agent. 12 (2) Sections 1 to 30 of this act shall not prevent enforcement of current laws 13 pertaining to the operation of any aircraft, vehicle, or vessel includi ng under KRS 14 Chapters 183, 189, 189A, and 235. 15 (3) If a cardholders violates subsection (1)(a) or (b) of this section, in addition to 16 penalties that may be imposed under KRS Chapters 183, 189, 189A, or 235, the 17 cardholder's registry identification card sha ll be revoked. 18 (4) (a) An individual who violates subsection (1)(g) of this section shall not be 19 considered to be in possession of medicinal cannabis or engaged in the use 20 of medicinal cannabis and may not benefit from the legal protections 21 afforded by Sec tions 1 to 30 of this Act. 22 (b) The odor or smell of medicinal cannabis shall not constitute conclusive 23 evidence of use or consumption of medicinal cannabis by smoking. 24 (c) Notwithstanding paragraph (a) of this subsection: 25 1. If an individual uses or consum es marijuana by smoking while on any 26 form of public transportation, in any public place as defined in KRS 27 UNOFFICIAL COPY 22 RS BR 50 Page 24 of 138 XXXX Jacketed 525.010, or in any place of public accommodation, resort, or 1 amusement as defined in KRS 344.130: 2 a. The department may suspend or revoke the individu al's registry 3 identification card; and 4 b. The individual may be subject to prosecution under Section 39 of 5 this Act. 6 2. If an individual violates subsection (1)(g) of this section by using or 7 consuming marijuana by smoking on residential property owned or 8 leased by that individual or with the permission of the owner or lessee 9 of the residential property on which the violation occurred, the penalty 10 shall be a fine of not more than one hundred dollars ($100) per 11 violation. 12 (5) As used in this section: 13 (a) \"Aircraft\" has the same meaning as in KRS 183.011; 14 (b) \"Vehicle\" has the same meaning as in KRS 189.010; and 15 (c) \"Vessel\" has the same meaning as in KRS 235.010. 16 SECTION 7. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 17 READ AS FOLLOWS: 18 (1) Nothing in Sections 1 to 30 of this Act shall: 19 (a) Require an employer to permit or accommodate the use, consumption, 20 possession, transfer, display, transportation, distribution, sale, or growing 21 of medicinal cannabis in the workplace; 22 (b) Prohibit an employer from implementing policies promoting workplace 23 health and safety by: 24 1. Restricting the use of medicinal cannabis by employees; or 25 2. Restricting or prohibiting the use of equipment, machinery, or power 26 tools by an employee who is a registered qualified patient, if the 27 UNOFFICIAL COPY 22 RS BR 50 Page 25 of 138 XXXX Jacketed employer believes that the use of such equipment, machinery, or 1 power tools by an employee who is a registered qualified patient poses 2 an unreasonable safety risk; 3 (c) Prohibit an employer fr om including in any contract, provisions that 4 prohibit the use of medicinal cannabis by employees; 5 (d) Subject an employer to liability for wrongful discharge or discrimination; 6 (e) Except as provided in Section 8 of this Act, prohibit a person, employer, 7 corporation, or any other entity who occupies, owns, or controls a property 8 from prohibiting or otherwise regulating the use, consumption, possession, 9 transfer, display, transportation, sale, or growing of medicinal cannabis on 10 or in that property; or 11 (f) Prohibit an employer from establishing and enforcing a drug testing policy, 12 drug -free workplace, or zero -tolerance drug policy. 13 (2) An employee who is discharged from employment for consuming medicinal 14 cannabis in the workplace, working while under the inf luence of medicinal 15 cannabis, or testing positive for a controlled substance shall not be eligible to 16 receive benefits under KRS Chapter 341 if such actions are in violation of an 17 employment contract or established personnel policy. 18 (3) An employer shall n ot be penalized or denied any benefit under state law for 19 employing a cardholder. 20 SECTION 8. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 21 READ AS FOLLOWS: 22 (1) Except as provided in Section 7 of this Act, the lawful us e of medicinal cannabis 23 by a cardholder is equivalent to the authorized use of any other medication used 24 at the direction of a practitioner, shall not constitute the use of an illicit 25 substance, and shall not constitute an acceptable basis for disqualifyin g a 26 cardholder from any rights or privileges that he or she may otherwise be entitled 27 UNOFFICIAL COPY 22 RS BR 50 Page 26 of 138 XXXX Jacketed to, including those guaranteed under KRS Chapter 344. 1 (2) A cardholder otherwise entitled to custody of or visitation time or parenting time 2 with a minor child shall not be denied that right, and there shall be no 3 presumption of dependency, neglect, or abuse, for conduct permitted under 4 Sections 1 to 30 of this Act unless the person's actions in relation to medicinal 5 cannabis create a danger that is not in the best interes t of the safety of the minor 6 child as established by clear and convincing evidence. 7 (3) (a) For the purposes of medical care, including organ transplants, a patient's 8 authorized use of medicinal cannabis is the equivalent of the authorized use 9 of any other medication used at the direction of a practitioner, and shall not 10 constitute the use of an illicit substance or otherwise disqualify a patient 11 from needed medical care. 12 (b) A health facility as defined in KRS 216B.015 may develop policies to allow a 13 patie nt who is a registered qualified patient or visiting qualified patient to 14 use medicinal cannabis on the premises of the health facility. 15 (4) (a) A school shall not refuse to enroll, or otherwise penalize, a person solely for 16 his or her status as a cardhold er, unless failing to do so would violate 17 federal law or regulations and cause the school to lose a monetary or 18 licensing -related benefit under federal law or regulations. 19 (b) A school shall not be penalized or denied any benefit under state law for 20 enroll ing a cardholder. 21 (c) Each local board of education and each board of directors of a public 22 charter school shall, within ninety (90) days after the effective date of this 23 section, establish policies to permit a pupil who is a registered qualified 24 patient t o consume medicinal cannabis on school property as deemed 25 necessary by the pupil's parent or legal guardian. Policies enacted pursuant 26 to this paragraph shall require medicinal cannabis be administered by a 27 UNOFFICIAL COPY 22 RS BR 50 Page 27 of 138 XXXX Jacketed school nurse or under the supervision of appropri ate school staff. 1 (5) (a) No landlord may be penalized or denied any benefit under state law for 2 leasing to a cardholder. 3 (b) A landlord shall not include in a rental agreement terms and conditions 4 that prohibit the use of medicinal cannabis by a cardholde r. 5 SECTION 9. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 6 READ AS FOLLOWS: 7 (1) Except as provided in subsection (13) of this section, a physician or an advanced 8 practice registered nurse seeking to become a medicinal cannabis practitioner 9 and provide written certifications for the use of medicinal cannabis shall apply to 10 the same state licensing board that issued his or her professional practice license, 11 on a form prescribed by the state licensing board, for authoriza tion to provide 12 written certifications for the use of medicinal cannabis. 13 (2) (a) A state licensing board shall approve an application for authorization to 14 provide written certifications for the use of medicinal cannabis if the 15 application is complete and meets the requirements established in 16 administrative regulations promulgated by the state licensing board. 17 (b) A state licensing board shall deny an application for authorization to 18 provide written certifications for the use of medicinal cannabis if the 19 applicant has an ownership or investment interest in or compensation 20 agreement with a cannabis business licensed under this chapter. A state 21 licensing board may consult with the department to determine if an 22 applicant has an ownership or investment interest in or compensation 23 agreement with a cannabis business. 24 (3) Authorization to provide written certifications for the use of medicinal cannabis 25 granted under this section shall expire, and may be renewed, in accordance with 26 administrative regulations promulga ted by a state licensing board. 27 UNOFFICIAL COPY 22 RS BR 50 Page 28 of 138 XXXX Jacketed (4) A medicinal cannabis practitioner may provide a patient with a written 1 certification only after the practitioner has: 2 (a) Established a bona fide practitioner -patient relationship with the patient; 3 (b) Diagnosed the pati ent with a qualifying medical condition or confirmed a 4 diagnosis for a qualifying medical condition provided by another health 5 care provider; 6 (c) Reviewed a report of information from the electronic monitoring system 7 established pursuant to Section 41 of this Act related to the patient for a 8 period of time that covers at least the twelve (12) months immediately 9 preceding the date of the report; 10 (d) Consulted with the patient, or the patient's custodial parent or legal 11 guardian responsible for providing co nsent to treatment if the patient is a 12 minor child, with respect to the possible risks and side effects associated 13 with medicinal cannabis, including possible interactions between medicinal 14 cannabis and any other drug or medication that the patient is taki ng at that 15 time; and 16 (e) Obtained the consent of the patient's custodial parent or legal guardian 17 responsible for providing consent to treatment, if the patient is a minor 18 child. 19 (5) A bona fide practitioner -patient relationship may be established followin g a 20 referral from the patient's primary care provider and may be maintained via 21 telehealth. However, a bona fide practitioner -patient relationship shall not be 22 established via telehealth. 23 (6) (a) When issuing a written certification for the use of medicina l cannabis to a 24 patient, the medicinal cannabis practitioner shall, to the best of his or her 25 professional medical knowledge, provide the patient with recommendations 26 for: 27 UNOFFICIAL COPY 22 RS BR 50 Page 29 of 138 XXXX Jacketed 1. The strains of medicinal cannabis and types of medicinal cannabis 1 products that m ay be most effective in providing medical, therapeutic, 2 or palliative relief to the patient; and 3 2. Medicinal cannabis dosing including the quantity and frequency of 4 doses. 5 (b) Recommendations provided pursuant to paragraph (a) of this subsection 6 shall com ply with medicinal cannabis dosing guidelines and the ten (10) 7 day and thirty (30) day maximum allowance of medicinal cannabis 8 developed by the department pursuant to Section 28 of this Act. 9 (7) (a) A written certification for the use of medicinal cannabis shall be provided to 10 a patient on a form prescribed by the department. 11 (b) An initial written certification for the use of medicinal cannabis shall be 12 provided during the course of an in -person examination of the patient by 13 the medicinal cannabis practiti oner. Subsequent written certifications, 14 including for the purpose of renewing a registry identification card, may be 15 provided electronically or during the course of a telehealth consultation. 16 (c) For the purpose of applying for a registry identification c ard, a written 17 certification provided under this section shall be valid for ninety (90) days 18 after the date of issuance by a medicinal cannabis practitioner. The 19 medicinal cannabis practitioner may renew a written certification for not 20 more than three (3) additional periods of not more than ninety (90) days 21 each. Thereafter, the medicinal cannabis practitioner may issue another 22 certification to the patient only after conducting an additional examination 23 of the patient in -person or via telehealth. 24 (d) Within twenty -four (24) hours of providing a patient with a written 25 certification for the use of medicinal cannabis, a medicinal cannabis 26 practitioner shall record the issuance of the written certification in the 27 UNOFFICIAL COPY 22 RS BR 50 Page 30 of 138 XXXX Jacketed electronic monitoring system established pursuant to Section 41 of this Act. 1 (8) A medicinal cannabis practitioner shall not: 2 (a) Dispense medicinal cannabis; or 3 (b) Provide a written certification for the use of medicinal cannabis to a family 4 member or to himself or herself. 5 (9) Nothing in Sections 1 to 30 of this Act shall prevent a practitioner from being 6 sanctioned for: 7 (a) Issuing a written certification without first obtaining authorization to 8 provide written certifications from a state licensing board; 9 (b) Issuing a written certification to a patie nt with whom the practitioner does 10 not have a bona fide practitioner -patient relationship; 11 (c) Failing to properly evaluate a patient's medical history and current medical 12 condition prior to issuing a written certification; 13 (d) Otherwise failing to use goo d faith in his or her treatment of the patient; or 14 (e) Any other violation of this section or any administrative regulation 15 promulgated thereunder. 16 (10) A state licensing board may suspend or revoke a medicinal cannabis 17 practitioner's authorization to prov ide written certification for the use of 18 medicinal cannabis and practice license for multiple violations or a serious 19 violation of this section or any administrative regulation promulgated 20 thereunder. 21 (11) The state licensing boards shall: 22 (a) No later tha n January 1, 2023, promulgate, in accordance with KRS 23 Chapter 13A, administrative regulations to establish at least the following: 24 1. The procedures for applying for authorization to provide written 25 certifications; 26 2. The conditions that must be met to be eligible for authorization to 27 UNOFFICIAL COPY 22 RS BR 50 Page 31 of 138 XXXX Jacketed provide written certifications; 1 3. The process and procedures for renewing authorization to provide 2 written certifications; 3 4. Continuing education requirements for medicinal cannabis 4 practitioners related to the use of medicinal cannabis and the 5 recommending of cannabis for medicinal use; 6 5. The reasons for which authorization to provide written certifications 7 for the use of medi cinal cannabis may be suspended or revoked; and 8 6. The minimal standards of care when providing written certifications; 9 (b) On a regular basis, provide the department with the names of all medicinal 10 cannabis practitioners; and 11 (c) Immediately provide the d epartment with the name of any medicinal 12 cannabis practitioner whose authorization to provide written certifications 13 is suspended or revoked. 14 (12) The continuing education requirements established by the state licensing boards 15 in accordance with subsection 11(a)4. of this section shall include continuing 16 education requirements related to medicinal cannabis dosing and dosing 17 guidelines established by the department pursuant to Section 28 of this Act. 18 (13) This section does not apply to a practitioner who rec ommends treatment with 19 cannabis or a drug derived from cannabis under any of the following that are 20 approved by an investigational review board or equivalent entity, the United 21 States Food and Drug Administration, or the National Institutes for Health or 22 any of its cooperative groups or centers under the United States Department of 23 Health and Human Services: 24 (a) A research protocol; 25 (b) A clinical trial; 26 (c) An investigational new drug application; or 27 UNOFFICIAL COPY 22 RS BR 50 Page 32 of 138 XXXX Jacketed (d) An expanded access submission. 1 SECTION 10. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 2 TO READ AS FOLLOWS: 3 (1) Except as provided in subsection (2) of this section, prior to making an initial 4 purchase of medicinal cannabis in this state and at least annually thereafter, a 5 registered qualified patient shall be required to complete a consultation with a 6 pharmacist wh o is authorized by the Kentucky Board of Pharmacy to provide 7 medicinal cannabis consultation services to cardholders. The consultation shall, 8 at a minimum, cover the possible risks and side effects of medicinal cannabis and 9 any potential drug interactions between medicinal cannabis and any other drug 10 that the registered qualified patient or visiting qualified patient is taking. The 11 consultation required by this subsection may be completed via telehealth. 12 (2) (a) A designated caregiver shall be permitted to complete the consultation 13 required by subsection (1) of this section on behalf of any registered 14 qualified patient to whom the designated caregiver is connected through the 15 department's registration process. 16 (b) If the registered qualified patient is under eighteen (18) years of age, the 17 registered qualified patient's parent or legal guardian who is responsible for 18 providing consent for medical treatment shall be present for the 19 consultation required by subsection (1) of this section and may complete the 20 consultation on behalf of the registered qualified patient. 21 (c) A visiting qualified patient who has not applied for and obtained a registry 22 identification card issued by the department but presents a valid out -of-state 23 registry identification card to purcha se medicinal cannabis in this state not 24 more than once per calendar year shall not be required to complete the 25 consultation required by subsection (1) of this section. 26 (3) A pharmacist who wishes to be authorized by the Kentucky Board of Pharmacy to 27 UNOFFICIAL COPY 22 RS BR 50 Page 33 of 138 XXXX Jacketed provid e medicinal cannabis consultation services to cardholders or to enter into a 1 collaborative agreement with dispensaries, as required by Section 22 of this Act, 2 shall apply to the board on a form prescribed by the board. 3 (4) No later than January 1, 2023, th e Kentucky Board of Pharmacy shall, in 4 accordance with KRS Chapter 13A, promulgate administrative regulations to: 5 (a) Establish the application and renewal process and fee for authorization to 6 provide medicinal cannabis consultation services and to enter i nto a 7 collaborative agreement with dispensaries; 8 (b) Establish continuing education and training requirements for pharmacists 9 who are authorized to provide medicinal cannabis consultation services and 10 to enter into a collaborative agreement with dispensari es; 11 (c) Define the standards of care for medicinal cannabis consultation services; 12 and 13 (d) Define the nature and scope of a collaborative agreement between a 14 pharmacist and a dispensary, including the process by which a pharmacist 15 and dispensary shall esta blish a collaborative agreement. The nature and 16 scope of the collaborative agreement shall not require a pharmacist to be 17 present at a dispensary. 18 (5) The department shall promulgate administrative regulations to establish: 19 (a) A fee for medicinal cannabis consultation services which shall not exceed 20 forty dollars ($40) per consultation; and 21 (b) A fee for collaborative agreements between a dispensary and a pharmacist. 22 (6) Members of the Kentucky Board of Pharmacy, its agents, its employees, and any 23 pharmacist authorized by the board to provide medicinal cannabis consultation 24 services to cardholders or to enter into a collaborative agreement with 25 dispensaries shall be immune from suit in any action, civil or criminal, which is 26 based upon any act that is conducted in accordance with this section and 27 UNOFFICIAL COPY 22 RS BR 50 Page 34 of 138 XXXX Jacketed administrative regulations promulgated thereunder. 1 SECTION 11. A NEW SECTION OF KRS CHAPTER 2 18A IS CREATED 2 TO READ AS FOLLOWS: 3 (1) Except as provided in subsection (9) of this section, no person shall possess, 4 purchase, acquire, or otherwise engage or assist in the use of medicinal cannabis 5 in Kentucky without first applying for and receiving a r egistry identification card 6 for registered qualified patients, designated caregivers, or visiting qualified 7 patients issued by the department. 8 (2) A person shall be eligible to apply for a registry identification card as a registered 9 qualified patient if h e or she is a resident of Kentucky, has obtained a written 10 certification issued by a medicinal cannabis practitioner in accordance with 11 Section 9 of this Act and administrative regulations promulgated thereunder, and 12 has not been convicted of a disqualifyi ng felony offense. 13 (3) A person shall be eligible to apply for a registry identification card as a 14 designated caregiver if he or she is a resident of Kentucky, is at least twenty -one 15 (21) years of age, has been identified as a designated caregiver on quali fied 16 patient's or registered qualified patient's registry identification card application 17 or renewal form, has not been convicted of a disqualifying felony offense, and 18 has agreed to assist no more than three (3) registered qualified patients with the 19 use of medicinal cannabis. 20 (4) A person shall be eligible to apply for a registry identification card as a visiting 21 qualified patient if he or she is not a resident of Kentucky or has been a resident 22 of Kentucky for less than thirty (30) days, possess a valid out-of-state registry 23 identification card, is at least twenty -one (21) years of age, has obtained a written 24 certification issued by a medicinal cannabis practitioner in accordance with 25 Section 9 of this Act and administrative regulations promulgated thereu nder, and 26 has not been convicted of a disqualifying felony offense. 27 UNOFFICIAL COPY 22 RS BR 50 Page 35 of 138 XXXX Jacketed (5) To apply for or renew a registry identification card, a qualified patient who is 1 eighteen (18) years of age or older shall submit the following, in accordance with 2 administrative regul ations promulgated by the department: 3 (a) The name, address, and date of birth of the qualified patient, except that if 4 the applicant is homeless an address where the applicant may be reached 5 shall be provided to the department; 6 (b) A valid written certifi cation issued to the qualified patient; 7 (c) The name, address, and telephone number of the qualified patient's 8 medicinal cannabis practitioner; 9 (d) A statement, signed by the qualified patient, pledging not to divert medicinal 10 cannabis to anyone who is not permitted to possess medicinal cannabis 11 pursuant to Sections 1 to 30 of this Act. The statement shall contain a 12 listing of potential penalties, including criminal prosecution, for diverting 13 medicinal cannabis; 14 (e) If the qualified patient determines that he or she needs a designated 15 caregiver: 16 1. A statement, signed by the qualified patient, attesting to such need; 17 2. The name, address, and date of birth of not more than two (2) 18 individuals chosen by the qualified patient to be designated as a 19 caregiver; a nd 20 3. A statement, signed by the individuals chosen by the qualified patient 21 to be designated as a caregiver agreeing to be designated as the 22 patient's designated caregiver and pledging not to divert medicinal 23 cannabis to anyone other than the registered q ualified patient to 24 whom the caregiver is connected through the department's 25 registration process. The statement shall contain a listing of potential 26 penalties, including criminal prosecution, for diverting medicinal 27 UNOFFICIAL COPY 22 RS BR 50 Page 36 of 138 XXXX Jacketed cannabis; and 1 (f) The application or re newal fee for a registry identification card for a 2 qualified patient and the application or renewal fee for a registry 3 identification card for any designated caregiver chosen by the qualified 4 patient. 5 (6) To apply for or renew a registry identification car d for a qualified patient who is 6 under eighteen (18) years of age, the qualified patient's custodial parent or legal 7 guardian with responsibility for health care decisions shall submit the following, 8 in accordance with administrative regulations promulgate d by the department: 9 (a) The name, address, and date of birth of the qualified patient, except that if 10 the applicant is homeless an address where the applicant may be reached 11 shall be provided to the department; 12 (b) A valid written certification issued to the qualified patient; 13 (c) The name, address, and telephone number of the qualified patient's 14 medicinal cannabis practitioner; 15 (d) A statement, signed by the qualified patient's custodial parent or legal 16 guardian with responsibility for health care decisio ns, attesting to the fact 17 that the custodial parent or legal guardian agrees to: 18 1. Allow the qualified patient to use medicinal cannabis; 19 2. Serve as the qualified patient's designated caregiver; and 20 3. Control the acquisition, dosage, and frequency of us e of medicinal 21 cannabis by the qualified patient; 22 (e) A statement, signed by the qualified patient's custodial parent or legal 23 guardian with responsibility for health care decisions, pledging not to 24 divert, or to knowingly allow the qualified patient to di vert, medicinal 25 cannabis to anyone who is not permitted to possess medicinal cannabis 26 pursuant to Sections 1 to 30 of this Act. The statement shall contain a 27 UNOFFICIAL COPY 22 RS BR 50 Page 37 of 138 XXXX Jacketed listing of potential penalties, including criminal prosecution, for diverting 1 medicinal cannabis; 2 (f) If the qualified patient's custodial parent or legal guardian with 3 responsibility for health care decisions determines that the qualified patient 4 needs an additional designated caregiver: 5 1. A statement, signed by the qualified patient's custodial pare nt or legal 6 guardian with responsibility for health care decisions, attesting to 7 such need; 8 2. The name, address, and date of birth of not more than one (1) 9 individual chosen by the qualified patient's custodial parent or legal 10 guardian with responsibility for health care decisions to be designated 11 as a second designated caregiver; and 12 3. A statement, signed by the individual chosen by the qualified patient's 13 custodial parent or legal guardian with responsibility for health care 14 decisions to be designated a s a caregiver, agreeing to be designated as 15 the patient's designated caregiver and pledging not to divert medicinal 16 cannabis to anyone other than the registered qualified patient to 17 whom the caregiver is connected through the department's 18 registration proc ess. The statement shall contain a listing of potential 19 penalties, including criminal prosecution, for diverting medicinal 20 cannabis; and 21 (g) The application or renewal fee for a registry identification card for a 22 qualified patient and the application or re newal fee for a registry 23 identification card for any designated caregiver chosen by the qualified 24 patient. 25 (7) To apply for or renew a registry identification card, a visiting qualified patient 26 shall submit the following, in accordance with administrative regulations 27 UNOFFICIAL COPY 22 RS BR 50 Page 38 of 138 XXXX Jacketed promulgated by the department: 1 (a) The name, address, and date of birth of the visiting qualified patient, except 2 that if the applicant is homeless an address where the applicant may be 3 reached shall be provided to the department; 4 (b) A copy of his or her valid out -of-state registry identification card; 5 (c) A valid written certification issued to the qualified patient; 6 (d) The name, address, and telephone number of the qualified patient's 7 medicinal cannabis practitioner; 8 (e) A statement, signed by the qualified patient, pledging not to divert medicinal 9 cannabis to anyone who is not permitted to possess medicinal cannabis 10 pursuant to Sections 1 to 30 of this Act. The statement shall contain a 11 listing of potential penalties, including criminal pros ecution, for diverting 12 medicinal cannabis; and 13 (f) The application or renewal fee for a registry identification card for a 14 visiting qualified patient; 15 (8) The application for qualified patients' registry identification cards shall ask 16 whether the patient w ould like the department to notify him or her of any clinical 17 studies needing human subjects for research on the use of medicinal cannabis. 18 The department shall notify interested patients if it is aware of studies that will be 19 conducted in the United State s. 20 (9) A visiting qualified patient who possess a valid out -of-state registry identification 21 card shall not be required to apply for or obtain a visiting qualified patient 22 registry identification card issued by the department and may use his or her valid 23 out-of-state registry identification card for all purposes established in Sections 1 24 to 30 of this Act, except that a visiting qualified patient who has not applied for 25 and obtained a registry identification card issued by the department shall only be 26 permi tted to purchase medicinal cannabis in this state once per calendar year. 27 UNOFFICIAL COPY 22 RS BR 50 Page 39 of 138 XXXX Jacketed SECTION 12. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 1 TO READ AS FOLLOWS: 2 (1) The department shall establish, implement, and operate a registry identification 3 card program for registered qualified patients, visiting qualified patients, and 4 designated caregivers. 5 (2) The following shall be clearly and visibly printed on registry identification cards: 6 (a) The name of the cardholder; 7 (b) A designati on of whether the cardholder is a registered qualified patient, 8 visiting qualified patient, or designated caregiver; 9 (c) The date of issuance and expiration date of the registry identification card; 10 (d) A random alphanumeric identification number of at lea st ten (10) 11 characters, containing at least four (4) numbers and at least four (4) letters, 12 that is unique to the cardholder; 13 (e) A photograph of the cardholder, if the department's administrative 14 regulations require one; 15 (f) The telephone number and Web s ite address for the electronic monitoring 16 system established pursuant to Section 41 of this Act; 17 (g) If the cardholder is a designated caregiver, the random alphanumeric 18 identification number of the registered qualified patient the designated 19 caregiver is receiving the registry identification card to assist; 20 (h) If the cardholder is under eighteen (18) years of age, a clear and obvious 21 designation or identifier indicating that the cardholder is under eighteen 22 (18) years of age; and 23 (i) A bar code or other m arking that can be scanned electronically to provide 24 access to the information described in subsection (4) of this section. 25 (3) (a) Except as provided in this subsection, the expiration date for registry 26 identification cards shall be one (1) year after the date of issuance. 27 UNOFFICIAL COPY 22 RS BR 50 Page 40 of 138 XXXX Jacketed (b) If a medicinal cannabis practitioner states in the written certification that 1 the qualified patient would ben efit from the use of medicinal cannabis until 2 a specified earlier date, then the registry identification card shall expire on 3 that date. 4 (4) The department shall electronically store in the card at least all of the 5 information listed in subsection (2) of t his section, the cardholder's the address, 6 and the cardholder's date of birth, so that it may be read electronically by law 7 enforcement agents and licensed cannabis businesses. 8 (5) The registry identification card application and renewal fees shall be as f ollows: 9 (a) A registry identification card for a qualified patient who is a Kentucky 10 resident shall be sixty dollars ($60); 11 (b) A registry identification card for a visiting qualified patient shall be sixty 12 dollars ($60); and 13 (c) A registry identification card for a designated caregiver shall be twenty 14 dollars ($20) per registered qualified patient to whom the designated 15 caregiver is connected unless the designated caregiver is the parent, legal 16 guardian, spouse, or adult child of the qualified patient, in which case there 17 shall be no fee for a registry identification card. 18 (6) (a) The department shall operate a provisional licensure receipt system for 19 registered qualified patients, designated caregivers, and visiting qualified 20 patients that shall be valid f or forty -five (45) days, or until a permanent card 21 can be issued, as if it is a registry identification card issued pursuant to this 22 section and Sections 11 and 13 of this Act. This program shall be 23 implemented and operational simultaneously with the depar tment's 24 implementation of the registry identification card program established in 25 this section. A provisional licensure receipt shall contain the following: 26 1. A temporary identification number; 27 UNOFFICIAL COPY 22 RS BR 50 Page 41 of 138 XXXX Jacketed 2. A barcode or other marking that can be scanned electronica lly; 1 3. The name of the applicant; 2 4. A designation of whether the cardholder is a registered qualified 3 patient, visiting qualified patient, or designated caregiver; 4 5. If the cardholder is under eighteen (18) years of age, a clear and 5 obvious designation or identifier indicating that the cardholder is 6 under eighteen (18) years of age; 7 6. The effective date of the receipt; 8 7. The expiration date of the receipt; 9 8. An indication that the cardholder fee has been paid; 10 9. An indication that the application has been submitted and is 11 apparently complete; and 12 10. The name of the qualified patient's medicinal cannabis practitioner. 13 (b) The licensure receipt system shall be designed so that this provisional 14 licensure receipt shall be produced by the application Web site upon 15 completion of an application that includes a valid written certification for 16 the use of medicinal cannabis issued by medicinal cannabis practitioner 17 and payment of the cardholder fee. To reduce application errors and 18 processing time, medicinal ca nnabis practitioners and licensed dispensaries 19 may offer a service that allows an applicant to use a computer and printer 20 on the premises of the practitioner's office or dispensary to complete an 21 application and receive a provisional licensure receipt purs uant to this 22 subsection. 23 (c) Notwithstanding any other provision of Sections 1 to 30 of this Act, a valid 24 provisional licensure receipt issued pursuant to this subsection shall convey 25 to the individual whose name appears on the provisional licensure receip t 26 all of the same rights and privileges as a registry identification card issued 27 UNOFFICIAL COPY 22 RS BR 50 Page 42 of 138 XXXX Jacketed pursuant to this section and Sections 11 and 13 of this Act and shall be 1 accepted by a cannabis business in place of a registry identification card. 2 (7) All registry identific ation card fees collected by the department pursuant to 3 subsection (5) of this section shall be forwarded to the medicinal cannabis trust 4 fund established in Section 31 of this Act. 5 SECTION 13. A NEW SECTION OF KRS CHAPT ER 218A IS CREATED 6 TO READ AS FOLLOWS: 7 (1) Except as provided in subsections (2) to (5) of this section, the department shall: 8 (a) Acknowledge receipt of an application or renewal within fifteen (15) days of 9 receipt, and approve or deny an application or r enewal within thirty (30) 10 days of receiving a completed application or renewal application; and 11 (b) Issue registry identification cards to a qualified patient and any individual 12 designated by the qualified patient as a designated caregiver, or a visiting 13 qualified patient within five (5) days of approving the application or 14 renewal. An individual designated as a caregiver shall be issued a 15 designated caregiver registry identification card for each registered 16 qualified patient to whom he or she is connected through the department's 17 registration process. 18 (2) The department shall not issue a registry identification card to a qualified patient 19 who is younger than eighteen (18) years of age unless: 20 (a) The custodial parent or legal guardian with responsibility for health care 21 decisions for the qualified patient consents in writing to: 22 1. Allow the qualified patient's use of medicinal cannabis; 23 2. Serve as the qualified patient's designated caregiver; and 24 3. Control the acquisition of the medicinal cannabis, the dosage, and the 25 frequency of the use by the qualified patient; and 26 (b) The designated caregiver application for the custodial parent or legal 27 UNOFFICIAL COPY 22 RS BR 50 Page 43 of 138 XXXX Jacketed guardian with responsibility for health care decisions for the qualified 1 patient is approved. 2 (3) (a) The department shall deny an application or renewal for a qualified 3 patient's or visiting qualified patient's registry identification card if the 4 applicant: 5 1. Did not provide the information or materials requ ired by Section 11 of 6 this Act; 7 2. Previously had a registry identification card revoked; 8 3. Provided false or falsified information; or 9 4. Does not meet the eligibility requirements established in Section 11 of 10 this Act. 11 (b) The department may deny an app lication or renewal for a qualified 12 patient's or visiting qualified patient's registry identification card for any 13 reason that the department, in the exercise of sound discretion, deems 14 sufficient. 15 (4) (a) The department shall deny an application or renewa l for a designated 16 caregiver's registration card if the applicant: 17 1. Is already registered as a designated caregiver for three (3) registered 18 qualified patients; 19 2. Does not meet the eligibility requirements established in Section 11 of 20 this Act; 21 3. Did n ot provide the information or materials required by Section 11 of 22 this Act; 23 4. Previously had a registry identification card revoked; 24 5. Provided false or falsified information; or 25 6. Has applied as a designated caregiver for a qualified patient whose 26 application or renewal for a registry identification card was denied. 27 UNOFFICIAL COPY 22 RS BR 50 Page 44 of 138 XXXX Jacketed (b) The department may deny application or renewal for a designated 1 caregiver's registration card for any reason that the department, in the 2 exercise of sound discretion, deems sufficient. 3 (5) The department may conduct a criminal background check of any applicant if the 4 criminal background check is conducted solely to determine whether the 5 applicant was previously convicted of a disqualifying felony offense. 6 (6) The department shall notify t he registered qualified patient who has designated 7 someone to serve as his or her designated caregiver if the individual designated as 8 a caregiver is denied a registry identification card. 9 (7) The department shall notify the applicant in writing of the den ial and reasons for 10 the denial by registered or certified mail at the address given in the application or 11 supplement. The applicant may, within thirty (30) days after the date of the 12 mailing of the department's notice, file a written request for an adminis trative 13 hearing on the application. The hearing shall be conducted on the application in 14 compliance with the requirements of KRS Chapter 13B. 15 (8) Final orders of the department after administrative hearings shall be subject to 16 judicial review. Jurisdiction and venue for judicial review are vested in the 17 Circuit Court of the county in which the appealing party resides. 18 SECTION 14. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 19 TO READ AS FOLLOWS: 20 (1) Cardholders shall be required to make the following notifications to the 21 department: 22 (a) A cardholder shall notify the department of any change in his or her name 23 or address; 24 (b) If a cardholder loses his or her registry identification card, he or she shal l 25 notify the department within ten (10) days of becoming aware that the card 26 has been lost; 27 UNOFFICIAL COPY 22 RS BR 50 Page 45 of 138 XXXX Jacketed (c) A cardholder shall immediately notify the department if he or she is 1 convicted of a disqualifying felony offense; 2 (d) A registered qualified patient shall not ify the department within thirty (30) 3 days if he or she ceases to suffer from the qualifying medical condition for 4 which a medicinal cannabis practitioner provided a written certification; 5 (e) A registered qualified patient shall immediately notify the dep artment if he 6 or she wishes to terminate a designated caregiver relationship with an 7 individual who has been designated as his or her caregiver; and 8 (f) A designated caregiver shall notify the department within ten (10) days if he 9 or she becomes aware that a registered qualified patient to whom the 10 caregiver is connected through the department's registration process has 11 died or has ceased to suffer from the qualifying medical condition for which 12 a medicinal cannabis practitioner provided a written certifica tion. 13 (2) When a cardholder notifies the department of items listed in subsection (1)(a) or 14 (b) of this section, but remains eligible under Sections 1 to 30 of this Act, the 15 department shall issue the cardholder a new registry identification card with a 16 new random ten (10) character alphanumeric identification number. If the 17 department issues a new registry identification card to a registered qualified 18 patient, the department shall also issue a new registry identification card with a 19 new ten (10) character alphanumeric number to the registered qualified patient's 20 designated caregiver. New registry identification cards issued under this 21 subsection shall be issued by the department within ten (10) days of receiving the 22 updated information and a twenty dollar ( $20) fee for each new registry 23 identification card to be issued. 24 (3) When a cardholder notifies the department of items listed in subsection (1)(c) to 25 (e) of this section, the cardholder shall, within ten (10) days of notification, 26 return any unused medici nal cannabis products to a licensed dispensary for 27 UNOFFICIAL COPY 22 RS BR 50 Page 46 of 138 XXXX Jacketed destruction. 1 (4) If a registered qualified patient ceases to be a registered qualified patient or 2 changes his or her designated caregiver, the department shall promptly notify the 3 designated caregiver in w riting. The designated caregiver's protections under 4 Sections 1 to 30 of this Act as to that registered qualified patient shall expire 5 fifteen (15) days after notification by the department. 6 (5) A cardholder who fails to make a notification to the departme nt that is required 7 by this section is subject to a violation, punishable by a penalty of no more than 8 one hundred fifty dollars ($150). 9 (6) All fees and penalties collected pursuant to this section shall be forwarded to the 10 medicinal cannabis trust fund e stablished in Section 31 of this Act. 11 SECTION 15. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 12 TO READ AS FOLLOWS: 13 (1) Any cardholder who sells, distributes, dispenses, or otherwise diverts medicinal 14 cannabis to a person who is not permitted to possess or use medicinal cannabis 15 under Sections 1 to 30 of this Act shall have his or her registry identification card 16 revoked, shall be permanently ineligible for a registry identification card in the 17 future, and shall be subject to other penalties, including but not limited to 18 criminal prosecution, under any relevant chapter of the Kentucky Revised 19 Statutes. 20 (2) The department may revoke the registry identification card of any cardholder 21 who knowingly commits multiple violations or a serious violation of Sections 1 to 22 30 of this Act. 23 (3) The department shall provide notice of revocation, fine, or any other 24 administrative penalty by mailing, via certified mail, the same in writing to the 25 cardholder. The cardholder may, within thirt y (30) days after the date of the 26 mailing of the department's notice, file a written request for an administrative 27 UNOFFICIAL COPY 22 RS BR 50 Page 47 of 138 XXXX Jacketed hearing regarding the revocation, fine, or other penalty. The hearing shall be 1 conducted in compliance with the requirements of KRS Chapter 1 3B. 2 (4) Final orders of the department after administrative hearings shall be subject to 3 judicial review. Jurisdiction and venue for judicial review are vested in the 4 Circuit Court of the county in which the appealing party resides. 5 SECTION 16. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 6 TO READ AS FOLLOWS: 7 (1) No person shall cultivate, process, produce, possess, test, transfer, transport, or 8 sell medicinal cannabis or otherwise operate a cannabis business in this state 9 without first obtaining a cannabis business licenses issued by the department. 10 (2) The department shall create separate licenses allowing persons to operate a 11 cannabis business, pursuant to Sections 1 to 30 of this Act and any administrative 12 regulations p romulgated thereunder, as: 13 (a) A cannabis cultivator, for which the license shall be tiered as follows: 14 1. Tier I, for which the initial licensing fee shall be five thousand dollars 15 ($5,000); 16 2. Tier II, for which the initial licensing fee shall be ten tho usand dollars 17 ($10,000); 18 3. Tier III, for which the initial licensing fee shall be twenty -five 19 thousand dollars ($25,000); and 20 4. Tier IV, for which the initial licensing fee shall be fifty thousand 21 dollars ($50,000); 22 (b) A cannabis dispensary, for which t he initial licensing fee shall be ten 23 thousand dollars ($10,000); 24 (c) A cannabis processor, for which the initial licensing fee shall be twenty 25 thousand dollars ($20,000); 26 (d) A cannabis producer, for which the initial licensing fee shall be seventy -five 27 UNOFFICIAL COPY 22 RS BR 50 Page 48 of 138 XXXX Jacketed thousand dollars ($75,000); or 1 (e) A cannabis safety compliance facility, for which the initial licensing fee 2 shall be two thousand five hundred dollars ($2,500). 3 (3) (a) Except as provided in paragraph (b) of this subsection, a cannabis business 4 shall be required to apply for and obtain from the department a separate 5 license for each location it intends to operate. 6 (b) A cannabis business licensed as a producer may operate culti vation and 7 processing activities at separate locations, but shall not operate more than 8 one (1) cultivation and one (1) processing facility per license. 9 (4) (a) A cannabis business license issued under this section and Sections 17 and 10 18 of this Act shall be valid for one (1) year from the date of issuance. The 11 department shall notify each licensee ninety (90) days prior to the date on 12 which the license expires to allow the licensee to begin the renewal process 13 established by the department through the prom ulgation of administrative 14 regulations pursuant to Section 28 of this Act. 15 (b) The renewal of a cannabis business license shall be contingent upon 16 successful achievement of minimal performance standards established by 17 the department as part of the biennial accreditation process established 18 pursuant to Section 28 of this Act. 19 (c) Cannabis business licensure renewal fees shall be: 20 1. Five hundred dollars ($500) plus one percent (1%) of all gross receipts 21 during the previous calendar year for a cannabis busine ss that, upon 22 applying for renewal of a cannabis business license, had no more than 23 two million dollars ($2,000,000) of gross receipts during the previous 24 calendar year; 25 2. Two thousand dollars ($2,000) plus one and one -half percent (1.5%) 26 of all gross rec eipts during the previous calendar year for a cannabis 27 UNOFFICIAL COPY 22 RS BR 50 Page 49 of 138 XXXX Jacketed business that, upon applying for renewal of a cannabis business 1 license, had more than two million dollars ($2,000,000) but not more 2 than eight million dollars ($8,000,000) of gross receipts during the 3 previous calendar year; and 4 3. Four thousand dollars ($4,000) plus two percent (2%) of all gross 5 receipts during the previous calendar year for a cannabis business 6 that, upon applying for renewal of a cannabis business license, had 7 over eight million doll ars ($8,000,000) of gross receipts during the 8 previous calendar year. 9 (5) All licensure fees collected pursuant to this section shall be forwarded to the 10 medicinal cannabis trust fund established in Section 31 of this Act. 11 (6) The department shall approve a license holder's sale of a license issued pursuant 12 to this section and Sections 17 and 18 of this Act if the purchaser and any new 13 facilities meet the requirements of Sections 1 to 30 of this Act and any 14 administrative regulations promulgated thereunder. 15 SECTION 17. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 16 TO READ AS FOLLOWS: 17 (1) The department shall create a uniform application form for the cannabis 18 business licenses established in Section 16 of this Act. 19 (2) When applying for a cannabis business license, the applicant shall submit the 20 following in accordance with the department's administrative regulations: 21 (a) The proposed legal name of the cannabis business; 22 (b) The proposed physical address of the cannabis busin ess and the global 23 positioning system coordinates for any proposed cultivation activities; 24 (c) The name, address, and date of birth of each principal officer and board 25 member of the cannabis business; 26 (d) Any instances in which a business or not -for-profit entity that any of the 27 UNOFFICIAL COPY 22 RS BR 50 Page 50 of 138 XXXX Jacketed prospective board members managed or served on the board of was 1 convicted, fined, censured, or had a registration or license suspended or 2 revoked in any administrative or judicial proceeding; 3 (e) Any other information required by th e department pursuant to 4 administrative regulations; and 5 (f) A nonrefundable licensure application fee of one hundred dollars ($100). 6 (3) The application fee required under subsection (2) of this section shall be applied 7 to the initial licensing fee if the license is approved; otherwise it shall be retained 8 by the department for administrative purposes. 9 (4) If a cannabis business license application is approved: 10 (a) The cannabis business shall, before it begins operations: 11 1. Submit the initial license fee established in Section 16 of this Act, 12 minus the one hundred dollars ($100) application fee, to the 13 department; and 14 2. If a physical address or the global positioning system coordinates for 15 any cultivation activities had not been finalized when it applied, 16 submit its complete physical address and the global positioning system 17 coordinates for any cultivation activities; and 18 (b) The department shall issue a copy of the license that includes the business's 19 identification number. The department shall also provide each licensed 20 dispensary with contact and access information for the electronic 21 monitoring system established pursuant to Section 41 of this Act. 22 SECTION 18. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 23 TO READ AS FOLLOWS: 24 (1) The department shall: 25 (a) Acknowledge receipt of an application for a cannabis business license 26 within fifteen (15) days of receipt; and 27 UNOFFICIAL COPY 22 RS BR 50 Page 51 of 138 XXXX Jacketed (b) Provide notification to the cannabis business license applicant as to whet her 1 the application for a cannabis business license has been approved or denied 2 within forty -five (45) days of receiving a completed application. 3 (2) (a) The department shall deny an application for a cannabis business license if: 4 1. The applicant failed t o submit the materials required by Section 17 of 5 this Act, including if the applicant's plans do not satisfy the security, 6 oversight, or recordkeeping administrative regulations promulgated by 7 the department pursuant to Section 28 of this Act; 8 2. The appli cant provided false or falsified information on the licensure 9 application; 10 3. The applicant would not be in compliance with local cannabis 11 business prohibitions enacted pursuant to Section 26 of this Act; 12 4. The applicant does not meet, or in the opinion o f the department is 13 unlikely to meet, the requirements for cannabis businesses established 14 in Section 19 of this Act; 15 5. One (1) or more of the prospective principal officers or board 16 members: 17 a. Has been convicted of a disqualifying felony offense, the 18 provisions of KRS 335B.020 and 335B.030 notwithstanding; 19 b. Has served as a principal officer or board member for a 20 cannabis business that has had its license revoked; 21 c. Is younger than twenty -one (21) years of age; or 22 d. Is a medicinal cannabis practitione r authorized by a state 23 licensing board to provide patients with written certifications; or 24 6. a. For a safety compliance facility, one (1) or more of the 25 prospective principal officers or board members is a principal 26 officer or board member of a cultivato r, processor, producer, or 27 UNOFFICIAL COPY 22 RS BR 50 Page 52 of 138 XXXX Jacketed dispensary licensed to operate in Kentucky; or 1 b. For a cultivator, processor, producer, or dispensary, one (1) or 2 more of the prospective principal officers or board members is a 3 principal officer or board member of a safety com pliance facility 4 licensed to operate in Kentucky. 5 (b) The department may deny an application for a cannabis business license for 6 any reason that the department, in the exercise of sound discretion, deems 7 sufficient. 8 (3) The department shall notify the appl icant in writing of a license denial and 9 reasons by registered or certified mail at the address given in the application or 10 supplement. Except for license denials based upon subsection (2)(a) of this 11 section, the applicant may, within thirty (30) days afte r the mailing of the 12 department's notice, file a written request for an administrative hearing on the 13 application. The hearing shall be conducted on the application in compliance 14 with the requirements of KRS Chapter 13B. 15 (4) Final orders of the department after administrative hearings shall be subject to 16 judicial review as provided in KRS 13B.140. Jurisdiction and venue for judicial 17 review are vested in the Circuit Court of the county in which the applicant's 18 business would be located. 19 SECTION 19. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 20 TO READ AS FOLLOWS: 21 (1) A cannabis business licensed under this chapter shall: 22 (a) Comply with Sections 1 to 30 of this Act and any administrative regulations 23 promulgated thereunder by the department; 24 (b) Conduct a criminal background check into the criminal history of each 25 person seeking to become a principal officer, board member, agen t, 26 volunteer, or employee before that person begins work. A cannabis business 27 UNOFFICIAL COPY 22 RS BR 50 Page 53 of 138 XXXX Jacketed shall not employ, accept as a volunteer, or have as a board member, 1 principal officer, or agent any person who: 2 1. Was convicted of a disqualifying felony offense; or 3 2. Is under twenty -one (21) years of age; 4 (c) Implement appropriate security measures required pursuant to 5 administrative regulations promulgated by the department in accordance 6 with Section 28 of this Act to deter and prevent the theft or diversion of 7 medicinal cann abis and unauthorized entrance into areas containing 8 medicinal cannabis; 9 (d) Display its license on the premises in a conspicuous place and manner at all 10 times; and 11 (e) Only acquire, possess, cultivate, process, manufacture, deliver, transfer, 12 transport, s upply, sell, or dispense medicinal cannabis: 13 1. For the purposes of distributing medicinal cannabis to cardholders 14 who possess a valid registry identification card issued by the 15 department, or for visiting qualified patients, a valid out -of-state 16 registry identification card; and 17 2. Cultivated and processed by a cannabis business licensed under 18 Sections 16, 17, and 18 of this Act. 19 (2) A cannabis business licensed under Sections 16, 17, and 18 of this Act this 20 chapter shall not: 21 (a) Be located within one tho usand (1,000) feet of an elementary or secondary 22 school or a day -care center; 23 (b) Acquire, possess, cultivate, process, manufacture, deliver, transfer, 24 transport, supply, dispense, or sell: 25 1. Raw plant material with a delta -9 tetrahydrocannabinol content of 26 more than thirty -five percent (35%); 27 UNOFFICIAL COPY 22 RS BR 50 Page 54 of 138 XXXX Jacketed 2. Medicinal cannabis products intended for oral consumption as an 1 edible, oil, or tincture with more than ten (10) milligrams of delta -9 2 tetrahydrocannabinol per serving; 3 3. Any medicinal cannabis product not descri bed in subparagraph 1. or 4 2. of this paragraph with a delta -9 tetrahydrocannabinol content of 5 more than seventy percent (70%); 6 4. Any medicinal cannabis product that contains vitamin E acetate; or 7 5. Medicinal cannabis cultivated, processed, or manufacture d in another 8 state; 9 (c) Permit a person under eighteen (18) years of age to enter or remain on the 10 premises of a cannabis business; 11 (d) Permit a person who is not a cardholder to enter or remain on the premises 12 of a cannabis business, except in accordance with subsection (6) of this 13 section; 14 (e) Employ, have as a board member, or be owned by, in part or in whole, a 15 medicinal cannabis practitioner authorized by a state licensing board to 16 provide patients with written certifications; or 17 (f) Advertise medicina l cannabis sales in print, broadcast, online, by paid in - 18 person solicitation of customers, or by any other advertising device as 19 defined in KRS 177.830, except that this paragraph shall not prevent 20 appropriate signs on the property of a licensed cannabis b usiness, listings in 21 business directories including phone books, listings in trade or medical 22 publications, or sponsorship of health or not -for-profit charity or advocacy 23 events. 24 (3) The operating documents of a cannabis business shall include procedures f or its 25 oversight and procedures to ensure accurate recordkeeping and inventory control 26 in accordance with administrative regulations promulgated by the department 27 UNOFFICIAL COPY 22 RS BR 50 Page 55 of 138 XXXX Jacketed pursuant to Section 28 of this Act. 1 (4) When transporting medicinal cannabis on behalf of a l icensed cannabis business, 2 a cannabis business agent shall have: 3 (a) A copy of the cannabis business license for the business that employs the 4 agent; 5 (b) Documentation that specifies the amount of medicinal cannabis being 6 transported and the date on which it is being transported; and 7 (c) The cannabis business license number and a working telephone number for 8 any other cannabis business receiving or otherwise involved in the 9 transportation of the medicinal cannabis. 10 (5) The cultivation of medicinal cannabis for cannabis businesses licensed in this 11 state shall only be done by cultivators and producers licensed under this chapter 12 and shall take place in an enclosed, locked facility which can be accessed by only 13 cannabis business agents working on behalf of the cultivator or producer at the 14 physical address or global positioning system coordinates provided to the 15 department during the license application process. 16 (6) A person who is at least eighteen (18) years of age but not a cardholder may be 17 allowed to enter and remain on the premises of a cannabis business if: 18 (a) The person is present at the cannabis business to perform contract work, 19 including but not limited to electrical, plumbing, or security maintenance, 20 that does not involve handling medicinal cannabis; or 21 (b) The person is a government employee and is at the cannabis business in the 22 course of his or her official duties. 23 SECTION 20. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 24 TO READ AS FOLLOWS: 25 (1) Cannabis businesses shall be subject to reasonable inspection by the department 26 pursuant to the department's procedures and administrative regulations. The 27 UNOFFICIAL COPY 22 RS BR 50 Page 56 of 138 XXXX Jacketed department may inspe ct any licensed cannabis business premises without having 1 to first obtain a search warrant. 2 (2) (a) Except as provided in Section 22 of this Act, the department may issue a 3 civil fine of up to three thousand dollars ($3,000) to a cannabis business for 4 a violation of Sections 1 to 30 of this Act or any administrative regulation 5 promulgated thereunder. All fines collected pursuant to this subsection 6 shall be forwarded to the medicinal cannabis trust fund established in 7 Section 31 of this Act. 8 (b) The departme nt may, on its own motion or on complaint and after 9 investigation, suspend or revoke a cannabis business license for multiple 10 violations or a serious violation of Sections 1 to 30 of this Act or any 11 administrative regulations promulgated thereunder by the licensee or any of 12 its agents. A suspension shall not be for a period of time longer than six (6) 13 months. 14 (c) The department shall, via certified mail, provide a written notice of license 15 suspension, revocation, fine to the cannabis business at the address on the 16 license. 17 (3) Subsection (2) of this section notwithstanding, the department shall not suspend 18 or revoke a cannabis business's license or impose a civil fine without first 19 providing the cannabis business with the opportunity for an administrative 20 hearing at which the cannabis business is afforded an opportunity to appear and 21 be heard pursuant to KRS Chapter 13B. A cannabis business may, within thirty 22 (30) days after the mailing of a written notice required by subsection (2)(c) of this 23 section, file a written request for an administrative hearing regarding the 24 suspension, revocation, or fine. If a cannabis business requests an administrative 25 hearing, prior to the disposition of the administrative hearing, the cannabis 26 business shall be allowed to opera te as normally permitted by Sections 1 to 30 of 27 UNOFFICIAL COPY 22 RS BR 50 Page 57 of 138 XXXX Jacketed this Act. 1 (4) Final orders of the department after administrative hearings shall be subject to 2 judicial review. Jurisdiction and venue for judicial review are vested in the 3 Circuit Court of the county in whic h the cannabis business is physically located. 4 (5) Under a suspended license: 5 (a) A cultivator may continue to cultivate and possess cannabis plants, but it 6 shall not transfer or sell medicinal cannabis during a suspension; 7 (b) A dispensary may continue t o possess its existing medicinal cannabis 8 inventory, but it shall not acquire additional medicinal cannabis, or 9 dispense, transfer, or sell medicinal cannabis to any cardholder or any 10 other cannabis business; 11 (c) A processor may continue to process and pos sess its existing medicinal 12 cannabis inventory, but it shall not acquire additional medicinal cannabis, 13 or dispense, transfer, or sell medicinal cannabis products to any other 14 cannabis business; 15 (d) A producer may continue to cultivate, process, and posses s cannabis plants 16 and its existing medicinal cannabis inventory, but it shall not acquire 17 additional medicinal cannabis, or dispense, transfer, or sell medicinal 18 cannabis to any other cannabis business; and 19 (e) A safety compliance facility may continue to possess medicinal cannabis, 20 but it shall not receive any new medicinal cannabis, test or otherwise 21 analyze medicinal cannabis, or transfer or transport medicinal cannabis. 22 SECTION 21. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 23 TO READ AS FOLLOWS: 24 (1) A cultivator or cultivator agent acting on behalf of a cultivator shall not be 25 subject to prosecution under state or local law, to search or inspection except by 26 the department pursuant to Section 20 of this Act, to seizure or penalty in any 27 UNOFFICIAL COPY 22 RS BR 50 Page 58 of 138 XXXX Jacketed manner, or be denied any right or privilege, including but not limited to civil 1 penalty or disciplinary action by a court or business licensing board, for acting 2 pursuant to Sections 1 to 30 of this Act and the department's administrativ e 3 regulations promulgated thereunder for: 4 (a) Acquiring, possessing, planting, cultivating, raising, harvesting, trimming, 5 or storing cannabis seeds, seedlings, plants, or raw plant material; 6 (b) Delivering, transporting, transferring, supplying, or sellin g raw plant 7 material or related supplies to other licensed cannabis businesses in this 8 state; or 9 (c) Selling cannabis seeds or seedlings to similar entities that are licensed to 10 cultivate cannabis in this state or in any other jurisdiction. 11 (2) Cultivators and cultivator agents acting on behalf of a cultivator shall: 12 (a) Only deliver raw plant material to a licensed processor, licensed producer, 13 licensed safety compliance facility, or licensed dispensary for fair market 14 value; 15 (b) Only deliver raw plant mat erial to a licensed dispensary, processor, or 16 producer after it has been checked by a safety compliance facility agent for 17 cannabinoid contents and contaminants in accordance with administrative 18 regulations promulgated by the department; 19 (c) Not supply a d ispensary with more than the amount of raw plant material 20 reasonably required by a dispensary; and 21 (d) Not deliver, transfer, or sell raw plant material with a delta -9 22 tetrahydrocannabinol content of more than thirty -five percent (35%) to a 23 licensed dispen sary, processor, or producer. 24 (3) (a) A Tier I cultivator shall not exceed an indoor growth area of two thousand 25 five hundred (2,500) square feet. 26 (b) A Tier II cultivator shall not exceed an indoor growth area of ten thousand 27 UNOFFICIAL COPY 22 RS BR 50 Page 59 of 138 XXXX Jacketed (10,000) square feet. 1 (c) A Tier III cultivator shall not exceed an indoor growth area of twenty -five 2 thousand (25,000) square feet. 3 (d) A Tier IV cultivator shall not exceed an indoor growth area of fifty 4 thousand (50,000) square feet. 5 SECTION 22. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 6 TO READ AS FOLLOWS: 7 (1) A dispensary or dispensary agent acting on behalf of a dispensary shall not be 8 subject to prosecution under state or local law, to search or inspection except by 9 the department pursuan t to Section 20 of this Act, to seizure or penalty in any 10 manner, or be denied any right or privilege, including but not limited to a civil 11 penalty or disciplinary action by a court or business licensing board, for acting 12 pursuant to Sections 1 to 30 of th is Act and the department's administrative 13 regulations promulgated thereunder for: 14 (a) Acquiring or possessing medicinal cannabis from a cultivator, processor, or 15 producer in this state; 16 (b) Acquiring or possessing medicinal cannabis accessories or educati onal 17 material; 18 (c) Supplying, selling, dispensing, distributing, or delivering medicinal 19 cannabis, medicinal cannabis accessories, and educational material to 20 cardholders or other licensed dispensaries; 21 (d) Selling cannabis seeds to an entity that are lice nsed to cultivate cannabis in 22 this state or in any other jurisdiction; or 23 (e) Acquiring, accepting, or receiving medicinal cannabis products from a 24 cardholder, except that a dispensary may not offer anything of monetary 25 value in return for medicinal cannab is received from a cardholder. Any 26 medicinal cannabis received by a dispensary under this paragraph or 27 UNOFFICIAL COPY 22 RS BR 50 Page 60 of 138 XXXX Jacketed pursuant to Section 14 of this Act shall be destroyed by the dispensary or its 1 agents and shall not be sold, dispensed, or distributed to another 2 cardhol der. 3 (2) A dispensary or dispensary agent acting on behalf of a dispensary shall: 4 (a) Maintain records that include specific notations of the type and quantity of 5 medicinal cannabis products being dispensed to a cardholder and whether it 6 was dispensed dire ctly to a registered qualified patient, a visiting qualified 7 patient, or a registered qualified patient's designated caregiver. Each entry 8 shall include sufficient information to identify the product or products 9 dispensed, the quantity dispensed, and the d ate and time of the dispensing. 10 The data required to be recorded by this paragraph shall be entered into the 11 electronic monitoring system established pursuant to Section 41 of this Act 12 in accordance with administrative regulations promulgated by the 13 depart ment for the recording of medicinal cannabis dispensing; 14 (b) Only dispense or sell medicinal cannabis after it has been checked by a 15 safety compliance facility agent for cannabinoid contents and contaminants 16 in accordance with administrative regulations pr omulgated by the 17 department; 18 (c) Only dispense or sell medicinal cannabis to a cardholder after making a 19 good faith, reasonable effort to verify: 20 1. That the registry identification card or, for visiting qualified patients, 21 the out -of-state registry identi fication card presented to the dispensary 22 is valid, including by checking the verification system, if it is 23 operational, or other department -designated databases; 24 2. That the person presenting the registry identification card or, for 25 visiting qualified pat ients, the out -of-state registry identification card 26 is at least eighteen (18) years of age and is the person identified on the 27 UNOFFICIAL COPY 22 RS BR 50 Page 61 of 138 XXXX Jacketed card by examining at least one (1) other form of government -issued 1 photo identification; 2 3. That the person presenting the regis try identification card has 3 consulted with a pharmacist as required by Section 10 of this Act; 4 4. The amount of medicinal cannabis the person is legally permitted to 5 purchase pursuant to subsection (4) of Section 4 of this Act at the time 6 of verification b y checking the electronic monitoring system 7 established pursuant to Section 41 of this Act; and 8 5. For a visiting qualified patient who presents an out -of-state registry 9 identification card, that the visiting qualified patient has not 10 purchased medicinal c annabis in this state during the current 11 calendar year by checking the electronic monitoring system 12 established pursuant to Section 41 of this Act; 13 (d) Require a visiting qualified patient who presents a valid out -of-state registry 14 identification card to s ign a statement attesting to the fact that the visiting 15 qualified patient has been diagnosed with a disease or medical condition 16 included on the list of qualifying medical conditions established by the 17 department; 18 (e) Not acquire, possess, dispense, sell, offer for sale, transfer, or transport: 19 1. Raw plant material with a delta -9 tetrahydrocannabinol content of 20 more than thirty -five percent (35%); 21 2. Medicinal cannabis products intended for oral consumption as an 22 edible, oil, or tincture with more than ten (10) milligrams of delta -9 23 tetrahydrocannabinol per serving; 24 3. Any medicinal cannabis product not described in subparagraph 1. or 25 2. of this paragraph with a delta -9 tetrahydrocannabinol content of 26 more than seventy percent (70%); or 27 UNOFFICIAL COPY 22 RS BR 50 Page 62 of 138 XXXX Jacketed 4. Any medicinal cannabis product that contains vitamin E acetate; 1 (f) Not acquire medicinal cannabis from any person other than a cannabis 2 business licensed under Sections 16, 17, and 18 of this Act or an agent 3 thereof, or a registered qualified patient or a designated caregiver as 4 provided for in Section 14 of this Act; 5 (g) Not sell or dispense medicinal cannabis products intended for consumption 6 by vaporizing to a cardholder who is less than twenty -one (21) years of age; 7 (h) Not dispense or sell medicinal c annabis to a minor; 8 (i) Not dispense or sell more medicinal cannabis to a cardholder than he or she 9 is legally permitted to purchase at the time of the transaction; and 10 (j) Not rent office space to a medicinal cannabis practitioner. 11 (3) A dispensary shall be required to establish and maintain a collaborative 12 agreement, as described in Section 10 of this Act and any administrative 13 regulation promulgated thereunder, with a pharmacist authorized by the 14 Kentucky Board of Pharmacy to engage in a collaborative ag reement with a 15 dispensary. 16 (4) (a) A dispensary may operate a delivery service for cardholders and may deliver 17 medicinal cannabis, medicinal cannabis accessories, and educational 18 material to cardholders at the address identified on the cardholder's registr y 19 identification. 20 (b) All delivery services operated or offered by a dispensary shall comply with 21 administrative regulations promulgated by the department pursuant to this 22 section and Section 28 of this Act. 23 (5) If a dispensary fails to comply with subsect ion (2)(c) of this section, the 24 department may issue the dispensary a civil fine of up to fifty thousand dollars 25 ($50,000), except that the fine shall be one hundred thousand dollars ($100,000) 26 if the person purchasing or attempting to purchase medicinal c annabis is a 27 UNOFFICIAL COPY 22 RS BR 50 Page 63 of 138 XXXX Jacketed minor. All fines collected pursuant to this subsection shall be forwarded to the 1 medicinal cannabis trust fund established in Section 31 of this Act. 2 (6) If a dispensary or dispensary agent fails to comply with subsection (2)(c), (d), (e), 3 (f), or (g) of this section, the dispensary and dispensary agent are liable in a civil 4 action for compensatory and punitive damages and reasonable attorney's fees to 5 any person or the representative of the estate of any person who sustains injury, 6 death, or l oss to person or property as a result of the failure to comply. In any 7 action under this subsection, the court may also award any injunctive or 8 equitable relief that the court considers appropriate. 9 SECTION 23. A NEW SEC TION OF KRS CHAPTER 218A IS CREATED 10 TO READ AS FOLLOWS: 11 (1) A processor or processor agent acting on behalf of a processor shall not be 12 subject to prosecution under state or local law, to search or inspection except by 13 the department pursuant to Section 20 of this Act, to seizure or penalty in any 14 manner, or be denied any right or privilege, including but not limited to civil 15 penalty or disciplinary action by a court or business licensing board, for acting 16 pursuant to Sections 1 to 30 of this Act and the de partment's administrative 17 regulations promulgated thereunder for: 18 (a) Acquiring or purchasing raw plant material from a cultivator, processor, or 19 producer in this state; 20 (b) Possessing, processing, preparing, manufacturing, manipulating, blending, 21 preparin g, or packaging medicinal cannabis; 22 (c) Transferring, transporting, supplying, or selling medicinal cannabis and 23 related supplies to other cannabis businesses in this state; or 24 (d) Selling cannabis seeds or seedlings to similar entities that are licensed t o 25 cultivate cannabis in this state or in any other jurisdiction. 26 (2) A processor licensed under this section shall not possess, process, produce, or 27 UNOFFICIAL COPY 22 RS BR 50 Page 64 of 138 XXXX Jacketed manufacture: 1 (a) Raw plant material with a delta -9 tetrahydrocannabinol content of more 2 than thirty -five pe rcent (35%); 3 (b) Medicinal cannabis products intended for oral consumption as an edible, 4 oil, or tincture with more than ten (10) milligrams of delta -9 5 tetrahydrocannabinol per serving; 6 (c) Any medicinal cannabis product not described in paragraph (a) or ( b) of 7 this subsection with a delta -9 tetrahydrocannabinol content of more than 8 seventy percent (70%) or 9 (d) Any medicinal cannabis product that contains vitamin E acetate. 10 SECTION 24. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 11 TO READ AS FOLLOWS: 12 (1) A producer or producer agent acting on behalf of a producer shall not be subject 13 to prosecution under state or local law, to search or inspection except by the 14 department pursuant to Section 20 of this Act, to seizure or pe nalty in any 15 manner, or be denied any right or privilege, including but not limited to civil 16 penalty or disciplinary action by a court or business licensing board, for acting 17 pursuant to Sections 1 to 30 of this Act and the department's administrative 18 regu lations promulgated thereunder for: 19 (a) Acquiring, possessing, planting, cultivating, raising, harvesting, trimming, 20 or storing cannabis seeds, seedlings, plants, or raw plant material; 21 (b) Delivering, transpo rting, transferring, supplying, or selling raw plant 22 material, medicinal cannabis products, or related supplies to other licensed 23 cannabis businesses in this state; 24 (c) Selling cannabis seeds or seedlings to similar entities that are licensed to 25 cultivate cannabis in this state or in any other jurisdiction; 26 (d) Acquiring or purchasing raw plant material from a cultivator in this state; 27 UNOFFICIAL COPY 22 RS BR 50 Page 65 of 138 XXXX Jacketed or 1 (e) Possessing, processing, preparing, manufacturing, manipulating, blending, 2 preparing, or packaging medicinal cannabi s; 3 (2) Producers and producer agents acting on behalf of a producer shall: 4 (a) Only deliver raw plant material to a licensed processor, licensed producer, 5 licensed safety compliance facility, or licensed dispensary for fair market 6 value; 7 (b) Only deliver r aw plant material to a licensed dispensary, processor, or 8 producer after it has been checked by a safety compliance facility agent for 9 cannabinoid contents and contaminants in accordance with administrative 10 regulations promulgated by the department; 11 (c) Not supply a dispensary with more than the amount of raw plant material 12 reasonably required by a dispensary; and 13 (d) Be limited to an indoor cannabis growth area of fifty thousand (50,000) 14 square feet. 15 (3) A producer licensed under this section shall not pos sess, process, produce, or 16 manufacture: 17 (a) Raw plant material with a delta -9 tetrahydrocannabinol content of more 18 than thirty -five percent (35%); 19 (b) Medicinal cannabis products intended for oral consumption as an edible, 20 oil, or tincture with more than t en (10) milligrams of delta -9 21 tetrahydrocannabinol per serving; 22 (c) Any medicinal cannabis product not described in paragraph (a) or (b) of 23 this subsection with a delta -9 tetrahydrocannabinol content of more than 24 seventy percent (70%;) or 25 (d) Any medicinal cannabis product that contains vitamin E acetate. 26 SECTION 25. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 27 UNOFFICIAL COPY 22 RS BR 50 Page 66 of 138 XXXX Jacketed TO READ AS FOLLOWS: 1 A safety compliance facility or safety compliance facility agent acting on behalf of a 2 safet y compliance facility shall not be subject to prosecution, search except by the 3 department pursuant to Section 20 of this Act, seizure, or penalty in any manner, or be 4 denied any right or privilege, including but not limited to civil penalty or disciplinar y 5 action by a court or business licensing board, for acting in accordance with Sections 1 6 to 30 of this Act and the department's administrative regulations promulgated 7 thereunder to provide the following services: 8 (1) Acquiring or possessing medicinal cann abis obtained from cardholders or 9 cannabis businesses in this state; 10 (2) Returning the medicinal cannabis to cardholders or cannabis businesses in this 11 state; 12 (3) Transporting medicinal cannabis that was produced by cannabis businesses in 13 this state; 14 (4) The production or sale of approved educational materials related to the use of 15 medicinal cannabis; 16 (5) The production, sale, or transportation of equipment or materials other than 17 medicinal cannabis, including but not limited to lab equipment and packaging 18 materials that are used by cannabis businesses and cardholders, to cardholders or 19 cannabis businesses licensed under this chapter; 20 (6) Testing of medicinal cannabis produced in this state, including testing for 21 cannabinoid content, pesticides, mold, contam ination, vitamin E acetate, and 22 other prohibited additives; 23 (7) Training cardholders and cannabis business agents. Training may include but 24 need not be limited to: 25 (a) The safe and efficient cultivation, harvesting, packaging, labeling, and 26 distribution of medicinal cannabis; 27 UNOFFICIAL COPY 22 RS BR 50 Page 67 of 138 XXXX Jacketed (b) Security and inventory accountability procedures; and 1 (c) Up-to-date scientific and medical research findings related to use of 2 medicinal cannabis; 3 (8) Receiving compensation for actions allowed under this section; and 4 (9) Engaging in any non -cannabis -related business activities that are not otherwise 5 prohibited or restricted by state law. 6 SECTION 26. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 7 TO READ AS FOLLOWS: 8 (1) For the purposes of this section, \"local government\" means a city, county, 9 urban -county government, consolidated local government, charter county 10 government, or unified local government. 11 (2) A local government may: 12 (a) 1. Enact ordinances, not in conflict with Sections 1 to 3 0 of this Act or 13 with the department's administrative regulations, regulating the time, 14 place, and manner of cannabis business operations, except that a local 15 government shall not enact ordinances that impose an undue burden 16 or make cannabis business opera tions unreasonable or impractical; 17 and 18 2. Enact an ordinance to assess a local fee on cannabis businesses 19 operating within the jurisdiction of the local government to 20 compensate the local government for any additional public safety 21 impact caused by the ope ration of cannabis businesses within the 22 jurisdiction of the local government. Any fee established pursuant to 23 this paragraph shall not exceed the additional public safety impact 24 caused by the operation of cannabis businesses within the jurisdiction 25 of the local government; 26 (b) Prohibit all cannabis business operations within its territory through the 27 UNOFFICIAL COPY 22 RS BR 50 Page 68 of 138 XXXX Jacketed passage of an ordinance; or 1 (c) Enact resolutions directing that the question of prohibiting cannabis 2 businesses from operating within its territory be submit ted to the voters of 3 its territory at the next regular election pursuant to subsection (4) of this 4 section. 5 (3) If a county, consolidated local government, charter county government, or 6 unified local government prohibits all cannabis business operations, t he 7 legislative body of a city located within the county, consolidated local 8 government, charter county government, or unified local government may: 9 (a) Approve cannabis business operations within the limits of the city through 10 the passage of an ordinance; or 11 (b) Enact resolutions directing that the question of allowing cannabis 12 businesses to operate within the limits of the city be submitted to the voters 13 who are eligible to vote in that city's elections at the next regular election 14 pursuant to subsection ( 4) of this section. 15 (4) If, not later than the second Tuesday in August preceding the day established for 16 a regular election, the county clerk has received a local government resolution 17 pursuant to subsection (2) or (3) of this section, the county clerk sh all have 18 prepared to place before the voters of the affected territory at the next regular 19 election the question, which shall be \"Are you in favor of the sale of medicinal 20 cannabis at a licensed dispensary and the operation of other cannabis businesses 21 in (affected territory)? Yes....No....\". The county clerk shall cause to be published 22 in accordance with KRS Chapter 424, at the same time as the remaining voter 23 information, the full text of the proposal. The county clerk shall cause to be 24 posted in each pol ling place one (1) copy of the full text of the proposal. 25 (5) (a) If the question submitted to the voters fails to pass, three (3) years shall 26 elapse before the question of medicinal cannabis sales and cannabis 27 UNOFFICIAL COPY 22 RS BR 50 Page 69 of 138 XXXX Jacketed business operations may be included on a regu lar election ballot for the 1 affected territory. 2 (b) If the question submitted to the voters passes, medicinal cannabis sales and 3 cannabis business operations may be conducted in the affected territory, 4 notwithstanding any local government ordinances which prohibit all 5 cannabis business operations within its territory. 6 (6) In circumstances where a county, consolidated local government, charter county 7 government, or unified local government prohibits cannabis business operations 8 but a city within that county, consolidated local government, charter county 9 government, or unified local government approves cannabis business operations 10 either through the adoption of an ordinance or following the affirmative vote of a 11 public question allowing cannabis business opera tions, then: 12 (a) The cannabis business operations may proceed within the limits of the city; 13 and 14 (b) The county, consolidated local government, charter county government, or 15 unified local government may assess an additional reasonable fee to 16 compensate for any additional public safety impact caused by the approval 17 of cannabis business operations. Any additional fees collected pursuant to 18 this subsection shall not exceed the additional public safety impact caused 19 by the approval of cannabis business operatio ns. 20 (7) In circumstances where both a city and the county, consolidated local 21 government, charter county government, or unified local government in which 22 the city is located have assessed a local fee on cannabis businesses pursuant to 23 subsection (2) of thi s section, a cannabis business shall be allowed to credit any 24 fee paid to the city against fees owed to the county, consolidated local 25 government, charter county government, or unified local government. 26 (8) The provisions of general election law shall appl y to public questions submitted to 27 UNOFFICIAL COPY 22 RS BR 50 Page 70 of 138 XXXX Jacketed voters under this section. 1 SECTION 27. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 2 TO READ AS FOLLOWS: 3 (1) The department shall maintain a confidential list of the persons to whom the 4 department has issued registry identification cards and their addresses, telephone 5 numbers, and registry identification numbers. 6 (2) The department shall, only at a cardholder's r equest, confirm his or her status as 7 a registered qualified patient, visiting qualified patient, or designated caregiver to 8 a third party, such as a landlord, employer, school, medical professional, or 9 court. 10 (3) The following information received and reco rds kept pursuant Sections 1 to 30 of 11 this Act and any administrative regulations promulgated thereunder shall be 12 confidential and exempt from the Open Records Act, KRS 61.870 to 61.884, and 13 shall not be subject to disclosure to any individual or public or private entity, 14 except as necessary for authorized employees of the department to perform 15 official duties pursuant to Sections 1 to 30 of this Act: 16 (a) Applications and renewals, their contents, and supporting information 17 submitted by qualified patients, visiting qualified patients, and designated 18 caregivers in compliance with Section 11 of this Act, including information 19 regarding their designated caregivers and medicinal cannabis practitioners; 20 (b) The individual names and other information identifying persons to whom 21 the department has issued registry identification cards; 22 (c) Any dispensing information required to be kept under Section 22 of this Act 23 or the department's administrative regulations w hich shall only identify 24 cardholders by their registry identification numbers and shall not contain 25 names or other personal identifying information; and 26 (d) Any department hard drives or other data -recording media that are no 27 UNOFFICIAL COPY 22 RS BR 50 Page 71 of 138 XXXX Jacketed longer in use and that contain cardholder information. These hard drives 1 and other media shall be destroyed after a reasonable time or after the data 2 is otherwise stored. 3 Data subject to this section shall not be combined or linked in any manner with 4 any other list or database maintai ned by the department or the Cabinet for Health 5 and Family Services and shall not be used for any purpose not provided for in 6 Sections 1 to 30 of this Act. 7 (4) Nothing in this section shall preclude: 8 (a) Notification by the department's employees to state or local law enforcement 9 about suspected falsified or fraudulent information submitted to the 10 department or of other apparently criminal violations of Sections 1 to 30 of 11 this Act; 12 (b) Notification by the department's employees to a state licensing board i f the 13 department has reasonable suspicion to believe a medicinal cannabis 14 practitioner did not have a bona fide practitioner -patient relationship with a 15 patient for whom he or she signed a written certification, that the medicinal 16 cannabis practitioner vio lated the standard of care, or that the medicinal 17 cannabis practitioner has violated any provision of Sections 1 to 30 of this 18 Act; 19 (c) Notification by dispensary agents to the department of a suspected violation 20 or attempted violation of Sections 1 to 30 of this Act or the administrative 21 regulations promulgated thereunder; 22 (d) Verification by the department of registry identification cards issued 23 pursuant to Sections 11, 12, and 13 of this Act; and 24 (e) The submission of the report required by Section 3 of this Act to the 25 General Assembly. 26 (5) It shall be a Class B misdemeanor for any person, including an employee or 27 UNOFFICIAL COPY 22 RS BR 50 Page 72 of 138 XXXX Jacketed official of the department or another state agency or local government, to 1 knowingly breach the confidentiality of information obtained pursuan t to 2 Sections 1 to 30 of this Act. 3 SECTION 28. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 4 TO READ AS FOLLOWS: 5 (1) No later than January 1, 2023, the department shall: 6 (a) Ensure that the electronic monitoring system es tablished pursuant to 7 Section 41 of this Act is designed to enable: 8 1. Medicinal cannabis practitioners to record the issuance of written 9 certifications to qualified patients, as required by Section 9 of this Act; 10 2. Pharmacists to perform and record the c ompletion of consultations 11 with cardholders as required under Section 10 of this Act; 12 3. The department and state licensing boards to monitor the issuance of 13 written certifications by medicinal cannabis practitioners; 14 4. Department personnel, law enforceme nt personnel, and dispensary 15 agents to verify the validity of registry identification cards issued by 16 the department by entering a registry identification number to 17 determine whether or not the identification number corresponds with 18 a current, valid regist ry identification card. The system shall only 19 disclose whether the identification card is valid and whether the 20 cardholder is a registered qualified patient, visiting qualified patient, 21 or designated caregiver; 22 5. Law enforcement personnel and dispensary a gents to access medicinal 23 cannabis sales data record by dispensary agents pursuant to Section 24 22 of this Act; 25 6. Dispensary agents to record the amount of medicinal cannabis that is 26 dispensed to a cardholder during each transaction as required by 27 UNOFFICIAL COPY 22 RS BR 50 Page 73 of 138 XXXX Jacketed Section 2 2 of this Act; and 1 7. The sharing of dispensing data recorded by dispensary agents 2 pursuant to Section 22 of this Act with all dispensaries in real time; 3 (b) Ensure that the electronic monitoring system established pursuant to 4 Section 41 of this Act is des igned to facilitate the tracking of medicinal 5 cannabis from the point of cultivation to the point of sale to cardholders; 6 (c) Promulgate administrative regulations, in accordance with KRS Chapter 7 13A, to establish: 8 1. A list of qualifying medical condition s for which medicinal cannabis 9 practitioners may provide a patient with a written certification for the 10 use of medicinal cannabis. The list shall, at a minimum, include the 11 following: 12 a. Any type or form of cancer regardless of stage; 13 b. Chronic, severe, i ntractable, or debilitating pain; 14 c. Epilepsy or any other intractable seizure disorder; 15 d. Multiple sclerosis, muscle spasms, or spasticity; and 16 e. Nausea or vomiting; 17 2. Procedures for the issuance, renewal, suspension, and revocation of 18 registry identification cards, including the creation of a uniform 19 written certification form and a uniform application form; 20 3. Procedures for the issuance, renewal, suspension, and revoc ation of 21 cannabis business licenses, including the creation of a uniform 22 licensure application form; 23 4. A convenience fee to be assessed and collected by dispensaries for 24 visiting qualified patients who do not possess a valid registry 25 identification card i ssued by the department and who purchase 26 medicinal cannabis with a valid out -of-state registry identification 27 UNOFFICIAL COPY 22 RS BR 50 Page 74 of 138 XXXX Jacketed card. The convenience fee established pursuant to this subparagraph 1 shall not exceed fifteen dollars ($15) per transaction; 2 5. In collaboration wi th the Board of Physicians and Advisors, as 3 required by Section 3 of this Act: 4 a. A definition of the amount of medicinal cannabis or delta -9 5 tetrahydrocannabinol that constitutes a ten (10) day maximum 6 allowance and a thirty (30) day maximum allowance of 7 medicinal cannabis for registered qualified patients who are over 8 eighteen (18) years of age; 9 b. A definition of the amount of medicinal cannabis or delta -9 10 tetrahydrocannabinol that constitutes a ten (10) day maximum 11 allowance and a thirty (30) day maximu m allowance of 12 medicinal cannabis for registered qualified patients who are 13 under eighteen (18) years of age; and 14 c. The amount of raw plant material that medicinal cannabis 15 products are considered to be equivalent to; 16 6. Provisions governing the following matters related to cannabis 17 businesses with the goal of protecting against diversion and theft, 18 without imposing any undue burden that would make cannabis 19 business operations unreasonable or impractical or compromising the 20 confidentiality of cardholders: 21 a. Recordkeeping and inventory control requirements that facilitate 22 the tracking of medicinal cannabis from the point of cultivation 23 to the point of sale to cardholders, including the use of the 24 electronic monitoring system established pursuant to Section 41 25 of this Act; 26 b. Procedures for the verification and validation of registry 27 UNOFFICIAL COPY 22 RS BR 50 Page 75 of 138 XXXX Jacketed identification cards issued by the department and out -of-state 1 registry identification cards; 2 c. Security requirements for safety compliance facilities, 3 processors, producers, di spensaries, and cultivators, which shall 4 include at a minimum lighting, video security, alarm 5 requirements, on -site parking, and measures to prevent loitering; 6 d. Procedures for the secure transportation, including delivery 7 services provided by dispensarie s, and storage of medicinal 8 cannabis by cannabis business licensees and their employees or 9 agents; 10 e. Employment and training requirements for licensees and their 11 agents, including requiring each licensee to create an 12 identification badge for each of the l icensee's agents or 13 employees; and 14 f. Restrictions on visits to licensed cultivation and processing 15 facilities, including requiring the use of visitor logs; 16 7. Procedures to establish, publish, and annually update a list of varieties 17 of cannabis that consi st of less than five percent (5%) 18 tetrahydrocannabinol; 19 8. A rating system that tracks the terpene content of at least the twelve 20 (12) major terpenoids within each strain of cannabis available for 21 medicinal use within the Commonwealth; 22 9. Requirements for random sample testing of medicinal cannabis to 23 ensure quality control, including testing for cannabinoids, terpenoids, 24 residual solvents, pesticides, poisons, toxins, mold, mildew, insects, 25 bacteria, and any other dangerous adulterant; 26 10. Requirements for licensed cultivators, producers, and processors to 27 UNOFFICIAL COPY 22 RS BR 50 Page 76 of 138 XXXX Jacketed contract with an independent safety compliance facility to test the 1 medicinal cannabis before it is sold at a dispensary. The department 2 may approve the safety compliance facility chosen by a cultivator, 3 producer, or processor and require that the safety compliance facility 4 report test results for a designated quantity of medicinal cannabis to 5 the cultivator, producer, or processor and department; 6 11. Standards for the operation of safety compliance facili ties which may 7 include: 8 a. Requirements for equipment; 9 b. Personnel qualifications; and 10 c. Requiring facilities to be accredited by a relevant certifying 11 entity; 12 12. Standards for the packaging and labeling of medicinal cannabis sold 13 or distributed by cann abis businesses which shall comply with 15 14 U.S.C. secs. 1471 to 1476 and shall include: 15 a. Packaging that requires at least a two (2) step process of initial 16 opening; 17 b. A warning label which may include the length of time it typically 18 takes for the produc t to take effect, how long the effects of the 19 product typically last, and any other information deemed 20 appropriate or necessary by the department; 21 c. The amount of medicinal cannabis the product is considered the 22 equivalent to; 23 d. Disclosing ingredients, possible allergens, and certain bioactive 24 components, including cannabinoids and terpenoids, as 25 determined by the department; 26 e. A nutritional fact panel; 27 UNOFFICIAL COPY 22 RS BR 50 Page 77 of 138 XXXX Jacketed f. Opaque, child -resistant packaging; 1 g. A requirement that all raw plant mat erial packaged or sold in 2 this state be marked or labeled as \"NOT INTENDED FOR 3 CONSUMPTION BY SMOKING\"; 4 h. A requirement that medicinal cannabis products be clearly 5 marked with an identifiable and standardized symbol indicating 6 that the product contains ca nnabis; 7 i. A requirement that all medicinal cannabis product packaging 8 include an expiration date; and 9 j. A requirement that medicinal cannabis products and their 10 packaging not be visually reminiscent of major brands of edible 11 noncannabis products or othe rwise present an attractive 12 nuisance to minors; 13 13. Health and safety requirements for the processing of medicinal 14 cannabis and the indoor cultivation of medicinal cannabis by 15 licensees; 16 14. Restrictions on: 17 a. Additives to medicinal cannabis that are toxi c, including vitamin 18 E acetate, or increase the likelihood of addiction; and 19 b. Pesticides, fertilizers, and herbicides used during medicinal 20 cannabis cultivation which pose a threat to human health and 21 safety; 22 15. Standards for the safe processing of medi cinal cannabis products 23 created by extracting or concentrating compounds from raw plant 24 material; 25 16. Standards for determining the amount of unprocessed raw plant 26 material that medicinal cannabis products are considered the 27 UNOFFICIAL COPY 22 RS BR 50 Page 78 of 138 XXXX Jacketed equivalent to; 1 17. Restrictions on advertising, marketing, and signage in regard to 2 operations or establishments owned by licensees necessary to prevent 3 the targeting of minors; 4 18. The requirement that evidence -based educational materials regarding 5 dosage and impairment be disseminated to cardholders who purchase 6 medicinal cannabis products; 7 19. Policies governing insurance requirements for cultivators, 8 dispensaries, processors, producers, and safety compliance facilities; 9 20. The process by which the Board of Physicians and Advisors wi ll 10 recommend to the department the inclusion of additional diseases and 11 medical conditions on the approved list of qualifying medical 12 conditions for which a medicinal cannabis practitioner may provide a 13 patient with a written certification for the use of m edicinal cannabis, 14 including the process by which an individual may petition the board to 15 recommend the inclusion of a disease or medical condition; and 16 21. A form to be signed by visiting qualified patients who use a valid out - 17 of-state registry identifica tion card to purchase medicinal cannabis in 18 this state that indicates that the visiting qualified patient has been 19 diagnosed with a disease or medical condition that is included on the 20 list of qualifying medical conditions established by the department; 21 and 22 22. Standards, procedures, or restrictions that the department deems 23 necessary to ensure the efficient, transparent, and safe operation of 24 the medicinal cannabis program, including procedures for the 25 submission of complaints from individual citizens of t he 26 Commonwealth regarding potential or suspected violations of Sections 27 UNOFFICIAL COPY 22 RS BR 50 Page 79 of 138 XXXX Jacketed 1 to 30 of this Act or any administrative regulation promulgated 1 thereunder by a licensed cannabis business. 2 (2) When promulgating administrative regulations under Sections 1 to 30 of this Act, 3 the department: 4 (a) Shall consider standards, procedures, and restrictions that have been found 5 to be best practices relative to the use and regulation of medicinal cannabis; 6 and 7 (b) Shall not promulgate any administrative regulation that would i mpose an 8 undue burden or make cannabis business operations unreasonable or 9 impractical. 10 (3) No later than July 1, 2023, the department shall: 11 (a) In collaboration with the Board of Physicians and Advisors established in 12 Section 3 of this Act, develop medic inal cannabis dosing guidelines to be 13 used by medicinal cannabis practitioners when providing patients with 14 medicinal cannabis dosing recommendations. Guidelines developed 15 pursuant to this paragraph shall be: 16 1. Regularly updated as additional scientific i nformation on the use of 17 medicinal cannabis become available; 18 2. Made publicly available on the department's Web site; and 19 3. Distributed to all medicinal cannabis practitioners who are authorized 20 to provide written certifications for the use of medicinal cannabis. 21 (b) Develop and implement a biennial accreditation process, including minimal 22 performance standards, based on evolvi ng continuous quality improvement 23 metrics to ensure best -practice standards. Pursuant to Section 16 of this 24 Act, the renewal of cannabis business licenses shall be contingent upon 25 successfully achievement of minimal performance standards established by 26 the department. 27 UNOFFICIAL COPY 22 RS BR 50 Page 80 of 138 XXXX Jacketed (4) If a need for additional cannabis cultivation in this state is demonstrated by 1 cannabis businesses or the department's own analysis, the department may, 2 through the promulgation of administrative regulations, increase the cultivation 3 area square footage limits for either cultivators or producers, or both by up to 4 three (3) times the limits established in Sections 21 and 24 of this Act. Any 5 increase in the cultivation square footage limits adopted by the department 6 pursuant to this section s hall not result in an increase in the licensure application 7 or renewal fees established in Section 16 of this Act. 8 (5) The department shall not restrict or limit methods of delivery, use, or 9 consumption of medicinal cannabis or the types of products that may be 10 acquired, produced, processed, possessed, sold, or distributed by a cannabis 11 business except as provided in: 12 (a) Subsection (1)(g) of Section 6 of this Act; 13 (b) Subsection (2)(b) of Section 19 of this Act; 14 (c) Subsection (2)(e) of Section 22 of this Act; 15 (d) Subsection (2) of Section 23 of this Act; 16 (e) Subsection (3) of Section 24 of this Act; and 17 (f) Subsection (1)(c)9., 12.,14., and 15. of this Section. 18 SECTION 29. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 19 TO READ AS FOLLOWS: 20 Nothing in Sections 1 to 30 of this Act shall require a government medical assistance 21 program, private health insurer or workers' compensation carrier, or self -funded 22 employer providing workers' compensation benefits to reimburse a person for costs 23 associated with the use of medicinal cannabis. 24 SECTION 30. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 25 TO READ AS FOLLOWS: 26 The provisions of KRS 138.870 to 138.889 shall not apply to any individual or entity 27 UNOFFICIAL COPY 22 RS BR 50 Page 81 of 138 XXXX Jacketed for: 1 (1) Any amount of medicinal cannabis that is necessary or reasonably necessary for 2 use of a license or registry identification card issued pursuant to Sections 1 to 30 3 of this Act; or 4 (2) Any use of medicinal cannabis that complies with Sections 1 to 30 of this Act and 5 any administrative regulations promulgated thereunder. 6 SECTION 31. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 7 TO READ AS FOLLOWS: 8 (1) The medicinal cannabis trust fund is hereby created within the St ate Treasury. 9 The fund shall consist of funds collected from registration fees, licensing fees, 10 fines, and penalties established pursuant to Sections 1 to 30 of this Act, excluding 11 Section 27 of this Act, and any administrative regulations promulgated 12 thereunder, a portion of the excise taxes imposed under Section 33 of this Act, 13 and any proceeds from grants, contributions, appropriations, or other moneys 14 made available for purposes of this fund. 15 (2) The medicinal cannabis trust fund shall be administered b y the Finance and 16 Administration Cabinet. 17 (3) The Finance and Administration Cabinet shall, no later than the fifteenth 18 calendar day of each calendar quarter, distribute the funds deposited into the 19 medicinal cannabis trust fund during the immediately prec eding calendar 20 quarter. Trust fund moneys shall be distributed as follows: 21 (a) Sixty percent (60%) shall be transferred to the Department for Public 22 Health to offset the department's actual cost and expenses for operating the 23 medicinal cannabis program and enforcement activities established in 24 Sections 1 to 30 of this Act; 25 (b) Two and one -half percent (2.5%) shall be transferred to the Department 26 For Public Health for the purpose of developing, implementing, and 27 UNOFFICIAL COPY 22 RS BR 50 Page 82 of 138 XXXX Jacketed administering a grant program to further educ ation and scientific and 1 clinical research on the use of medicinal cannabis; 2 (c) Thirteen and three -quarters percent (13.75%) shall be transferred to the 3 Office of Drug Control Policy, as established in KRS 15A.020, for the 4 purpose of developing, implement ing, and administering a grant program 5 for city and county law enforcement agencies to enforce medicinal cannabis 6 laws, hire and train additional drug recognition experts (DRE), and provide 7 advanced roadside impaired driving enforcement (ARIDE) training; 8 (d) Thirteen and three -quarters percent (13.75%) shall be returned equally to 9 dispensaries for the use of indigent persons who are registered qualified 10 patients enrolled in Medicaid, receiving Supplemental Security Income or 11 Social Security disability insur ance, or veterans of the United States Armed 12 Forces; and 13 (e) The remaining ten percent (10%) shall be retained by the Finance and 14 Administration Cabinet in the fund to cover any additional administrative 15 costs that the Department for Public Health may incu r related to its 16 operational and enforcement responsibilities as established in Sections 1 to 17 30 of this Act. If the department is able to demonstrate to the Finance and 18 Administration Cabinet a need for any portion of the retained funds, the 19 Finance and A dministration Cabinet shall distribute the additional funds 20 for which the department has demonstrated need no later than the fifteenth 21 calendar day of the next calendar quarter. If the department cannot 22 demonstrate a need for the additional funding describ ed in this paragraph, 23 the retained funds shall be equally divided between the grant programs and 24 the indigent patient program described in paragraphs (b), (c), and (d) of this 25 subsection at the close of each fiscal year. 26 (4) Notwithstanding KRS 45.229, moneys in the fund not expended at the close of the 27 UNOFFICIAL COPY 22 RS BR 50 Page 83 of 138 XXXX Jacketed fiscal year shall not lapse but shall be equally divided between the grant 1 programs and the indigent patient program described in subsection (3)(b), (c), 2 and (d) of this sectio n. 3 (5) Any interest earnings of the trust fund shall become part of the fund and shall 4 not lapse. 5 (6) Moneys transferred to the fund are hereby appropriated for the purposes set forth 6 in this section. 7 SECTION 32. A NEW S ECTION OF KRS CHAPTER 218A IS CREATED 8 TO READ AS FOLLOWS: 9 (1) The local medicinal cannabis trust fund is hereby created within the State 10 Treasury. The fund shall consist of funds collected from a portion of the excise 11 taxes imposed under Section 33 of this Act. 12 (2) The local medicinal cannabis trust fund shall be administered by the Finance 13 and Administration Cabinet. 14 (3) The Finance and Administration Cabinet shall, no later than the fifteenth 15 calendar day of each calendar quarter, distribute the funds dep osited into the 16 local medicinal cannabis trust fund during the calendar quarter immediately 17 preceding the most recent calendar quarter. Funds shall be distributed among 18 those cities and counties in which at least one (1) cannabis business licensed as a 19 cultivator, dispensary, processor, or producer operated during the calendar 20 quarter immediately preceding the most recent calendar quarter as follows: 21 (a) The funds deposited into the local medicinal cannabis trust fund during the 22 calendar quarter immediately preceding the most recent calendar quarter 23 shall be divided into two (2) equal parts; 24 (b) One-half (1/2) of the funds deposited into the local medicinal cannabis trust 25 fund during the calendar quarter immediately preceding the most recent 26 calendar quarter shall be distributed to cities and counties in which at least 27 UNOFFICIAL COPY 22 RS BR 50 Page 84 of 138 XXXX Jacketed one (1) cannabis business licensed as a cultivator, processor, or producer 1 operated during the calendar quarter immediately preceding the most recent 2 calendar quarter as follows: 3 1. a. A city i n which at least one (1) cannabis business licensed as a 4 cultivator, processor, or producer operated during the calendar 5 quarter immediately preceding the most recent calendar quarter 6 shall receive an amount equal to seven and one -half percent 7 (7.5%) of th e total excise tax revenue collected from all cannabis 8 businesses licensed to operate inside the territory of the city 9 during the calendar quarter immediately preceding the most 10 recent calendar quarter; or 11 b. If the county in which the city is located has prohibited the 12 operation of cannabis businesses, then the city shall receive an 13 amount equal to ten percent (10%) of the total excise tax revenue 14 collected from all cannabis businesses licensed to operate inside 15 the territory of the city during the calend ar quarter immediately 16 preceding the most recent calendar quarter; and 17 2. A county that has not prohibited the operation of cannabis businesses, 18 pursuant to Section 26 of this Act, and in which at least one (1) 19 cannabis business licensed as a cultivator, p rocessor, or producer 20 operated during the calendar quarter immediately preceding the most 21 recent calendar quarter shall receive an amount equal to: 22 a. Ten percent (10%) of the total excise tax revenue collected from 23 all cannabis businesses licensed to oper ate within the territory of 24 the county, but outside the territory of any city in that county, 25 during the calendar quarter immediately preceding the most 26 recent calendar quarter; and 27 UNOFFICIAL COPY 22 RS BR 50 Page 85 of 138 XXXX Jacketed b. Two and one -half percent (2.5%) of the total excise tax revenue 1 collect ed from all cannabis businesses licensed to operate inside 2 the territory of an incorporated municipality inside the territory 3 of the county during the calendar quarter immediately preceding 4 the most recent calendar quarter; and 5 (c) One-half (1/2) of the fu nds deposited into the local medicinal cannabis trust 6 fund during the calendar quarter immediately preceding the most recent 7 calendar quarter shall be distributed to cities and counties in which at least 8 one (1) cannabis business licensed as a dispensary w as operated during the 9 calendar quarter immediately preceding the most recent calendar quarter as 10 follows: 11 1. a. A city in which at least one (1) cannabis business licensed as a 12 dispensary operated during the calendar quarter immediately 13 preceding the most recent calendar quarter shall receive a 14 percentage of the funds described in this subparagraph equal to 15 seventy -five percent (75%) of the city's proportionate share of 16 gross receipts derived from the retail sales of medicinal cannabis 17 products by licensed dispensaries in the territory of that city 18 divided by the total statewide retail sales of medicinal cannabis 19 products by all licensed dispensaries in the state during the 20 calendar quarter immediately preceding the most recent 21 calendar quarter; or 22 b. If th e county in which the city is located has prohibited the 23 operation of cannabis businesses, then the city shall receive a 24 percentage of the funds described in this subparagraph equal to 25 one hundred percent (100%) of the city's proportionate share of 26 gross r eceipts derived from the retail sales of medicinal cannabis 27 UNOFFICIAL COPY 22 RS BR 50 Page 86 of 138 XXXX Jacketed products by licensed dispensaries in the territory of that city 1 divided by the total statewide retail sales of medicinal cannabis 2 products by all licensed dispensaries in the state during the 3 calendar quarter immediately preceding the most recent 4 calendar quarter; and 5 2. A county that has not prohibited the operation of cannabis businesses, 6 pursuant to Section 26 of this Act, and in which at least one (1) 7 cannabis business licensed as a dispensary operated during the 8 calendar quarter immediately preceding the most recent calendar 9 quarter shall receive a percentage of the funds described in this 10 subparagraph equal to: 11 a. One hundred percent (100%) of the county's proportionate share 12 of gross receipts derived from the retail sales of medicinal 13 cannabis products by licensed dispensaries within the territory of 14 that county, but outside the territory of any city in that county, 15 divided by the total statewide retail sales of medicinal cannabis 16 products by all licensed dispensaries in the state during the 17 calendar quarter immediately preceding the most recent 18 calendar quarter; and 19 b. A percentage of the funds described in this subparagraph equal 20 to twenty -five percent (25%) of the proportionate share of gros s 21 receipts derived from the retail sales of medicinal cannabis 22 products by licensed dispensaries within the territory of all cities 23 in the county divided by the total statewide retail sales of 24 medicinal cannabis products by all licensed dispensaries in the 25 state during the calendar quarter immediately preceding the 26 most recent calendar quarter. 27 UNOFFICIAL COPY 22 RS BR 50 Page 87 of 138 XXXX Jacketed (4) Trust fund moneys may be used for the purposes of local enforcement of 1 medicinal cannabis laws by local law enforcement agencies, local medicinal 2 cannabis licens ing, the hiring or training of additional drug recognition experts 3 (DRE), advanced roadside impaired driving enforcement (ARIDE) training, local 4 evidence -based drug addiction rehabilitation projects, or educational activities 5 within local jails. 6 (5) Notwit hstanding KRS 45.229, moneys in the fund not expended at the close of the 7 fiscal year shall not lapse but shall be carried forward to the next fiscal year. 8 (6) Any interest earnings of the trust fund shall become part of the fund and shall 9 not lapse. 10 (7) Moneys transferred to the fund are hereby appropriated for the purposes set forth 11 in this section. 12 (8) As used in this section, \"county\" has the same meaning as in KRS 65A.010. 13 SECTION 33. A NEW SECTION OF KRS CHAPTER 138 IS CREATED TO 14 READ AS FOLLOWS: 15 (1) As used in this section: 16 (a) \"Cultivator\" has the same meaning as in Section 1 of this Act; 17 (b) \"Department\" means the Department of Revenue; 18 (c) \"Dispensary\" has the same meaning as i n Section 1 of this Act; 19 (d) \"Medicinal cannabis\" has the same meaning as in Section 1 of this Act; 20 (e) \"Processor\" has the same meaning as in Section 1 of this Act; and 21 (f) \"Producer\" has the same meaning as in Section 1 of this Act. 22 (2) Effective January 1, 2023: 23 (a) An excise tax is hereby imposed on the gross receipts of a cultivator, 24 processor, or producer received from the sale of medicinal cannabis by a 25 cultivator, processor, or producer to a dispensary, to be paid by the 26 cultivator, processor, or pr oducer at a rate of twelve percent (12%) of the 27 UNOFFICIAL COPY 22 RS BR 50 Page 88 of 138 XXXX Jacketed actual price for which a cultivator, processor, or producer sells medicinal 1 cannabis to a dispensary in this state; and 2 (b) The tax shall be charged against and be paid by the cultivator, processor, or 3 produc er and shall not be added as a separate charge or line item on any 4 sales slip, invoice, receipt, or other statement or memorandum of the price 5 paid by the dispensary. 6 (3) (a) Eighty percent (80%) of the revenue from the excise tax established in this 7 section shall be deposited in the medicinal cannabis trust fund established 8 in Section 31 of this Act for the purpose of administration of the medicinal 9 cannabis program and for the purposes established in that section. 10 (b) Twenty percent (20%) of the revenue f rom the excise tax established in this 11 section shall be deposited in the local medicinal cannabis trust fund 12 established in Section 32 of this Act for the purposes of distributing tax 13 proceeds among participating local governments and for the purposes 14 established in that section. 15 (4) Cultivators, processors, and producers licensed under KRS Chapter 218A shall: 16 (a) Register with the department; 17 (b) Report and pay the tax levied under this section on or before the twentieth 18 day of the calendar month immediate ly following the month in which the 19 medicinal cannabis was sold. A tax return shall be filed for each reporting 20 period whether or not tax is due; and 21 (c) Identify the county and city, if any, in which the medicinal cannabis 22 business is located. 23 (5) Any per son who violates any provision of this section shall be subject to the 24 uniform civil penalties imposed pursuant to KRS 131.180 and interest at the tax 25 interest rate as defined in KRS 131.010 from the date due until the date of 26 payment. 27 UNOFFICIAL COPY 22 RS BR 50 Page 89 of 138 XXXX Jacketed (6) (a) Notwithstand ing any other provision of this section, the president, vice 1 president, secretary, treasurer, or any other person holding any equivalent 2 corporate office of any corporation subject to this section shall be 3 personally and individually liable, both jointly a nd severally, for the taxes 4 imposed under this section. 5 (b) Corporate dissolution, withdrawal of the corporation from the state, or the 6 cessation of holding any corporate office shall not discharge the liability of 7 any person. The personal and individual l iability shall apply to every person 8 holding a corporate office at the time the tax becomes or became due. 9 (c) Notwithstanding any other provision of this chapter, KRS 275.150, 362.1 - 10 306(3) or predecessor law, or 362.2 -404(3) to the contrary, the managers of 11 a limited liability company, the partners of a limited liability partnership, 12 and the general partners of a limited liability limited partnership, or any 13 other person holding any equivalent office of a limited liability company, 14 limited liability partne rship, or limited liability limited partnership subject to 15 the provisions of this section shall be personally and individually liable, 16 both jointly and severally, for the tax imposed under this section. 17 (d) Dissolution, withdrawal of the limited liability company, limited liability 18 partnership, or limited liability limited partnership from the state, or the 19 cessation of holding any office shall not discharge the liability of any 20 person. The personal and individual liability shall apply to every manager 21 of a limited liability company, partner of a limited liability partnership, or 22 general partner of a limited liability limited partnership at the time the tax 23 becomes or became due. 24 (e) No person shall be personally and individually liable under this section wh o 25 had no authority to truthfully account for, or pay over, any tax imposed by 26 this section at the time the tax imposed becomes or became due. 27 UNOFFICIAL COPY 22 RS BR 50 Page 90 of 138 XXXX Jacketed (f) \"Taxes\" as used in this section includes interest accrued at the rate 1 provided by KRS 131.183, all applicable penalties imposed under the 2 provisions of this chapter, and all applicable penalties imposed under KRS 3 131.180, 131.410 to 131.445, and 131.990. 4 (7) The department shall administer the provisions of this section and shall have all 5 of the powers, rights, du ties, and authority with respect to the assessment, 6 collection, refunding, and administration of the taxes levied by this section, 7 conferred generally upon the department by the Kentucky Revised Statutes, 8 including KRS Chapters 131, 134, and 135. 9 (8) Every cultivator, processor, and producer shall keep records, receipts, invoices, 10 and other pertinent papers in such form as the department may require for not 11 less than four (4) years from the making of such records, receipts, invoices, and 12 other pertinent pap ers. 13 Section 34. KRS 139.470 is amended to read as follows: 14 There are excluded from the computation of the amount of taxes imposed by this chapter: 15 (1) Gross receipts from the sale of, and the storage, use, or other consumption in this 16 state of, tangible personal property or digital property which this state is prohibited 17 from taxing under the Constitution or laws of the United States, or under the 18 Consti tution of this state; 19 (2) Gross receipts from sales of, and the storage, use, or other consumption in this state 20 of: 21 (a) Nonreturnable and returnable containers when sold without the contents to 22 persons who place the contents in the container and sell the contents together 23 with the container; and 24 (b) Returnable containers when sold with the contents in connection with a retail 25 sale of the contents or when resold for refilling; 26 As used in this section the term \"returnable containers\" means containers of a k ind 27 UNOFFICIAL COPY 22 RS BR 50 Page 91 of 138 XXXX Jacketed customarily returned by the buyer of the contents for reuse. All other containers are 1 \"nonreturnable containers\"; 2 (3) Gross receipts from occasional sales of tangible personal property or digital 3 property and the storage, use, or other consumption in t his state of tangible personal 4 property or digital property, the transfer of which to the purchaser is an occasional 5 sale; 6 (4) Gross receipts from sales of tangible personal property to a common carrier, 7 shipped by the retailer via the purchasing carrier u nder a bill of lading, whether the 8 freight is paid in advance or the shipment is made freight charges collect, to a point 9 outside this state and the property is actually transported to the out -of-state 10 destination for use by the carrier in the conduct of i ts business as a common carrier; 11 (5) Gross receipts from sales of tangible personal property sold through coin -operated 12 bulk vending machines, if the sale amounts to fifty cents ($0.50) or less, if the 13 retailer is primarily engaged in making the sales and maintains records satisfactory 14 to the department. As used in this subsection, \"bulk vending machine\" means a 15 vending machine containing unsorted merchandise which, upon insertion of a coin, 16 dispenses the same in approximately equal portions, at random and without 17 selection by the customer; 18 (6) Gross receipts from sales to any cabinet, department, bureau, commission, board, or 19 other statutory or constitutional agency of the state and gross receipts from sales to 20 counties, cities, or special districts as defi ned in KRS 65.005. This exemption shall 21 apply only to purchases of tangible personal property, digital property, or services 22 for use solely in the government function. A purchaser not qualifying as a 23 governmental agency or unit shall not be entitled to the exemption even though the 24 purchaser may be the recipient of public funds or grants; 25 (7) (a) Gross receipts from the sale of sewer services, water, and fuel to Kentucky 26 residents for use in heating, water heating, cooking, lighting, and other 27 UNOFFICIAL COPY 22 RS BR 50 Page 92 of 138 XXXX Jacketed residential u ses. As used in this subsection, \"fuel\" shall include but not be 1 limited to natural gas, electricity, fuel oil, bottled gas, coal, coke, and wood. 2 Determinations of eligibility for the exemption shall be made by the 3 department; 4 (b) In making the determinat ions of eligibility, the department shall exempt from 5 taxation all gross receipts derived from sales: 6 1. Classified as \"residential\" by a utility company as defined by applicable 7 tariffs filed with and accepted by the Public Service Commission; 8 2. Classifi ed as \"residential\" by a municipally owned electric distributor 9 which purchases its power at wholesale from the Tennessee Valley 10 Authority; 11 3. Classified as \"residential\" by the governing body of a municipally owned 12 electric distributor which does not purc hase its power from the 13 Tennessee Valley Authority, if the \"residential\" classification is 14 reasonably consistent with the definitions of \"residential\" contained in 15 tariff filings accepted and approved by the Public Service Commission 16 with respect to utilit ies which are subject to Public Service Commission 17 regulation. 18 If the service is classified as residential, use other than for \"residential\" 19 purposes by the customer shall not negate the exemption; 20 (c) The exemption shall not apply if charges for sewer se rvice, water, and fuel are 21 billed to an owner or operator of a multi -unit residential rental facility or 22 mobile home and recreational vehicle park other than residential 23 classification; and 24 (d) The exemption shall apply also to residential property which m ay be held by 25 legal or equitable title, by the entireties, jointly, in common, as a 26 condominium, or indirectly by the stock ownership or membership 27 UNOFFICIAL COPY 22 RS BR 50 Page 93 of 138 XXXX Jacketed representing the owner's or member's proprietary interest in a corporation 1 owning a fee or a leasehold initi ally in excess of ninety -eight (98) years; 2 (8) Gross receipts from sales to an out -of-state agency, organization, or institution 3 exempt from sales and use tax in its state of residence when that agency, 4 organization, or institution gives proof of its tax -exempt status to the retailer and the 5 retailer maintains a file of the proof; 6 (9) (a) Gross receipts derived from the sale of tangible personal property, as provided 7 in paragraph (b) of this subsection, to a manufacturer or industrial processor if 8 the prope rty is to be directly used in the manufacturing or industrial 9 processing process of: 10 1. Tangible personal property at a plant facility; 11 2. Distilled spirits or wine at a plant facility or on the premises of a 12 distiller, rectifier, winery, or small farm win ery licensed under KRS 13 243.030 that includes a retail establishment on the premises; or 14 3. Malt beverages at a plant facility or on the premises of a brewer or 15 microbrewery licensed under KRS 243.040 that includes a retail 16 establishment; 17 and which will be for sale. 18 (b) The following tangible personal property shall qualify for exemption under 19 this subsection: 20 1. Materials which enter into and become an ingredient or component part 21 of the manufactured product; 22 2. Other tangible personal property which is directly used in the 23 manufacturing or industrial processing process, if the property has a 24 useful life of less than one (1) year. Specifically these items are 25 categorized as follows: 26 a. Materials. This refers to th e raw materials which become an 27 UNOFFICIAL COPY 22 RS BR 50 Page 94 of 138 XXXX Jacketed ingredient or component part of supplies or industrial tools exempt 1 under subdivisions b. and c. below; 2 b. Supplies. This category includes supplies such as lubricating and 3 compounding oils, grease, machine waste, abrasives, chemicals, 4 solvents, fluxes, anodes, filtering materials, fire brick, catalysts, 5 dyes, refrigerants, and explosives. The supplies indicated above 6 need not come in direct contact with a manufactured product to be 7 exempt. \"Supplies\" does not include repair, replacement, or spare 8 parts of any kind; and 9 c. Industrial tools. This group is limited to hand tools such as jigs, 10 dies, drills, cutters, rolls, reamers, chucks, saws, and spray guns 11 and to tools attached to a machine such as molds, grinding balls, 12 grind ing wheels, dies, bits, and cutting blades. Normally, for 13 industrial tools to be considered directly used in the manufacturing 14 or industrial processing process, they shall come into direct contact 15 with the product being manufactured or processed; and 16 3. Materials and supplies that are not reusable in the same manufacturing 17 or industrial processing process at the completion of a single 18 manufacturing or processing cycle. A single manufacturing cycle shall 19 be considered to be the period elapsing from the time the raw materials 20 enter into the manufacturing process until the finished product emerges 21 at the end of the manufacturing process. 22 (c) The property described in paragraph (b) of this subsection shall be regarded as 23 having been purchased for resale. 24 (d) For purposes of this subsection, a manufacturer or industrial processor 25 includes an individual or business entity that performs only part of the 26 manufacturing or industrial processing activity, and the person or business 27 UNOFFICIAL COPY 22 RS BR 50 Page 95 of 138 XXXX Jacketed entity need not take title to tangible personal property that is incorporated into, 1 or becomes the product of, the activity. 2 (e) The exemption provided in this subsection does not include repair, 3 replacement, or spare parts; 4 (10) Any water use fee paid or passed through to the Kentucky River A uthority by 5 facilities using water from the Kentucky River basin to the Kentucky River 6 Authority in accordance with KRS 151.700 to 151.730 and administrative 7 regulations promulgated by the authority; 8 (11) Gross receipts from the sale of newspaper inserts o r catalogs purchased for storage, 9 use, or other consumption outside this state and delivered by the retailer's own 10 vehicle to a location outside this state, or delivered to the United States Postal 11 Service, a common carrier, or a contract carrier for deliv ery outside this state, 12 regardless of whether the carrier is selected by the purchaser or retailer or an agent 13 or representative of the purchaser or retailer, or whether the F.O.B. is retailer's 14 shipping point or purchaser's destination. 15 (a) As used in thi s subsection: 16 1. \"Catalogs\" means tangible personal property that is printed to the special 17 order of the purchaser and composed substantially of information 18 regarding goods and services offered for sale; and 19 2. \"Newspaper inserts\" means printed materials t hat are placed in or 20 distributed with a newspaper of general circulation. 21 (b) The retailer shall be responsible for establishing that delivery was made to a 22 non-Kentucky location through shipping documents or other credible evidence 23 as determined by the de partment; 24 (12) Gross receipts from the sale of water used in the raising of equine as a business; 25 (13) Gross receipts from the sale of metal retail fixtures manufactured in this state and 26 purchased for storage, use, or other consumption outside this state and delivered by 27 UNOFFICIAL COPY 22 RS BR 50 Page 96 of 138 XXXX Jacketed the retailer's own vehicle to a location outside this state, or delivered to the United 1 States Postal Service, a common carrier, or a contract carrier for delivery outside 2 this state, regardless of whether the carrier is selected by the pu rchaser or retailer or 3 an agent or representative of the purchaser or retailer, or whether the F.O.B. is the 4 retailer's shipping point or the purchaser's destination. 5 (a) As used in this subsection, \"metal retail fixtures\" means check stands and 6 belted and nonbelted checkout counters, whether made in bulk or pursuant to 7 specific purchaser specifications, that are to be used directly by the purchaser 8 or to be distributed by the purchaser. 9 (b) The retailer shall be responsible for establishing that delivery w as made to a 10 non-Kentucky location through shipping documents or other credible evidence 11 as determined by the department; 12 (14) Gross receipts from the sale of unenriched or enriched uranium purchased for 13 ultimate storage, use, or other consumption outside this state and delivered to a 14 common carrier in this state for delivery outside this state, regardless of whether the 15 carrier is selected by the purchaser or retailer, or is an agent or representative of the 16 purchaser or retailer, or whether the F.O.B. is the retailer's shipping point or 17 purchaser's destination; 18 (15) Amounts received from a tobacco buydown. As used in this subsection, \"buydown\" 19 means an agreement whereby an amount, whether paid in money, credit, or 20 otherwise, is received by a retailer from a manufacturer or wholesaler based upon 21 the quantity and unit price of tobacco products sold at retail that requires the retailer 22 to reduce the selling price of the product to the purchaser without the use of a 23 manufacturer's or wholesaler's coupon or rede mption certificate; 24 (16) Gross receipts from the sale of tangible personal property or digital property 25 returned by a purchaser when the full sales price is refunded either in cash or credit. 26 This exclusion shall not apply if the purchaser, in order to obt ain the refund, is 27 UNOFFICIAL COPY 22 RS BR 50 Page 97 of 138 XXXX Jacketed required to purchase other tangible personal property or digital property at a price 1 greater than the amount charged for the property that is returned; 2 (17) Gross receipts from the sales of gasoline and special fuels subject to tax under KRS 3 Chapter 138; 4 (18) The amount of any tax imposed by the United States upon or with respect to retail 5 sales, whether imposed on the retailer or the consumer, not including any 6 manufacturer's excise or import duty; 7 (19) Gross receipts from the sale of an y motor vehicle as defined in KRS 138.450 which 8 is: 9 (a) Sold to a Kentucky resident, registered for use on the public highways, and 10 upon which any applicable tax levied by KRS 138.460 has been paid; or 11 (b) Sold to a nonresident of Kentucky if the nonresident registers the motor 12 vehicle in a state that: 13 1. Allows residents of Kentucky to purchase motor vehicles without 14 payment of that state's sales tax at the time of sale; or 15 2. Allows residents of Kentucky t o remove the vehicle from that state 16 within a specific period for subsequent registration and use in Kentucky 17 without payment of that state's sales tax; 18 (20) Gross receipts from the sale of a semi -trailer as defined in KRS 189.010(12) and 19 trailer as define d in KRS 189.010(17); 20 (21) Gross receipts from the collection of: 21 (a) Any fee or charge levied by a local government pursuant to KRS 65.760; 22 (b) The charge imposed by KRS 65.7629(3); 23 (c) The fee imposed by KRS 65.7634; and 24 (d) The service charge imposed by KRS 65.7636; 25 (22) Gross receipts derived from charges for labor or services to apply, install, repair, or 26 maintain tangible personal property directly used in manufacturing or industrial 27 UNOFFICIAL COPY 22 RS BR 50 Page 98 of 138 XXXX Jacketed processing process of: 1 (a) Tangible personal property at a plant fac ility; 2 (b) Distilled spirits or wine at a plant facility or on the premises of a distiller, 3 rectifier, winery, or small farm winery licensed under KRS 243.030; or 4 (c) Malt beverages at a plant facility or on the premises of a brewer or 5 microbrewery license d under KRS 243.040 6 that is not otherwise exempt under subsection (9) of this section or KRS 7 139.480(10), if the charges for labor or services are separately stated on the invoice, 8 bill of sale, or similar document given to purchaser; 9 (23) (a) For persons selling services included in KRS 139.200(2)(g) to (q) prior to 10 January 1, 2019, gross receipts derived from the sale of those services if the 11 gross receipts were less than six thousand dollars ($6,000) during calendar 12 year 2018. When gross receipts from t hese services exceed six thousand 13 dollars ($6,000) in a calendar year: 14 1. All gross receipts over six thousand dollars ($6,000) are taxable in that 15 calendar year; and 16 2. All gross receipts are subject to tax in subsequent calendar years. 17 (b) The exemption provided in this subsection shall not apply to a person also 18 engaged in the business of selling tangible personal property, digital property, 19 or services included in KRS 139.200(2)(a) to (f); [ and] 20 (24) (a) For persons that first begin making sales of serv ices included in KRS 21 139.200(2)(g) to (q) on or after January 1, 2019, gross receipts derived from 22 the sale of those services if the gross receipts are less than six thousand dollars 23 ($6,000) within the first calendar year of operation. When gross receipts from 24 these services exceed six thousand dollars ($6,000) in a calendar year: 25 1. All gross receipts over six thousand dollars ($6,000) are taxable in that 26 calendar year; and 27 UNOFFICIAL COPY 22 RS BR 50 Page 99 of 138 XXXX Jacketed 2. All gross receipts are subject to tax in subsequent calendar years. 1 (b) The exe mption provided in this subsection shall not apply to a person that is 2 also engaged in the business of selling tangible personal property, digital 3 property, or services included in KRS 139.200(2)(a) to (f) ; and 4 (25) Gross receipts from the sale of medicina l cannabis as defined in Section 1 of this 5 Act and subject to tax under Section 33 of this Act . 6 Section 35. KRS 138.870 is amended to read as follows: 7 As used in KRS 138.870 to 138.889, unless the context requires otherwise: 8 (1) \"Marijuana\" means marijuana, whether real or counterfeit, as defined in KRS 9 218A.010 and does not include medicinal cannabis as defined in Section 1 of this 10 Act. 11 (2) \"Controlled substance\" means any controlled substance, whether real or counterfeit, 12 as defined in KRS 218A.010 or any regulation promulgated thereunder, except that 13 it shall not include marijuana. 14 (3) \"Offender\" means a person who engages in this state in a taxable ac tivity as defined 15 in subsection (4) of this section. 16 (4) \"Taxable activity\" means producing, cultivating, manufacturing, importing, 17 transporting, distributing, acquiring, purchasing, storing, selling, using, or otherwise 18 possessing, in violation of KRS Cha pter 218A, more than five (5) marijuana plants 19 with foliation, 42.5 grams of marijuana which has been detached from the plant on 20 which it grew, seven (7) grams of any controlled substance, or fifty (50) or more 21 dosage units of any controlled substance whic h is not sold by weight. The weight or 22 dosage units in this subsection shall include the weight of marijuana or the weight 23 or dosage units of the controlled substance, whether pure, impure, or diluted. A 24 quantity of a controlled substance is diluted if it consists of a detectable quantity of 25 a pure controlled substance and any excipients or fillers. 26 (5) \"Dosage unit\" means a tablet, capsule, vial, or ampule of a controlled substance or, 27 UNOFFICIAL COPY 22 RS BR 50 Page 100 of 138 XXXX Jacketed in cases of mass volume or diluted quantities, the proper dose or quant ity of a 1 controlled substance to be taken all at one (1) time or in fractional amounts within a 2 given period, as defined and adopted by the United States Pharmacopeia. 3 (6) \"Possessing\" includes either actual possession or constructive possession, or a 4 comb ination of both actual and constructive possession. Mere possession or 5 ownership of real estate or an interest therein does not establish constructive 6 possession. 7 Section 36. KRS 216B.402 is amended to read as follows: 8 (1) When a person is admitted to a hospital emergency department or hospital 9 emergency room for treatment of a drug overdose: 10 (a)[(1)] The person shall be informed of available substance use disorder 11 treatment services known to the hospital that are provid ed by that hospital, 12 other local hospitals, the local community mental health center, and any other 13 local treatment programs licensed pursuant to KRS 222.231; 14 (b)[(2)] The hospital may obtain permission from the person when stabilized, or 15 the person's lega l representative, to contact any available substance use 16 disorder treatment programs offered by that hospital, other local hospitals, the 17 local community mental health center, or any other local treatment programs 18 licensed pursuant to KRS 222.231, on behal f of the person to connect him or 19 her to treatment; and 20 (c)[(3)] The local community mental health center may provide an on -call 21 service in the hospital emergency department or hospital emergency room for 22 the person who was treated for a drug overdose to p rovide information about 23 services and connect the person to substance use disorder treatment, as funds 24 are available. These services, when provided on the grounds of a hospital, 25 shall be coordinated with appropriate hospital staff. 26 (2) When a person who is a registered qualified patient or a visiting qualified patient 27 UNOFFICIAL COPY 22 RS BR 50 Page 101 of 138 XXXX Jacketed as defined in Section 1 of this Act is admitted to a hospital emergency department 1 or a hospital emergency room for treatment of cannabinoid hyperemesis 2 syndrome, the hospital shall notify the Department for Public Health within 3 forty -eight (48) hours. Notification shall include the registered qualified patient's 4 or a visiting qualified patient's name and registry identification card number, if 5 available. The department shall record all cases o f cannabinoid hyperemesis 6 syndrome in the electronic monitoring system established pursuant to Section 41 7 of this Act. 8 Section 37. KRS 218A.010 is amended to read as follows: 9 As used in this chapter: 10 (1) \"Administer\" mea ns the direct application of a controlled substance, whether by 11 injection, inhalation, ingestion, or any other means, to the body of a patient or 12 research subject by: 13 (a) A practitioner or by his or her authorized agent under his or her immediate 14 supervisi on and pursuant to his or her order; or 15 (b) The patient or research subject at the direction and in the presence of the 16 practitioner; 17 (2) \"Anabolic steroid\" means any drug or hormonal substance chemically and 18 pharmacologically related to testosterone that promotes muscle growth and includes 19 those substances classified as Schedule III controlled substances pursuant to KRS 20 218A.020 but does not include estrogens, progestins, and anticosteroids; 21 (3) \"Cabinet\" means the Cabinet for Health and Family Services; 22 (4) \"Carfentanil\" means any substance containing any quantity of carfentanil, or any of 23 its salts, isomers, or salts of isomers; 24 (5) \"Certified community based palliative care program\" means a palliative care 25 program which has received certification from th e Joint Commission; 26 (6) \"Child\" means any person under the age of majority as specified in KRS 2.015; 27 UNOFFICIAL COPY 22 RS BR 50 Page 102 of 138 XXXX Jacketed (7) \"Cocaine\" means a substance containing any quantity of cocaine, its salts, optical 1 and geometric isomers, and salts of isomers; 2 (8) \"Controlled substa nce\" means methamphetamine, or a drug, substance, or 3 immediate precursor in Schedules I through V and includes a controlled substance 4 analogue; 5 (9) (a) \"Controlled substance analogue,\" except as provided in paragraph (b) of this 6 subsection, means a substan ce: 7 1. The chemical structure of which is substantially similar to the structure 8 of a controlled substance in Schedule I or II; and 9 2. Which has a stimulant, depressant, or hallucinogenic effect on the 10 central nervous system that is substantially similar to or greater than the 11 stimulant, depressant, or hallucinogenic effect on the central nervous 12 system of a controlled substance in Schedu le I or II; or 13 3. With respect to a particular person, which such person represents or 14 intends to have a stimulant, depressant, or hallucinogenic effect on the 15 central nervous system that is substantially similar to or greater than the 16 stimulant, depressan t, or hallucinogenic effect on the central nervous 17 system of a controlled substance in Schedule I or II. 18 (b) Such term does not include: 19 1. Any substance for which there is an approved new drug application; 20 2. With respect to a particular person, any subst ance if an exemption is in 21 effect for investigational use for that person pursuant to federal law to 22 the extent conduct with respect to such substance is pursuant to such 23 exemption; or 24 3. Any substance to the extent not intended for human consumption befor e 25 the exemption described in subparagraph 2. of this paragraph takes 26 effect with respect to that substance; 27 UNOFFICIAL COPY 22 RS BR 50 Page 103 of 138 XXXX Jacketed (10) \"Counterfeit substance\" means a controlled substance which, or the container or 1 labeling of which, without authorization, bears the trademark, trade name, or other 2 identifying mark, imprint, number, or device, or any likeness thereof, of a 3 manufacturer, distributor, or dispenser other than the person who in fact 4 manufactured, distributed, or dispensed the substance; 5 (11) \"Dispense\" means to deliv er a controlled substance to an ultimate user or research 6 subject by or pursuant to the lawful order of a practitioner, including the packaging, 7 labeling, or compounding necessary to prepare the substance for that delivery; 8 (12) \"Dispenser\" means a person who lawfully dispenses a Schedule II, III, IV, or V 9 controlled substance to or for the use of an ultimate user; 10 (13) \"Distribute\" means to deliver other than by administering or dispensing a controlled 11 substance; 12 (14) \"Dosage unit\" means a single pill, cap sule, ampule, liquid, or other form of 13 administration available as a single unit; 14 (15) \"Drug\" means: 15 (a) Substances recognized as drugs in the official United States Pharmacopoeia, 16 official Homeopathic Pharmacopoeia of the United States, or official Nation al 17 Formulary, or any supplement to any of them; 18 (b) Substances intended for use in the diagnosis, care, mitigation, treatment, or 19 prevention of disease in man or animals; 20 (c) Substances (other than food) intended to affect the structure or any function of 21 the body of man or animals; and 22 (d) Substances intended for use as a component of any article specified in this 23 subsection. 24 It does not include devices or their components, parts, or accessories; 25 (16) \"Fentanyl\" means a substance containing any quantity o f fentanyl, or any of its salts, 26 isomers, or salts of isomers; 27 UNOFFICIAL COPY 22 RS BR 50 Page 104 of 138 XXXX Jacketed (17) \"Fentanyl derivative\" means a substance containing any quantity of any chemical 1 compound, except compounds specifically scheduled as controlled substances by 2 statute or by administrative r egulation pursuant to this chapter, which is structurally 3 derived from 1 -ethyl -4-(N-phenylamido) piperadine: 4 (a) By substitution: 5 1. At the 2 -position of the 1 -ethyl group with a phenyl, furan, thiophene, or 6 ethyloxotetrazole ring system; and 7 2. Of the ter minal amido hydrogen atom with an alkyl, alkoxy, cycloalkyl, 8 or furanyl group; and 9 (b) Which may be further modified in one (1) or more of the following ways: 10 1. By substitution on the N -phenyl ring to any extent with alkyl, alkoxy, 11 haloalkyl, hydroxyl, or halide substituents; 12 2. By substitution on the piperadine ring to any extent with alkyl, allyl, 13 alkoxy, hydroxy, or halide substituents at the 2 -, 3-, 5-, and/or 6 - 14 positions; 15 3. By substitution on the piperadine ring to any extent with a phenyl, 16 alkoxy, or carboxylate ester substituent at the 4 - position; or 17 4. By substitution on the 1 -ethyl group to any extent with alkyl, alkoxy, or 18 hydroxy substituents; 19 (18) \"Good faith prior ex amination,\" as used in KRS Chapter 218A and for criminal 20 prosecution only, means an in -person medical examination of the patient conducted 21 by the prescribing practitioner or other health -care professional routinely relied 22 upon in the ordinary course of his or her practice, at which time the patient is 23 physically examined and a medical history of the patient is obtained. \"In -person\" 24 includes telehealth examinations. This subsection shall not be applicable to hospice 25 providers licensed pursuant to KRS Chapter 216B; 26 (19) \"Hazardous chemical substance\" includes any chemical substance used or intended 27 UNOFFICIAL COPY 22 RS BR 50 Page 105 of 138 XXXX Jacketed for use in the illegal manufacture of a controlled substance as defined in this section 1 or the illegal manufacture of methamphetamine as defined in KRS 218A.1431, 2 which: 3 (a) Poses an explosion hazard; 4 (b) Poses a fire hazard; or 5 (c) Is poisonous or injurious if handled, swallowed, or inhaled; 6 (20) \"Heroin\" means a substance containing any quantity of heroin, or any of its salts, 7 isomers, or salts of isomers; 8 (21) \"Hydrocodone combination product\" means a drug with: 9 (a) Not more than three hundred (300) milligrams of dihydrocodeinone, or any of 10 its salts, per one hundred (100) milliliters or not more than fifteen (15) 11 milligrams per dosage unit, with a fourfold or grea ter quantity of an 12 isoquinoline alkaloid of opium; or 13 (b) Not more than three hundred (300) milligrams of dihydrocodeinone, or any of 14 its salts, per one hundred (100) milliliters or not more than fifteen (15) 15 milligrams per dosage unit, with one (1) or mor e active, nonnarcotic 16 ingredients in recognized therapeutic amounts; 17 (22) \"Immediate precursor\" means a substance which is the principal compound 18 commonly used or produced primarily for use, and which is an immediate chemical 19 intermediary used or likely to be used in the manufacture of a controlled substance 20 or methamphetamine, the control of which is necessary to prevent, curtail, or limit 21 manufacture; 22 (23) \"Industrial hemp\" has the same meaning as in KRS 260.850; 23 (24) \"Industrial hemp products\" has the sa me meaning as in KRS 260.850; 24 (25) \"Intent to manufacture\" means any evidence which demonstrates a person's 25 conscious objective to manufacture a controlled substance or methamphetamine. 26 Such evidence includes but is not limited to statements and a chemical substance's 27 UNOFFICIAL COPY 22 RS BR 50 Page 106 of 138 XXXX Jacketed usage, quantity, manner of storage, or proximity to other chemical substances or 1 equipment used to manufacture a controlled substance or methamphetamine; 2 (26) \"Isomer\" means the optical isomer, except the Cabinet for Health and Family 3 Services may include the optical, positional, or geometric isomer to classify any 4 substance pursuant to KRS 218A.020; 5 (27) \"Manufacture,\" except as provided in KRS 218A.1431, means the production, 6 preparation, propagation, compounding, conversion, or processing of a controlled 7 substance, either directly or indirectly by extraction from substances of natural 8 origin or independently by means of chemical synthesis, or by a combination of 9 extraction and chemical synthesis, and includes any packaging or repackaging of t he 10 substance or labeling or relabeling of its container except that this term does not 11 include activities: 12 (a) By a practitioner as an incident to his or her administering or dispensing of a 13 controlled substance in the course of his or her professional pra ctice; 14 (b) By a practitioner, or by his or her authorized agent under his supervision, for 15 the purpose of, or as an incident to, research, teaching, or chemical analysis 16 and not for sale; or 17 (c) By a pharmacist as an incident to his or her dispensing of a controlled 18 substance in the course of his or her professional practice; 19 (28) \"Marijuana\" means all parts of the plant Cannabis sp., whether growing or not; the 20 seeds thereof; the resin extracted from any part of the plant; and every compound, 21 manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin 22 or any compound, mixture, or preparation which contains any quantity of these 23 substances. The term \"marijuana\" does not include: 24 (a) Industrial hemp that is in the possession, custo dy, or control of a person who 25 holds a license issued by the Department of Agriculture permitting that person 26 to cultivate, handle, or process industrial hemp; 27 UNOFFICIAL COPY 22 RS BR 50 Page 107 of 138 XXXX Jacketed (b) Industrial hemp products that do not include any living plants, viable seeds, 1 leaf materials , or floral materials; 2 (c) The substance cannabidiol, when transferred, dispensed, or administered 3 pursuant to the written order of a physician practicing at a hospital or 4 associated clinic affiliated with a Kentucky public university having a college 5 or school of medicine; 6 (d) For persons participating in a clinical trial or in an expanded access program, 7 a drug or substance approved for the use of those participants by the United 8 States Food and Drug Administration; 9 (e) A cannabidiol product derived from industrial hemp, as defined in KRS 10 260.850; 11 (f) For the purpose of conducting scientific research, a cannabinoid product 12 derived from industrial hemp, as defined in KRS 260.850; [ or] 13 (g) A cannabinoid product approved as a prescription medication by the United 14 States Food and Drug Administration; or 15 (h) Medicinal cannabis as defined in Section 1 of this Act; 16 (29) \"Medical history,\" as used in KRS Chapter 218A and for criminal prosecution o nly, 17 means an accounting of a patient's medical background, including but not limited to 18 prior medical conditions, prescriptions, and family background; 19 (30) \"Medical order,\" as used in KRS Chapter 218A and for criminal prosecution only, 20 means a lawful ord er of a specifically identified practitioner for a specifically 21 identified patient for the patient's health -care needs. \"Medical order\" may or may 22 not include a prescription drug order; 23 (31) \"Medical record,\" as used in KRS Chapter 218A and for criminal pr osecution only, 24 means a record, other than for financial or billing purposes, relating to a patient, 25 kept by a practitioner as a result of the practitioner -patient relationship; 26 (32) \"Methamphetamine\" means any substance that contains any quantity of 27 UNOFFICIAL COPY 22 RS BR 50 Page 108 of 138 XXXX Jacketed metha mphetamine, or any of its of isomers; 1 (33) \"Narcotic drug\" means any of the following, whether produced directly or indirectly 2 by extraction from substances of vegetable origin, or independently by means of 3 chemical synthesis, or b y a combination of extraction and chemical synthesis: 4 (a) Opium and opiate, and any salt, compound, derivative, or preparation of 5 opium or opiate; 6 (b) Any salt, compound, isomer, derivative, or preparation thereof which is 7 chemically equivalent or identica l with any of the substances referred to in 8 paragraph (a) of this subsection, but not including the isoquinoline alkaloids 9 of opium; 10 (c) Opium poppy and poppy straw; 11 (d) Coca leaves, except coca leaves and extracts of coca leaves from which 12 cocaine, ecgoni ne, and derivatives of ecgonine or their salts have been 13 removed; 14 (e) Cocaine, its salts, optical and geometric isomers, and salts of isomers; 15 (f) Ecgonine, its derivatives, their salts, isomers, and salts of isomers; and 16 (g) Any compound, mixture, or prep aration which contains any quantity of any of 17 the substances referred to in paragraphs (a) to (f) of this subsection; 18 (34) \"Opiate\" means any substance having an addiction -forming or addiction -sustaining 19 liability similar to morphine or being capable of co nversion into a drug having 20 addiction -forming or addiction -sustaining liability. It does not include, unless 21 specifically designated as controlled under KRS 218A.020, the dextrorotatory 22 salts does racemic and levorotatory forms; 24 (35) \"Opium poppy\" means the plant of the species papaver somniferum L., except its 25 seeds; 26 (36) \"Person\" means individual, corporation, government or governmental subdivision 27 UNOFFICIAL COPY 22 RS BR 50 Page 109 of 138 XXXX Jacketed or agency, business trust, estate, trust, partnership or association, or any other legal 1 entity; 2 (37) \"Physical injury\" has the same meaning it has in KRS 500.080; 3 (38) \"Poppy straw\" means all parts, except the seeds, of the opium poppy, after mowing; 4 (39) \"Pharmacist\" means a natur al person licensed by this state to engage in the practice 5 of the profession of pharmacy; 6 (40) \"Practitioner\" means a physician, dentist, podiatrist, veterinarian, scientific 7 investigator, optometrist as authorized in KRS 320.240, advanced practice 8 registe red nurse as authorized under KRS 314.011, physician assistant as authorized 9 under KRS 311.858, or other person licensed, registered, or otherwise permitted by 10 state or federal law to acquire, distribute, dispense, conduct research with respect to, 11 or to a dminister a controlled substance in the course of professional practice or 12 research in this state. \"Practitioner\" also includes a physician, dentist, podiatrist, 13 veterinarian, or advanced practice registered nurse authorized under KRS 314.011 14 who is a resi dent of and actively practicing in a state other than Kentucky and who 15 is licensed and has prescriptive authority for controlled substances under the 16 professional licensing laws of another state, unless the person's Kentucky license 17 has been revoked, suspe nded, restricted, or probated, in which case the terms of the 18 Kentucky license shall prevail; 19 (41) \"Practitioner -patient relationship,\" as used in KRS Chapter 218A and for criminal 20 prosecution only, means a medical relationship that exists between a patien t and a 21 practitioner or the practitioner's designee, after the practitioner or his or her 22 designee has conducted at least one (1) good faith prior examination; 23 (42) \"Prescription\" means a written, electronic, or oral order for a drug or medicine, or 24 combin ation or mixture of drugs or medicines, or proprietary preparation, signed or 25 given or authorized by a medical, dental, chiropody, veterinarian, optometric 26 practitioner, or advanced practice registered nurse, and intended for use in the 27 UNOFFICIAL COPY 22 RS BR 50 Page 110 of 138 XXXX Jacketed diagnosis, cure, mi tigation, treatment, or prevention of disease in man or other 1 animals; 2 (43) \"Prescription blank,\" with reference to a controlled substance, means a document 3 that meets the requirements of KRS 218A.204 and 217.216; 4 (44) \"Presumptive probation\" means a sente nce of probation not to exceed the maximum 5 term specified for the offense, subject to conditions otherwise authorized by law, 6 that is presumed to be the appropriate sentence for certain offenses designated in 7 this chapter, notwithstanding contrary provisio ns of KRS Chapter 533. That 8 presumption shall only be overcome by a finding on the record by the sentencing 9 court of substantial and compelling reasons why the defendant cannot be safely and 10 effectively supervised in the community, is not amenable to commu nity-based 11 treatment, or poses a significant risk to public safety; 12 (45) \"Production\" includes the manufacture, planting, cultivation, growing, or harvesting 13 of a controlled substance; 14 (46) \"Recovery program\" means an evidence -based, nonclinical service th at assists 15 individuals and families working toward sustained recovery from substance use and 16 other criminal risk factors. This can be done through an array of support programs 17 and services that are delivered through residential and nonresidential means; 18 (47) \"Salvia\" means Salvia divinorum or Salvinorin A and includes all parts of the plant 19 presently classified botanically as Salvia divinorum, whether growing or not, the 20 seeds thereof, any extract from any part of that plant, and every compound, 21 manufacture , derivative, mixture, or preparation of that plant, its seeds, or its 22 extracts, including salts, isomers, and salts of isomers whenever the existence of 23 such salts, isomers, and salts of isomers is possible within the specific chemical 24 designation of that plant, its seeds, or extracts. The term shall not include any other 25 species in the genus salvia; 26 (48) \"Second or subsequent offense\" means that for the purposes of this chapter an 27 UNOFFICIAL COPY 22 RS BR 50 Page 111 of 138 XXXX Jacketed offense is considered as a second or subsequent offense, if, prior to his or her 1 conviction of the offense, the offender has at any time been convicted under this 2 chapter, or und er any statute of the United States, or of any state relating to 3 substances classified as controlled substances or counterfeit substances, except that 4 a prior conviction for a nontrafficking offense shall be treated as a prior offense 5 only when the subsequ ent offense is a nontrafficking offense. For the purposes of 6 this section, a conviction voided under KRS 218A.275 or 218A.276 shall not 7 constitute a conviction under this chapter; 8 (49) \"Sell\" means to dispose of a controlled substance to another person for 9 consideration or in furtherance of commercial distribution; 10 (50) \"Serious physical injury\" has the same meaning it has in KRS 500.080; 11 (51) \"Synthetic cannabinoids or piperazines\" means any chemical compound which is 12 not approved by the United States Food and Drug Administration or, if approved, 13 which is not dispensed or possessed in accordance with state and federal law, that 14 contains Benzylpiperazine (BZP); Trifluoromethylphenylpiperazine dexanabinol (HU -211); or any 17 compound in the following structural classes: 18 (a) Naphthoylindoles: Any compound containing a 3 -(1-naphthoyl)indole 19 structure with substitution at the nitrogen a tom of the indole ring by an alkyl, or 2 -(4-morpholinyl)ethyl group, whether or not further 22 substituted in the indole ring to any extent and whether or not substituted in 23 the naphthyl ring to any extent. Examples of this structural class include but 24 are not limited (b) Phenylacetylindoles: Any compound containing a 3 -phenylacetylindole 27 UNOFFICIAL COPY 22 RS BR 50 Page 112 of 138 XXXX Jacketed struct ure with substitution at the nitrogen atom of the indole ring by an alkyl, or 2 -(4-morpholinyl)ethyl group whether or not further 3 substituted in the indole ring to any extent and whether or not substituted in 4 the phenyl ring to any extent. Examples of this structural class include but are 5 not limited to JWH -167, JWH -250, JWH -251, and RCS Benzoylindoles: Any compound containing a 3 -(benzoyl)indole structure with 7 substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, -(N-methyl -2-piperidinyl)methyl, 9 or 2-(4-morpholinyl)ethyl group whether or not further substituted in the 10 indole ring to any extent an d whether or not substituted in the phenyl ring to 11 any extent. Examples of this structural class include but are not limited to 12 AM-630, AM -2233, AM -694, Pravadoline (WIN 48,098), and RCS -4; 13 (d) Cyclohexylphenols: Any compound containing a 2 -(3- 14 hydroxycyclo hexyl)phenol structure with substitution at the 5 -position of the 15 phenolic ring by -(N-methyl -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl 17 group whether or not substituted in the cyclohex yl ring to any extent. 18 Examples of this structural class include but are not limited to CP 47,497 and 19 its C8 homologue (cannabicyclohexanol); compound containing a 1H -indol -3-yl-(1- 21 naphthyl)methane structure with substitution at the nitrogen atom of the indole 22 ring by an alkyl, haloalkyl, alkenyl, -(N- 23 methyl -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl group whether or not 24 further substituted in the indole ring to any extent and whether o r not 25 substituted in the naphthyl ring to any extent. Examples of this structural class 26 include but are not limited to JWH -175, JWH -184, and JWH -185; 27 UNOFFICIAL COPY 22 RS BR 50 Page 113 of 138 XXXX Jacketed (f) Naphthoylpyrroles: Any compound containing a 3 -(1-naphthoyl)pyrrole 1 structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, or 2 -(4-morpholinyl)ethyl group whether or not further 4 substituted in the pyrrole ring to any extent and whether or not substituted in 5 the naphthyl ring to any extent. Examples of this structural class include but 6 are not limited to compound containing a 1 -(1- 8 naphthylmethyl)indene structure wit h substitution at the 3 -position of the 9 indene ring -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl group whether 11 or not further substituted in the indene ring to any extent an d whether or not 12 substituted in the naphthyl ring to any extent. Examples of this structural class 13 include but are not limited to JWH -176; 14 (h) Tetramethylcyclopropanoylindoles: Any compound containing a 3 -(1- 15 tetramethylcyclopropoyl)indole structure with su bstitution at the nitrogen 16 atom of the indole ring by an alkyl, haloalkyl, cycloalkylmethyl, 17 cycloalkylethyl, 1 -(N-methyl -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl 18 group, whether or not further substituted in the indole ring to any extent and 19 whether or not further substituted in the tetramethylcyclopropyl ring to any 20 extent. Examples of this structural class include but are not limited to UR -144 21 and XLR -11; 22 (i) Adamantoylindoles: Any compound containing a 3 -(1-adamantoyl)indole 23 structure with substit ution at the nitrogen atom of the indole ring alkyl, or 2 -(4-morpholinyl)ethyl group, whether or not further 26 substituted in the indole ring to any extent and whe ther or not substituted in 27 UNOFFICIAL COPY 22 RS BR 50 Page 114 of 138 XXXX Jacketed the adamantyl ring system to any extent. Examples of this structural class 1 include but are not limited to AB -001 and AM -1248; or 2 (j) Any other synthetic cannabinoid or piperazine which is not approved by the 3 United States Food an d Drug Administration or, if approved, which is not 4 dispensed or possessed in accordance with state and federal law; 5 (52) \"Synthetic cathinones\" means any chemical compound which is not approved by the 6 United States Food and Drug Administration or, if appr oved, which is not dispensed 7 or possessed in accordance with state and federal law (not including bupropion or 8 compounds listed under a different schedule) structurally derived from 2 - 9 aminopropan -1-one by substitution at the 1 -position with either phenyl, naphthyl, or 10 thiophene ring systems, whether or not the compound is further modified in one (1) 11 or more of the following ways: 12 (a) By substitution in the ring system to any extent with alkyl, alkylenedioxy, 13 alkoxy, haloalkyl, hydroxyl, or halide substituen ts, whether or not further 14 substituted in the ring system by one (1) or more other univalent substituents. 15 Examples of this class include but are not limited to 3,4 - 16 Methylenedioxycathinone (bk -MDA); 17 (b) By substitution at the 3 -position with an acyclic alk yl substituent. Examples of 18 this class include but are not limited to 2 -methylamino -1-phenylbutan -1-one 19 (buphedrone); 20 (c) By substitution at the 2 -amino nitrogen atom with alkyl, dialkyl, benzyl, or 21 methoxybenzyl groups, or by inclusion of the 2 -amino nitr ogen atom in a 22 cyclic structure. Examples of this class include but are not limited to 23 Dimethylcathinone, Ethcathinone, and -Pyrrolidinopropiophenone ( -PPP); 24 or 25 (d) Any other synthetic cathinone w hich is not approved by the United States 26 Food and Drug Administration or, if approved, is not dispensed or possessed 27 UNOFFICIAL COPY 22 RS BR 50 Page 115 of 138 XXXX Jacketed in accordance with state or federal law; 1 (53) \"Synthetic drugs\" means any synthetic cannabinoids or piperazines or any synthetic 2 cathinone s; 3 (54) \"Telehealth\" has the same meaning it has in KRS 311.550; 4 (55) \"Tetrahydrocannabinols\" means synthetic equivalents of the substances contained in 5 the plant, or in the resinous extractives of the plant Cannabis, sp. or synthetic 6 substances, derivativ es, and their isomers with similar chemical structure and 7 pharmacological activity such as the following: 8 (a) Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; 9 (b) Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; an d 10 (c) Delta 3, 4 cis or trans tetrahydrocannabinol, and its optical isomers; 11 (56) \"Traffic,\" except as provided in KRS 218A.1431, means to manufacture, distribute, 12 dispense, sell, transfer, or possess with intent to manufacture, distribute, dispense, 13 or se ll a controlled substance; 14 (57) \"Transfer\" means to dispose of a controlled substance to another person without 15 consideration and not in furtherance of commercial distribution; and 16 (58) \"Ultimate user\" means a person who lawfully possesses a controlled sub stance for 17 his or her own use or for the use of a member of his or her household or for 18 administering to an animal owned by him or her or by a member of his or her 19 household. 20 Section 38. KRS 218A.1421 is amended to read as follows: 21 (1) A person is guilty of trafficking in marijuana when he or she knowingly and 22 unlawfully traffics in marijuana , and the trafficking is not in compliance with, or 23 otherwise authorized by, Sections 1 to 30 o f this Act . 24 (2) Unless authorized by Sections 1 to 30 of this Act, trafficking in less than eight (8) 25 ounces of marijuana is: 26 (a) For a first offense a Class A misdemeanor. 27 UNOFFICIAL COPY 22 RS BR 50 Page 116 of 138 XXXX Jacketed (b) For a second or subsequent offense a Class D felony. 1 (3) Unless authorized by S ections 1 to 30 of this Act, trafficking in eight (8) or more 2 ounces but less than five (5) pounds of marijuana is: 3 (a) For a first offense a Class D felony. 4 (b) For a second or subsequent offense a Class C felony. 5 (4) Unless authorized by Sections 1 to 30 of this Act, trafficking in five (5) or more 6 pounds of marijuana is: 7 (a) For a first offense a Class C felony. 8 (b) For a second or subsequent offense a Class B felony. 9 (5) Unless authorized by Sections 1 to 30 of this Act, the unlawful possession by any 10 person of eight (8) or more ounces of marijuana shall be prima facie evidence that 11 the person possessed the marijuana with the intent to sell or transfer it. 12 (6) This section does not apply to: 13 (a) A cannabis business or a cannabis business agent, as define d in Section 1 14 of this Act, when acting in compliance with Sections 1 to 30 of this Act; or 15 (b) A cardholder, as defined in Section 1 of this Act, whose use of medicinal 16 cannabis is in compliance with Sections 1 to 30 of this Act. 17 Section 39. KRS 218A.1422 is amended to read as follows: 18 (1) A person is guilty of possession of marijuana when he or she knowingly and 19 unlawfully possesses marijuana , and the possession is not in compliance with, or 20 otherwise authorized by, Sec tions 1 to 30 of this Act . 21 (2) Possession of marijuana is a Class B misdemeanor, except that, KRS Chapter 532 22 to the contrary notwithstanding, the maximum term of incarceration shall be no 23 greater than forty -five (45) days. 24 (3) This section does not apply to: 25 (a) A cannabis business or a cannabis business agent, as defined in Section 1 26 of this Act, when acting in compliance with Sections 1 to 30 of this Act; or 27 UNOFFICIAL COPY 22 RS BR 50 Page 117 of 138 XXXX Jacketed (b) A cardholder, as defined in Section 1 of this Act, whose use of medicinal 1 cannabis is in comp liance with Sections 1 to 30 of this Act. 2 Section 40. KRS 218A.1423 is amended to read as follows: 3 (1) A person is guilty of marijuana cultivation when he or she knowingly and 4 unlawfully plants, cultivates, or harvests m arijuana with the intent to sell or transfer 5 it, and the cultivation is not in compliance with, or otherwise authorized by, 6 Sections 1 to 30 of this Act . 7 (2) Unless authorized by Sections 1 to 30 of this Act, marijuana cultivation of five (5) 8 or more plant s of marijuana is: 9 (a) For a first offense a Class D felony. 10 (b) For a second or subsequent offense a Class C felony. 11 (3) Unless authorized by Sections 1 to 30 of this Act, marijuana cultivation of fewer 12 than five (5) plants is: 13 (a) For a first offense a C lass A misdemeanor. 14 (b) For a second or subsequent offense a Class D felony. 15 (4) Unless authorized by Sections 1 to 30 of this Act, the planting, cultivating, or 16 harvesting of five (5) or more marijuana plants shall be prima facie evidence that 17 the marijuana plants were planted, cultivated, or harvested for the purpose of sale or 18 transfer. 19 (5) This section does not apply to a cannabis business or a cannabis business agent, 20 as defined in Section 1 of this Act, when acting in compliance with Sections 1 to 21 30 of this Act. 22 Section 41. KRS 218A.202 is amended to read as follows: 23 (1) As used in this sectio n: 24 (a) \"Cabinet\" means the cabinet for Health and Family Services; 25 (b) \"Cannabis business\" has the same meaning as in Section 1 of this Act; 26 (c) \"Controlled substance\" means Schedules II, III, IV, and V controlled 27 UNOFFICIAL COPY 22 RS BR 50 Page 118 of 138 XXXX Jacketed substances and does not include medicinal cannabis; 1 (d) \"Dispensary\" has the same meaning as in Section 1 of this Act; 2 (e) \"Dispensary agent\" has the same meaning as in Section 1 of this Act; 3 (f) \"Disqualifying felony offense\" has the same meaning as in Section 1 of this 4 Act; 5 (g) \"Medicinal cannab is\" has the same meaning as in Section 1 of this Act; 6 (h) \"Medical cannabis practitioner\" has the same meaning as in Section 1 of 7 this Act; 8 (i) \"Registry identification card\" has the same meaning as in Section 1 of this 9 Act; 10 (j) \"State licensing board\" has the same meaning as in Section 1 of this Act; 11 (k) \"Use of medicinal cannabis\" has the same meaning as in Section 1 of this 12 Act; and 13 (l) \"Written certification\" has the same meaning as in Section 1 of this Act. 14 (2) The cabinet [ for Health and Family Servic es] shall establish and maintain an 15 electronic system for monitoring Schedules II, III, IV, and V controlled substances 16 and medicinal cannabis as defined in Section 1 of this Act . The cabinet may 17 contract for the design, upgrade, or operation of this syste m if the contract preserves 18 all of the rights, privileges, and protections guaranteed to Kentucky citizens under 19 this chapter and the contract requires that all other aspects of the system be operated 20 in conformity with the requirements of this or any othe r applicable state or federal 21 law. 22 (3)[(2)] For the purpose of monitoring the prescribing and dispensing of controlled 23 substances: 24 (a) A practitioner or a pharmacist authorized to prescribe or dispense controlled 25 substances to humans shall register with th e cabinet to use the system 26 provided for in this section and shall maintain such registration continuously 27 UNOFFICIAL COPY 22 RS BR 50 Page 119 of 138 XXXX Jacketed during the practitioner's or pharmacist's term of licensure and shall not have to 1 pay a fee or tax specifically dedicated to the operation of the sys tem. 2 (b)[(3)] Every practitioner or pharmacy which dispenses a controlled substance 3 to a person in Kentucky, or to a person at an address in Kentucky, shall report 4 to the cabinet [ for Health and Family Services] the data required by this 5 section, which inc ludes the reporting of any Schedule II controlled substance 6 dispensed at a facility licensed by the cabinet and a Schedule II through 7 Schedule V controlled substance regardless of dosage when dispensed by the 8 emergency department of a hospital to an emerge ncy department patient. 9 Reporting shall not be required for: 10 1.[(a)] A drug administered directly to a patient in a hospital, a resident of 11 a health care facility licensed under KRS Chapter 216B, a resident of a 12 child -caring facility as defined by KRS 199. 011, or an individual in a 13 jail, correctional facility, or juvenile detention facility; 14 2.[(b)] A Schedule III through Schedule V controlled substance dispensed 15 by a facility licensed by the cabinet provided that the quantity dispensed 16 is limited to an am ount adequate to treat the patient for a maximum of 17 forty -eight (48) hours and is not dispensed by the emergency department 18 of a hospital; or 19 3.[(c)] A drug administered or dispensed to a research subject enrolled in 20 a research protocol approved by an inst itutional review board that has an 21 active federalwide assurance number from the United States Department 22 of Health and Human Services, Office for Human Research Protections, 23 where the research involves single, double, or triple blind drug 24 administration or is additionally covered by a certificate of 25 confidentiality from the National Institutes of Health. 26 (c)[(4)] In addition to the data required by paragraph (d) of this subsection [(5) 27 UNOFFICIAL COPY 22 RS BR 50 Page 120 of 138 XXXX Jacketed of this section] , a Kentucky -licensed acute care hospital or critical ac cess 1 hospital shall report to the cabinet all positive toxicology screens that were 2 performed by the hospital's emergency department to evaluate the patient's 3 suspected drug overdose. 4 (d)[(5)] Data for each controlled substance that is reported shall include but not 5 be limited to the following: 6 1.[(a)] Patient identifier; 7 2.[(b)] National drug code of the drug dispensed; 8 3.[(c)] Date of dispensing; 9 and 11 6.[(f)] Dispenser. 12 (e)[(6)] The data shall be provided in the electronic format specified by the 13 cabinet [ for Health and Family Services] unless a waiver has been granted by 14 the cabinet to an individual dispenser. The cabinet shall establis h acceptable 15 error tolerance rates for data. Dispensers shall ensure that reports fall within 16 these tolerances. Incomplete or inaccurate data shall be corrected upon 17 notification by the cabinet if the dispenser exceeds these error tolerance rates. 18 (f)[(7)] The cabinet [ for Health and Family Services] shall only disclose data to 19 persons and entities authorized to receive that data under this 20 subsection [section] . Disclosure to any other person or entity, including 21 disclosure in the context of a civil action w here the disclosure is sought either 22 for the purpose of discovery or for evidence, is prohibited unless specifically 23 authorized by this section. The cabinet [ for Health and Family Services] shall 24 be authorized to provide data to: 25 1.[(a)] A designated repre sentative of a board responsible for the 26 licensure, regulation, or discipline of practitioners, pharmacists, or other 27 UNOFFICIAL COPY 22 RS BR 50 Page 121 of 138 XXXX Jacketed person who is authorized to prescribe, administer, or dispense controlled 1 substances and who is involved in a bona fide specific investiga tion 2 involving a designated person; 3 2.[(b)] Employees of the Office of the Inspector General of the cabinet [ 4 for Health and Family Services] who have successfully completed 5 training for the electronic system and who have been approved to use the 6 system, fe deral prosecutors, Kentucky Commonwealth's attorneys and 7 assistant Commonwealth's attorneys, county attorneys and assistant 8 county attorneys, a peace officer certified pursuant to KRS 15.380 to 9 15.404, a certified or full -time peace officer of another stat e, or a federal 10 agent whose duty is to enforce the laws of this Commonwealth, of 11 another state, or of the United States relating to drugs and who is 12 engaged in a bona fide specific investigation involving a designated 13 person; 14 3.[(c)] A state -operated Medic aid program in conformity with subsection 15 (8) of this section; 16 4.[(d)] A properly convened grand jury pursuant to a subpoena properly 17 issued for the records; 18 5.[(e)] A practitioner or pharmacist, or employee of the practitioner's or 19 pharmacist's practice a cting under the specific direction of the 20 practitioner or pharmacist, who certifies that the requested information 21 is for the purpose of: 22 a[1]. Providing medical or pharmaceutical treatment to a bona fide 23 current or prospective patient; 24 b[2]. Reviewing dat a on controlled substances that have been reported 25 for the birth mother of an infant who is currently being treated by 26 the practitioner for neonatal abstinence syndrome, or has 27 UNOFFICIAL COPY 22 RS BR 50 Page 122 of 138 XXXX Jacketed symptoms that suggest prenatal drug exposure; or 1 c[3]. Reviewing and assessing the individual prescribing or dispensing 2 patterns of the practitioner or pharmacist or to determine the 3 accuracy and completeness of information contained in the 4 monitoring system; 5 6.[(f)] The chief medical officer of a hospital or long -term-care facility, 6 an employee of the hospital or long -term-care facility as designated by 7 the chief medical officer and who is working under his or her specific 8 direction, or a physician designee if the hospital or facility has no chief 9 medical officer, if the officer, emp loyee, or designee certifies that the 10 requested information is for the purpose of providing medical or 11 pharmaceutical treatment to a bona fide current or prospective patient or 12 resident in the hospital or facility; 13 7.[(g)] In addition to the purposes autho rized under subparagraph 1. of 14 this paragraph [ (a) of this subsection] , the Kentucky Board of Medical 15 Licensure, for any physician who is: 16 a[1]. Associated in a partnership or other business entity with a 17 physician who is already under investigation by the Board of 18 Medical Licensure for improper prescribing or dispensing 19 practices; 20 b[2]. In a designated geographic area for which a trend report indicates a 21 substantial likelihood that inappropriate prescribing or dispensing 22 may be occurring; or 23 c[3]. In a des ignated geographic area for which a report on another 24 physician in that area indicates a substantial likelihood that 25 inappropriate prescribing or dispensing may be occurring in that 26 area; 27 UNOFFICIAL COPY 22 RS BR 50 Page 123 of 138 XXXX Jacketed 8.[(h)] In addition to the purposes authorized under subparagraph 1. of 1 this paragraph [ (a) of this subsection] , the Kentucky Board of Nursing, 2 for any advanced practice registered nurse who is: 3 a[1]. Associated in a partnership or other business entity with a 4 physician who is already under investigation by the Kentucky 5 Board of Medical Licensure for improper prescribing or dispensing 6 practices; 7 b[2]. Associated in a partnership or other business entity with an 8 advanced practice registered nurse who is already under 9 investigation by the Board of Nursing for improper prescribing 10 practices; 11 c[3]. In a designated geographic area for which a trend report in dicates a 12 substantial likelihood that inappropriate prescribing or dispensing 13 may be occurring; or 14 d[4]. In a designated geographic area for which a report on a physician 15 or another advanced practice registered nurse in that area indicates 16 a substantial li kelihood that inappropriate prescribing or 17 dispensing may be occurring in that area; 18 9.[(i)] A judge or a probation or parole officer administering a diversion 19 or probation program of a criminal defendant arising out of a violation 20 of this chapter or of a criminal defendant who is documented by the 21 court as a substance abuser who is eligible to participate in a court - 22 ordered drug diversion or probation program; or 23 10.[(j)] A medical examiner engaged in a death investigation pursuant to 24 KRS 72.026. 25 (g)[(8)] The Department for Medicaid Services shall use any data or reports from 26 the system for the purpose of identifying Medicaid providers or recipients 27 UNOFFICIAL COPY 22 RS BR 50 Page 124 of 138 XXXX Jacketed whose prescribing, dispensing, or usage of controlled substances may be: 1 1.[(a)] Appropriately managed by a s ingle outpatient pharmacy or primary 2 care physician; or 3 2.[(b)] Indicative of improper, inappropriate, or illegal prescribing or 4 dispensing practices by a practitioner or drug seeking by a Medicaid 5 recipient. 6 (h)[(9)] A person who receives data or any repo rt of the system from the cabinet 7 shall not provide it to any other person or entity except as provided in this 8 subsection [section] , in another statute, or by order of a court of competent 9 jurisdiction and only to a person or entity authorized to receive t he data or the 10 report under this section, except that: 11 1.[(a)] A person specified in paragraph (f)2. of this subsection [ (7)(b) of 12 this section] who is authorized to receive data or a report may share that 13 information with any other persons specified in paragraph (f)2. of this 14 subsection [(7)(b) of this section ] authorized to receive data or a report if 15 the persons specified in paragraph (f)2. of this subsection [ (7)(b) of this 16 section] are working on a bona fide specific investigation involving a 17 designate d person. Both the person providing and the person receiving 18 the data or report under this subparagraph [paragraph] shall document in 19 writing each person to whom the data or report has been given or 20 received and the day, month, and year that the data or rep ort has been 21 given or received. This document shall be maintained in a file by each 22 agency engaged in the investigation; 23 2.[(b)] A representative of the Department for Medicaid Services may 24 share data or reports regarding overutilization by Medicaid recipi ents 25 with a board designated in paragraph (f)1. of this subsection [ (7)(a) of 26 this section] , or with a law enforcement officer designated in paragraph 27 UNOFFICIAL COPY 22 RS BR 50 Page 125 of 138 XXXX Jacketed (f)2. of this subsection [ (7)(b) of this section] ; 1 3.[(c)] The Department for Medicaid Services may submi t the data as 2 evidence in an administrative hearing held in accordance with KRS 3 Chapter 13B; 4 4.[(d)] If a state licensing board as defined in KRS 218A.205 initiates 5 formal disciplinary proceedings against a licensee, and data obtained by 6 the board is relev ant to the charges, the board may provide the data to 7 the licensee and his or her counsel, as part of the notice process required 8 by KRS 13B.050, and admit the data as evidence in an administrative 9 hearing conducted pursuant to KRS Chapter 13B, with the bo ard and 10 licensee taking all necessary steps to prevent further disclosure of the 11 data; and 12 5.[(e)] A practitioner, pharmacist, or employee who obtains data under 13 paragraph (f)5. of this subsection [ (7)(e) of this section] may share the 14 report with the pati ent or person authorized to act on the patient's behalf. 15 Any practitioner, pharmacist, or employee who obtains data under 16 paragraph (f)5. of this subsection [(7)(e) of this section ] may place the 17 report in the patient's medical record, in which case the in dividual report 18 shall then be deemed a medical record subject to disclosure on the same 19 terms and conditions as an ordinary medical record in lieu of the 20 disclosure restrictions otherwise imposed by this section. 21 (i)[(10)] The cabinet [ for Health and Famil y Services] , all peace officers 22 specified in paragraph (f)2. of this subsection [ (7)(b) of this section] , all 23 officers of the court, and all regulatory agencies and officers, in using the data 24 for investigative or prosecution purposes, shall consider the n ature of the 25 prescriber's and dispenser's practice and the condition for which the patient is 26 being treated. 27 UNOFFICIAL COPY 22 RS BR 50 Page 126 of 138 XXXX Jacketed (j)[(11) The data and any report obtained therefrom shall not be a public record, 1 except that the Department for Medicaid Services may submit the d ata as 2 evidence in an administrative hearing held in accordance with KRS Chapter 3 13B. 4 (12)] Intentional failure to comply with the reporting requirements of this 5 subsection [section] shall be a Class B misdemeanor for the first offense and a 6 Class A misdeme anor for each subsequent offense. 7 (k) If the cabinet becomes aware of a prescriber's or dispenser's failure to 8 comply with this section, the cabinet shall notify the licensing board or 9 agency responsible for licensing the prescriber or dispenser. The licen sing 10 board shall treat the notification as a complaint against the licensee. 11 (4) For the purpose of monitoring the cultivation, production, recommending, and 12 dispensing of medical cannabis: 13 (a) Every medicinal cannabis practitioner who is authorized to pro vide written 14 certifications for the use of medicinal cannabis and every licensed cannabis 15 business shall register with the cabinet to use the system provided for in this 16 section and shall maintain such registration continuously during the 17 medicinal practit ioner's authorization to provide written certifications or a 18 cannabis business's term of licensure and shall not have to pay a fee or tax 19 specifically dedicated to the operation of the system. 20 (b) No later than January 1, 2023, the cabinet shall ensure tha t the system 21 provided for in this section allows: 22 1. Medicinal cannabis practitioners to record the issuance of written 23 certifications to a patient as required by Section 11 of this Act; 24 2. Pharmacists to record the completion of consultations with 25 cardhol ders as required by Section 10 of this Act; 26 3. The cabinet, law enforcement personnel, and dispensary agents to 27 UNOFFICIAL COPY 22 RS BR 50 Page 127 of 138 XXXX Jacketed verify the validity of registry identification cards issued by the 1 Department for Public Health. When verifying the validity of an 2 identificatio n card, system shall only disclose whether the 3 identification card is valid and whether the cardholder is a registered 4 qualified patient, visiting qualified patient, or designated caregiver; 5 4. Dispensary agents to record the amount of medicinal cannabis t hat is 6 dispensed to a cardholder during each transaction, as required by 7 Section 22 of this Act; 8 5. Law enforcement personnel and dispensary agents to access medicinal 9 cannabis sales data recorded by dispensary agents pursuant to Section 10 22 of this Act; 11 6. The sharing of dispensing data recorded by dispensary agents, 12 pursuant to Section 22 of this Act, with all licensed dispensaries in 13 real time; 14 7. Licensed cannabis businesses to record data required by 15 administrative regulations promulgated pursuant to wi th Section 28 of 16 this Act to facilitate the tracking of medicinal cannabis from the point 17 of cultivation to the point of sale to cardholders; and 18 8. The cabinet to track all medicinal cannabis in the state from the point 19 of cultivation to the point of sale to a cardholder. 20 (c) The cabinet shall only disclose data related to the cultivation, production, 21 recommending, and dispensing of medical cannabis to persons and entities 22 authorized to receive that data under this subsection. Disclosure to any 23 other perso n or entity, including disclosure in the context of a civil action 24 where the disclosure is sought either for the purpose of discovery or for 25 evidence, is prohibited unless specifically authorized by this subsection. The 26 cabinet shall be authorized to provi de data to: 27 UNOFFICIAL COPY 22 RS BR 50 Page 128 of 138 XXXX Jacketed 1. Any person or entity authorized to receive data pursuant to paragraph 1 (b) of this subsection; 2 2. A designated representative of a state licensing board responsible for 3 the licensure, regulation, or discipline of medicinal cannabis 4 practitioners and who is involved in a bona fide specific investigation 5 involving a designated person; 6 3. Employees of the Office of the Inspector General of the cabinet who 7 have successfully completed training for the electronic system and 8 who have been approved to use the system, Kentucky Commonwealth's 9 attorneys and assistant Commonwealth's attorneys, and county 10 attorneys and assistant county attorneys who are engaged in a bona 11 fide specific investigation involving a designated person; 12 4. A properly convened grand jury pursuant to a subpoena properly 13 issued for the records; 14 5. A medicinal cannabis practitioner or an employe e of a medicinal 15 cannabis practitioner's practice acting under the specific direction of 16 the medicinal cannabis practitioner, who certifies that the request for 17 information is for the purpose of complying with subsection (4)(c) of 18 Section 9 of this Act; 19 6. The chief medical officer of a hospital or long -term -care facility, an 20 employee of the hospital or long -term -care facility as designated by the 21 chief medical officer and who is working under his or her specific 22 direction, or a physician designee if the ho spital or facility has no 23 chief medical officer, if the officer, employee, or designee certifies that 24 the requested information is for the purpose of providing medical or 25 pharmaceutical treatment to a bona fide current or prospective patient 26 or resident in the hospital or facility; 27 UNOFFICIAL COPY 22 RS BR 50 Page 129 of 138 XXXX Jacketed 7. In addition to the purposes authorized under subparagraph 2. of this 1 paragraph, the Kentucky Board of Medical Licensure, for any 2 physician who is: 3 a. Associated in a partnership or other business entity with a 4 physician who is already under investigation by the Board of 5 Medical Licensure for improper issuance of written 6 certifications; 7 b. In a designated geographic area for which a trend report 8 indicates a substantial likelihood that inappropriate issuance of 9 written certificat ions may be occurring; or 10 c. In a designated geographic area for which a report on another 11 physician in that area indicates a substantial likelihood that 12 inappropriate issuance of written certifications may be occurring 13 in that area; 14 8. In addition to the purposes authorized under subparagraph 2. of this 15 paragraph, the Kentucky Board of Nursing, for any advanced practice 16 registered nurse who is: 17 a. Associated in a partnership or other business entity with a 18 physician who is already under investigation by th e Kentucky 19 Board of Medical Licensure for improper issuance of written 20 certifications; 21 b. Associated in a partnership or other business entity with an 22 advanced practice registered nurse who is already under 23 investigation by the Board of Nursing for imprope r issuance of 24 written certifications; 25 c. In a designated geographic area for which a trend report 26 indicates a substantial likelihood that inappropriate issuance of 27 UNOFFICIAL COPY 22 RS BR 50 Page 130 of 138 XXXX Jacketed written certifications may be occurring; or 1 d. In a designated geographic area for which a r eport on a 2 physician or another advanced practice registered nurse in that 3 area indicates a substantial likelihood that inappropriate 4 issuance of written certifications may be occurring in that area; 5 9. A judge or a probation or parole officer administerin g a diversion or 6 probation program of a criminal defendant arising out of a violation 7 of this chapter or of a criminal defendant who is documented by the 8 court as a substance abuser who is eligible to participate in a court - 9 ordered drug diversion or probat ion program; or 10 10. A medical examiner engaged in a death investigation pursuant to KRS 11 72.026. 12 (d) A person who receives data or any report of the system from the cabinet 13 shall not provide it to any other person or entity except as provided in this 14 sectio n, in another statute, or by order of a court of competent jurisdiction 15 and only to a person or entity authorized to receive the data or the report 16 under this section, except that: 17 1. A person specified in paragraph (c)3. of this subsection who is 18 authoriz ed to receive data or a report may share that information with 19 any other persons specified in paragraph (c)3. of this subsection 20 authorized to receive data or a report if the persons specified in 21 paragraph (c)3. of this subsection are working on a bona fid e specific 22 investigation involving a designated person. Both the person providing 23 and the person receiving the data or report under this subparagraph 24 shall document in writing each person to whom the data or report has 25 been given or received and the day, m onth, and year that the data or 26 report has been given or received. This document shall be maintained 27 UNOFFICIAL COPY 22 RS BR 50 Page 131 of 138 XXXX Jacketed in a file by each agency engaged in the investigation; 1 2. If a state licensing board initiates formal disciplinary proceedings 2 against a licensee, and data obtained by the board is relevant to the 3 charges, the board may provide the data to the licensee and his or her 4 counsel, as part of the notice process required by KRS 13B.050, and 5 admit the data as evidence in an administrative hearing conducted 6 pursuant to KRS Chapter 13B, with the board and licensee taking all 7 necessary steps to prevent further disclosure of the data; and 8 3. A medicinal cannabis practitioner or an employee of a medicinal 9 cannabis practitioner's practice acting under the specific directio n of 10 the medicinal cannabis practitioner who obtains data under 11 paragraph (c)5. of this subsection may share the report with the 12 patient or person authorized to act on the patient's behalf. Any 13 medicinal cannabis practitioner or employee who obtains data u nder 14 paragraph (c)5. of this subsection may place the report in the patient's 15 medical record, in which case the individual report shall then be 16 deemed a medical record subject to disclosure on the same terms and 17 conditions as an ordinary medical record in lieu of the disclosure 18 restrictions otherwise imposed by this section. 19 (5) The data and any report obtained therefrom shall not be a public record, except 20 that the Department for Medicaid Services may submit the data as evidence in an 21 administrative hearin g held in accordance with KRS Chapter 13B. 22 (6)[(13)] Intentional disclosure of transmitted data to a person not authorized by 23 subsection (3)(f) to (h) or subsection (4)(c) and (d) [subsections (7) to (9) ] of this 24 section or authorized by KRS 315.121, or obtaining information under this section 25 not relating to a bona fide current or prospective patient or a bona fide specific 26 investigation, shall be a Class B misdemeanor for the first offense and a Class A 27 UNOFFICIAL COPY 22 RS BR 50 Page 132 of 138 XXXX Jacketed misdemeanor for each subsequent of fense. 1 (7)[(14)] The cabinet [ for Health and Family Services] may, by promulgating an 2 administrative regulation, limit the length of time that data remain in the electronic 3 system. Any data removed from the system shall be archived and subject to retrieval 4 within a reasonable time after a request from a person authorized to review data 5 under this section. 6 (8)[(15)] (a) The cabinet [ for Health and Family Services] shall work with each board 7 responsible for the licensure, regulation, or discipline of practiti oners, 8 pharmacists, or other persons who are authorized to prescribe, administer, or 9 dispense controlled substances for the development of a continuing education 10 program about the purposes and uses of the electronic system for monitoring 11 established in thi s section. 12 (b) The cabinet shall work with each board responsible for the licensure, 13 regulation, or discipline of medicinal cannabis practitioners, as defined in 14 Section 1 of this Act, who are authorized to provider written certifications 15 for the use of me dicinal cannabis for the development of a continuing 16 education program about the purposes and uses of the electronic system for 17 monitoring established in this section. 18 (c)[(b)] The cabinet shall work with the Kentucky Bar Association for the 19 development of a continuing education program for attorneys about the 20 purposes and uses of the electronic system for monitoring established in this 21 section. 22 (d)[(c)] The cabinet shall work wi th the Justice and Public Safety Cabinet for the 23 development of a continuing education program for law enforcement officers 24 about the purposes and uses of the electronic system for monitoring 25 established in this section. 26 (e) The cabinet shall work with the Department for Public Health for the 27 UNOFFICIAL COPY 22 RS BR 50 Page 133 of 138 XXXX Jacketed development of a training program for cannabis business agents about the 1 purposes and uses of the electronic system for monitoring established in this 2 section. 3 [(16) If the cabinet becomes aware of a prescriber's or di spenser's failure to comply with 4 this section, the cabinet shall notify the licensing board or agency responsible for 5 licensing the prescriber or dispenser. The licensing board shall treat the notification 6 as a complaint against the licensee.] 7 (9)[(17)] The cabinet [ for Health and Family Services] , Office of Inspector General, 8 shall conduct quarterly reviews to identify patterns of potential improper, 9 inappropriate, or illegal prescribing or dispensing of a controlled substance , 10 issuance of written certific ations, or cultivation, processing, or dispensing of 11 medical cannabis . The Office of Inspector General may independently investigate 12 and submit findings and recommendations to the appropriate boards of licensure or 13 other reporting agencies. 14 (10)[(18)] The cabinet shall promulgate administrative regulations to implement the 15 provisions of this section. Included in these administrative regulations shall be: 16 (a) An error resolution process allowing a patient to whom a report had been 17 disclosed under subsections (3) and (4) [subsection (9)] of this section to 18 request the correction of inaccurate information contained in the system 19 relating to that patient; and 20 (b) A requirement that data be reported to the system under subsection (3) (b) of 21 this section within one (1) day of dispensing. 22 (11)[(19)] (a) Before July 1, 2018, the Administrative Office of the Courts shall 23 forward data regarding any felony or Class A misdemeanor conviction that 24 involves the trafficking or possession of a controlled substance or other 25 prohibited acts under KRS Chapter 218A for the previous five (5) calendar 26 years to the cabinet for inclusion in the electronic monitoring system 27 UNOFFICIAL COPY 22 RS BR 50 Page 134 of 138 XXXX Jacketed established under this section. On or after July 1, 2018 , such data shall be 1 forwarded by the Administrative Offic e of the Courts to the cabinet on a 2 continuing basis. The cabinet shall incorporate the data received into the 3 system so that a query by patient name indicates any prior drug conviction . 4 (b) Before January 1, 2023, the Administrative Office of the Courts s hall 5 forward data regarding any disqualifying felony offense for the previous 6 five (5) calendar years to the cabinet for inclusion in the electronic 7 monitoring system established under this section. On or after January 1, 8 2023, such data shall be forwarded by the Administrative Office of the 9 Courts to the cabinet on a continuing basis. The cabinet shall incorporate 10 the data received into the system so that a query by patient name indicates 11 any prior disqualifying felony conviction . 12 Section 42. KRS 218A.500 is amended to read as follows: 13 As used in this section and KRS 218A.510: 14 (1) \"Drug paraphernalia\" means all equipment, products and materials of any kind 15 which are used, intended for use, or designed for use in planting, propagating, 16 cultivating, growing, harvesting, manufacturing, compounding, converting, 17 producing, processing, preparing, testing, analyzing, packaging, repackaging, 18 storing, containing, concealing, injecting, ingesting, inhaling, or otherwise 19 introducing into the human body a controlled substance in violation of this chapter. 20 The term \"drug paraphernalia\" does not include medicinal cannabis accessories 21 as defined in Section 1 of this Act. It includes but is not limited to: 22 (a) Kits used, intended for use, or designed for use in planting, propagating, 23 cultivating, growing, or harvesting of any species of plant which is a 24 controlled substance or from which a controlled substance can be derived; 25 (b) Kits used, intended for use, or designed for use in manufactu ring, 26 compounding, converting, producing, processing, or preparing controlled 27 UNOFFICIAL COPY 22 RS BR 50 Page 135 of 138 XXXX Jacketed substances; 1 (c) Isomerization devices used, intended for use, or designed for use in increasing 2 the potency of any species of plant which is a controlled substance; 3 (d) Testing e quipment used, intended for use, or designed for use in identifying, 4 or in analyzing the strength, effectiveness or purity of controlled substances; 5 (e) Scales and balances used, intended for use, or designed for use in weighing or 6 measuring controlled sub stances; 7 (f) Diluents and adulterants, such as quinine hydrochloride, mannitol, mannite, 8 dextrose and lactose, used, intended for use, or designed for use in cutting 9 controlled substances; 10 (g) Separation gins and sifters used, intended for use, or designed for use in 11 removing twigs and seeds from, or in otherwise cleaning or refining 12 marijuana; 13 (h) Blenders, bowls, containers, spoons, and mixing devices used, intended for 14 use, or designed for use in compounding controlled substances; 15 (i) Capsules, balloons, envelopes, and other containers used, intended for use, or 16 designed for use in packaging small quantities of controlled substances; 17 (j) Containers and other objects used, intended for use, or designed for use in 18 storing or concealing controlled substances ; 19 (k) Hypodermic syringes, needles, and other objects used, intended for use, or 20 designed for use in parenterally injecting controlled substances into the human 21 body; and 22 (l) Objects used, intended for use, or designed for use in ingesting, inhaling, or 23 otherwise introducing marijuana, cocaine, hashish, or hashish oil into the 24 human body, such as: metal, wooden, acrylic, glass, stone, plastic, or ceramic 25 pipes with or without screens, permanent screens, hashish heads, or punctured 26 metal bowls; water pipes; carburetion tubes and devices; smoking and 27 UNOFFICIAL COPY 22 RS BR 50 Page 136 of 138 XXXX Jacketed carburetion masks; roach clips which mean objects used to hold burning 1 material, such as marijuana cigarettes, that have become too small or too short 2 to be held in the hand; miniature cocaine spoons, and cocaine vials; chamber 3 pipes; electric pipes; chillums; bongs; ice 4 pipes or chillers. 5 (2) It is unlawful for any person to use, or to possess with intent to use, drug 6 paraphernalia for the purpose of planting, propagating, culti vating, growing, 7 harvesting, manufacturing, compounding, converting, producing, processing, 8 preparing, testing, analyzing, packing, repacking, storing, containing, concealing, 9 injecting, ingesting, inhaling, or otherwise introducing into the human body a 10 controlled substance in violation of this chapter. 11 (3) It is unlawful for any person to deliver, possess with intent to deliver, or 12 manufacture with intent to deliver, drug paraphernalia, knowing, or under 13 circumstances where one reasonably should know, that it will be used to plant, 14 propagate, cultivate, grow, harvest, manufacture, compound, convert, produce, 15 process, prepare, test, analyze, pack, repack, store, contain, conceal, inject, ingest, 16 inhale, or otherwise introduce into the human body a controlled substance in 17 violation of this chapter. 18 (4) It is unlawful for any person to place in any newspaper, magazine, handbill, or othe r 19 publication any advertisement, knowing, or under circumstances where one 20 reasonably should know, that the purpose of the advertisement, in whole or in part, 21 is to promote the sale of objects designed or intended for use as drug paraphernalia. 22 (5) (a) This section shall not prohibit a local health department from operating a 23 substance abuse treatment outreach program which allows participants to 24 exchange hypodermic needles and syringes. 25 (b) To operate a substance abuse treatment outreach program under this 26 subsection, the local health department shall have the consent, which may be 27 UNOFFICIAL COPY 22 RS BR 50 Page 137 of 138 XXXX Jacketed revoked at any time, of the local board of health and: 1 1. The legislative body of the first or home rule class city in which the 2 program would operate if located in such a city; and 3 2. The legislative body of the county, urban -county government, or 4 consolidated local government in which the program would operate. 5 (c) Items exchanged at the program shall not be deemed drug paraphernalia under 6 this section while located at the progr am. 7 (6) (a) Prior to searching a person, a person's premises, or a person's vehicle, a peace 8 officer may inquire as to the presence of needles or other sharp objects in the 9 areas to be searched that may cut or puncture the officer and offer to not 10 charge a person with possession of drug paraphernalia if the person declares to 11 the officer the presence of the needle or other sharp object. If, in response to 12 the offer, the person admits to the presence of the needle or other sharp object 13 prior to the search, t he person shall not be charged with or prosecuted for 14 possession of drug paraphernalia for the needle or sharp object or for 15 possession of a controlled substance for residual or trace drug amounts present 16 on the needle or sharp object. 17 (b) The exemption un der this subsection shall not apply to any other drug 18 paraphernalia that may be present and found during the search or to controlled 19 substances present in other than residual or trace amounts. 20 (7) (a) This section shall not prohibit the retail sale of hypo dermic syringes and 21 needles without a prescription in pharmacies. 22 (b) Hypodermic syringe and needle inventory of a pharmacy shall not be deemed 23 drug paraphernalia under this section. 24 (8) Any person who violates any provision of this section shall be guilty of a Class A 25 misdemeanor. 26 Section 43. KRS 342.815 is amended to read as follows: 27 UNOFFICIAL COPY 22 RS BR 50 Page 138 of 138 XXXX Jacketed (1) The authority may provide coverage for insurance, authorized in KRS 342.803, to 1 any employer in the Commonwealth, and who tenders the required premium for 2 coverage and comply with other conditions and qualifications for obtaining and 3 maintaining coverage adopted by the authority to protect and ensure its actuarial 4 soundness and solvency. 5 (2) The authority shall provide coverage to any em ployer who is unable to secure 6 coverage in the voluntary market unless : 7 (a) The employer owes undisputed premiums to a previous workers' 8 compensation carrier or to a workers' compensation residual market 9 mechanism ; or 10 (b) Providing coverage to the employer would subject the authority or its 11 employees to a violation of federal or state law . 12 Section 44. Section 2, Sections 4 to 8, Section 11, Sections 13 to 15, Sections 13 18 to 25, Section 30 , and Sections 37 to 43 of this Act take effect July 1, 2023. 14 "}